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Ethnobotanical knowledge of plants’ medicinal use could make a contribution to 
bioprospecting by identifying plants to target for drug discovery. In recent years, 
methods to investigate the medicinal uses of flowering plants using a phylogenetic 
framework have been developed. Drugs derived from higher plants are prevalent, and 
ferns are relatively neglected. Thus, this thesis investigates the evolutionary patterns 
amongst fern species that are used medicinally using phylogenetic tools at a range of 
taxonomic and spatial scales, from global to regional scales, for the first time.  
 
Dense sampling at species levels may be critical for comparative studies, thus an 
updated fern megaphylogeny focusing on four gene regions, rbcL, rps4, atpA and atpB 
was reconstructed. This large-scale phylogeny comprises more than 3500 fern species in  
273 genera and 47 families, covering over a quarter of extant global fern species. To 
evaluate the medicinal importance of ferns, a database based on a comprehensive 
review of records published in books, journals or in online sources including databases 
was assembled. The use database comprised 3220 use-reports for 442 species, and 
showed that approximately 5% of total estimated extant fern species have a documented 
therapeutic use, but only 189 species have become the focus of screening concerning 
their bioactivity properties.  
 
Using a comprehensive phylogenetic tree and medicinal data from the database, species 
used in traditional medicine were shown to be significantly dispersed across the fern 
phylogeny, contrary to previous findings in many similar studies of flowering plants. 
Whatever the hierarchical level or spatial scale investigated, the results consistently 
found evidence of phylogenetic overdispersion of medicinal use, suggesting more 
exploration of medicinal uses in a phylogenetic context is required before the generality 
of this approach is globally accepted. Finally, safety and toxicity of ferns that are used 
as medicine and food were also explored, since fern consumption can pose a serious 
health risk. The distributions of toxic compounds and arsenic hyperaccumulation in 
ferns were investigated using taxonomic and phylogenetic approaches in order to access 
the risk to consumers. Overall, assessment of toxicity in ferns is still limited and 
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Chapter  1. General Introduction 
 
1.1 General introduction  
 
1.1.1 What are medicinal plants? 
 
Medicinal plants are defined as plants that contain substances or properties which can 
be used for therapeutic purposes. They are generally considered to play a beneficial role 
in health care (Srivastava et al., 1996; Odugbemi, 2008). Whether the use of medicinal 
plants in traditional systems are efficacious or not is controversial (Calixto, 2000; 
Saslis-Lagoudakis et al., 2012). The continued use of plants in traditional cultures 
maybe because of their perceived magical or symbolic importance. There maybe no 
scientific proof of efficacy, but beliefs are passed verbally from one generation to the 
next generation by elders or shamans (Chin, 2005; Van Wyk & Wink, 2004).  
 
It is estimated that more than 50,000 species of Angiosperms have been used for 
medicinal purposes (Schippmann et al., 2002) in the form of crude drugs, as tinctures, 
powders, teas, poultices or other herbal formulations (Balunas & Kinghorn, 2005; 
Lewis & Elvin-Lewis, 1995). The majority may have been used in the treatment and 
prevention of disease for thousands of years (Samuelson, 1999) and many have been 
documented in local folk pharmacopeias or in ancient literature (Ebbell, 1937; 
Unschuld, 1986; Saito, 2000). According to the World Health Organization (WHO), 
many developing countries still rely on traditional medicinal plants for their healthcare 
needs (Gurib-Fakim, 2006; Hamann, 1991; Van Wyk & Wink, 2004). The importance 
of medicinal plants has gained considerable attention amongst the scientific community 




since documentation of medicinal plants is not only crucial for conservation but also 
assists in the search for new drugs (Cox & Balick, 1994; Balick & Cox, 1996; Heinrich, 
2000; Fabricant & Farnsworth, 2001; Sheng-Ji, 2001; Heinrich & Bremner, 2006; Gu et 
al., 2014). The value of medicinal plants to human livelihoods is significant since 
collecting and trading medicinal plants provides an additional source of income for 
local communities (Hamilton, 2004). 
 
The Doctrine of Signatures may seem to be an irrational concept found in many of the 
healing cultures around the world. The concept is based on the appearance of plants 
providing signs or clues to their medicinal properties. For example, bile and jaundice 
are believed to be treated by yellow flowering plants, and the human shape of particular 
roots is associated with the female form and fertility. It has been suggested that the 
placebo effect may apply to plants perceived in this way when those species with 
characteristics resembling the disease treated maybe seen to be more effective by 
patients (Bennett, 2007). However, sometimes, plants identified through Doctrine of 
Signature are proven efficacious. For example, Chelidonium majus has yellow flowers 
and a yellow alkaloid containing latex that has successfully been used to treat jaundice 
(Gurib-Fakim, 2006; Van Wyk & Wink, 2004). 
 
1.1.2 Medicinal plants and the pharmaceutical industry 
 
In a survey published in 2001, Fabricant and Farnsworth described 122 compounds 
from only 94 species of plants that are used globally as drugs (Fabricant & Farnsworth, 
2001). It seems that plants are important sources of leads for the pharmaceutical 
industry since plants are able to synthesize an enormous variety of potentially medicinal 




of genus Taxus provided a new chemotherapy drug to treat ovarian and breast cancer 
(Cragg, 1998; Goodman & Walsh, 2001). Other drugs derived from medicinal plants 
include campthothecins from Camptotheca acuminata used for cancer treatment (Sriram 
et al., 2005), etopside from Podophyllum peltatum used to treat variety of tumors (Van 
Maanen et al., 1988) and tiotropium, a derivative of atropine from Atropa belladonna 
used to treat chronic obstructive pulmonary disease (Barnes et al., 1995; Balunas & 
Kinghorn, 2005). With more than 400,000 species of land plant (Govaerts, 2001), there 
may be an abundance of potential drug leads remaining to be discovered.  
 
Ethnobotanical data could make a tremendous contribution to bioprospecting by 
identifying plants for drug discovery. Fabricant and Farnsworth (2001) showed of the 
122 drug compounds from plants and demonstrated that 80% have identical or related 
ethnomedicinal uses. However, ethnobotanical bioprospecting has been criticized 
because some traditionally used medicinal plants may not be efficacious, resulting in 
disappointing outcomes (Firn, 2003; Saslis-Lagoudakis et al., 2012). In addition to this, 
the ethnomedicinal information collection process from primary sources requires 
extended periods of ethnobotanists’ time, thus increasing the financial cost (Cox & 
Balick, 1994). Furthermore, difficulties in agreeing prior informed consent and 
negotiating benefit sharing for traditional knowledge acts to limit international research 
(Ningthoujam et al., 2012). Nevertheless, surveying and understanding how medicinal 
plants are selected for traditional use, and predicting which plants might yield important 







1.1.3 Medicinal plants and public health 
 
The popularity of traditional medicine globally is associated with ease of access, ‘low 
cost’ and the assumption of safety. This assumption is based on the perception that 
plants are ‘natural’, but there is evidence that many plants contain carcinogenic and 
toxic compounds. These toxins have proven to be associated with numerous health 
problems. For instance, pyrrrolizidine alkaloids (PAs) were the amongst the first 
compounds demonstrated to have carcinogenic activities (Bull, 1955; Mattocks, 1968; 
Hirono, 1987; Chan et al., 2003; Chen et al., 2010) and they are present in various 
plants, some of which are used as food and herbal remedies (Hirono, 1987). Since then, 
many carcinogenic principles were isolated from plants such as Ptaquiloside (PTA) that 
has been found in a variety of ferns and which can cause cancer in farm animals (Saito 
et al., 1989; Saito et al., 1990), and aristolochic acid in species of Aristolochia that is 
associated with a high incidence of upper urinary tract cancer (Michl et al., 2013). 
Reliance on medicinal plants in developing countries raises concerns about exposure to 
toxins since many traditional herbal medicines known to contain toxic compounds are 
still used (Roeder & Wiedenfeld, 2013) but cases of negative side effects from 
consuming these plants as herbal medicines are rarely reported in the literature. Apart 
from naturally-occurring carcinogenic chemical compounds present in some medicinal 
plants, contamination by heavy metals such as cadmium, chromium, lead and arsenic 
should also be a major concern. For example, several medicinal plants in Brazil (Caldas 
& Machado, 2004) and some herbal dietary supplements in Mexico (García-Rico et al., 
2007) have been shown to contain dangerous amounts of heavy metals resulting in 





In addition to the health risks associated with traditional medicinal plant use if the 
medicinal species are toxic, adverse effects of herbal products may also result from 
other factors. From the cultivation of medicinal plants to the final herbal products, 
factors such as adulteration, substitution, contamination, misidentification, lack of 
standardization or incorrect preparation may influence their quality and safety (Woo, 
2000; Zhang et al., 2012). For example, seven cases of toxicity were identified in 
infants following the home administration of star anise tea, attributable to the 
adulteration of Chinese star anise (Illicium verum) with toxic Japanese star anise 
(Illicium anisatum) (Ize-Ludlow et al., 2004). With the great growth and worldwide 
interest in using complementary and alternative medicine (CAM) involving herbal 
medicines (Barnes et al., 2004; Hyodo et al., 2005; Hornerber et al., 2011), authorities 
have been charged with ensuring the safety of imported plant medicines through newly 
enacted legislation. In the United Kingdom, for instance, the Medicines and Healthcare 
Products Regulatory Agency (MHRA) is responsible for herbal medicine safety, while 
in other countries, such as Malaysia and Singapore, the regulation of herbal medicines is 
controlled by their Ministries of Health (Woo, 2000; Jayaraj, 2010). Nevertheless, risks 
associated with herbal medicines still occur if individual consumers who have bought 
products from overseas for their own use are unaware of ‘hidden’ ingredients which 
may cause serious toxic effects (Miller, 1998; Coghlan et al., 2012). Therefore, greater 
control over the safety of herbal medicines could be achieved not only through a global 
improvement in regulatory processes, but also through greater awareness among 







1.1.4 Ferns as medicinal plants  
 
It has been reported that different fern species have been used for the health benefits 
they provide and to treat various ailments throughout the world since antiquity (Winter 
& Amoroso, 2003; Van Wyk & Wink, 2004; Chin, 2005; Srivastava, 2007; Mannan et 
al., 2008). These uses have either been transmitted orally, from generation to 
generation, or recorded in pharmacopoeia (Chin, 2005; Van Wyk & Wink, 2004). 
Despite literature describing medicinal use of ferns for a variety of diseases, interesting 
biological activities of few ferns are known. Antioxidant activity has been reported in 
various ferns such as Adiantum capillus-veneris (Kumar, 2009), Blechnum orientale, 
Stenoclaena palustris and Dicranopteris linearis (Lai et al., 2010; Lai & Lim, 2011; 
Chai et al., 2012) while antimicrobial activity has been reported in Osmunda regalis 
(Thomas, 2011), Athyrium filix-femina and Pleopeltis macrocarpa (Kumarpal, 2013).  
Some of these biological activities support the traditional use of fern species. 
 
1.2 New methods for investigating medicinal plants  
 
This study uses a phylogenetic framework to interrogate published use data, newly 
compiled here, and explore the evolutionary patterns amongst fern species that are used 
medicinally and the distribution of known toxins in ferns. The use of phylogeny 
alongside existing use data is emerging as a new method in medicinal plant research 








1.2.1 Applications of phylogenetic methods 
 
Phylogenetic predictivity has been a principle used to justify phylogenetic research, for 
example in conservation biology (Vane-Wright et al., 1991; Faith, 1992) as well as the 
possibility of using phylogenies to guide bioprospecting (Smith & Wheeler, 2006). The 
application of phylogeny to understanding medicinal plants has included studies of the 
distribution of phytochemicals (Wink, 2003; Wink & Mohamed, 2003; Muellner et al., 
2005) and studies of the ethnobotanical use in a phylogentic context (Saslis-Lagoudakis 
et al., 2011; Saslis-Lagoudakis et al., 2012; Yessoufou et al., 2015). Whilst phylogenetic 
methods are emerging as a way of understanding how organisms have and could be 
used, phylogeny has hardly been used to predict health risks of exposure to plants or 
animals. The investigation of the phylogeny of the diatom genus Pseudo-nitzschia is 
one exception (Trainer et al., 2012).  
 
Combined phylogenetic and phytochemical studies have revealed that there is strong 
phylogenetic signal in the distribution of chemical constituents in plants (Wink, 2003; 
Rønsted et al., 2008; Rønsted et al., 2012), which can be applied in finding new sources 
of natural products. Nevertheless, chemical data for the majority of species are 
unavailable and can be costly to generate. Recent studies also have shown that species 
with traditional medicinal use are not randomly scattered within plant lineages. These 
studies have shown that phylogenetic tools can reveal whether plant lineages are 
independently selected, and whether related plants find a similar use (Lukhoba et al., 
2006; Forest et al., 2007; Saslis-Lagoudakis et al., 2011; Saslis-Lagoudakis et al., 2012; 
Yessoufou et al., 2015; Ernst et al., 2016). These findings were interpreted to indicate 
that closely related plant species share the same medicinal properties, implying 




1.2.2 Meta-analysis: compilation and interrogation of published use data 
 
As ethnobotanical data are scattered in various publications in different languages with 
limited accessibility and application, initiatives are needed to collect all the data into a 
centralized database for easy reference (Gaikwad et al., 2011). Nowadays, with the 
increasingly rapid development of information technology (IT), computerized databases 
have become an indispensable tool for managing, compiling, disseminating and 
analyzing large amounts of data in diverse arenas. 
 
Several of the published studies using phylogeny have depended on the compilation and 
use of published data. For example, studies using data sets compiled from literature 
have tested whether there are global patterns of plant use between distantly related 
peoples (Saslis-Lagoudaskis et al, 2012), and determined the relative importance of 
different drivers of plant selection at national levels (de la Torre et al., 2012; de 
Madeiros et al. 2013; Saslis-Lagoudaskis et al, 2014). Indeed, there has been a call for 
meta-analysis in ethnobotany, as it is increasingly recognized that there may be patterns 
in use, which are informative of the processes acting on cultures and plants 
(Albuquerque & de Medeiros, 2012; de Medeiros et al, 2013).  
 
1.3 A summary of aims and an overview of the structure of this thesis  
 
This thesis describes the finding of three years of study of medicinal ferns. The relative 
lack of interest in medicinal ferns, compared to flowering plants, means that a synthesis 
of the relatively dispersed literature describing medicinal fern use can provide new 
insights into the ways in which ferns have been selected and used in traditional 




and databases have been reconstructed to explore the patterns of fern species that are 
used medicinally throughout the globe and at the same time predict the risk related with 
medicinal species.  
 
Previous studies have greatly improved our understanding of fern evolution and 
provided a backbone for modern classification. Phylogeny reconstructed using 
molecular, morphological or combined molecular and morphological data have revealed 
many major branches of the fern tree of life and in this light the classification of ferns 
has been revised and updated (Smith et al., 2006a; Christenhusz et al., 2011). The most 
comprehensive fern phylogeny to date represents over one-fifth of extant global fern 
diversity, so understanding of the relationships between ferns is fairly good (Lehtonen, 
2011). However, many species are unplaced and these could include economically 
important species. In addition, there are still some controversies in the exact position of 
several families and some genera are still poorly defined thus further studies for certain 
families must be undertaken. One of the factors contributing to the lack of clarity 
regarding fern relationships is probably a lack of data. Therefore a more comprehensive 
approach with a larger dataset and more taxa could contribute to more robust phylogeny 
and provide a pivotal platform to for future hypothesis-driven ecological, 
biogeographical and other related studies of ferns. As publically available sequence data 
are accumulating from ongoing phylogenetic studies, a global analysis using a denser 
sampling than a previous fern megaphylogeny (Lehtonen, 2011) was performed 
(Chapter 2). This ‘supermatrix’ analysis not only permits exploration of large-scale 
evolutionary patterns in ferns, but also permitted further evaluation of their utilities 




Existing data on medicinal use of fern species was compiled into a single source of 
comprehensive literature in one database (Chapter 3). The application of this database is 
to facilitate the storage of data for fern species throughout the globe, access to, and use 
any relevant data for further analyses (Chapter 4 and Chapter 5). A review of the 
pharmacological of medicinally-used ferns was also made (Chapter 3), to point out the 
gap between modern pharmacological knowledge and traditional uses of ferns.  
 
The phylogenetic relatedness of ferns that are used medicinally were explored for the 
first time in Chapter 4. This investigation focussed on exploring patterns at different a 
range of spatial scales, from global to continental and regional/national scales by using 
methods from phylogenetic community ecology.  
 
It is desirable to recognize which fern species that are used medicinally have been 
shown to contain toxic properties. Finally, Chapter 5 highlights specifically the presence 
of PTA and arsenic hyperaccumulation in ferns that are used for human consumption as 
a food or medicine. Many of these species have close relatives that may also be toxic. 
By using data on medicinal use of ferns from Chapter 3 and the reconstructed fern 
phylogeny from Chapter 2, Chapter 5 also investigates the phylogenetic distribution of 
toxic plant as this might suggest which groups are likely to have the same properties and 









To summarize, this thesis comprises four main chapters that include data analysis:  
 
 Chapter 2 presents a phylogeny based on a supermatrix approach focusing on 
four gene regions; rbcL, rps4, atpA, and atpB, mostly based on published 
sequences available in Genbank; 
 Chapter 3 consists of the compilation of a database to describe the traditional use 
of medicinal ferns and what is known about their pharmacology; 
 Chapter 4 focuses on an investigation of large-scale phylogenetic patterns 
amongst fern species that are used medicinally; 
 Chapter 5 reviews the toxicity and carcinogenicity of ferns, focussing on PTA 
and arsenic hyperaccumulation by fern species, especially on species that are 
used as traditional medicine or eaten as vegetables. The chapter assesses the 
distribution of known toxins, taking a taxonomic and phylogenetic approach to 























Ferns (monilophytes sensu (Pryer et al., 2001)), also known as pteridophytes, comprise 
approximately 9,000 to 12,000 species (Smith et al., 2006; Lehtonen, 2011; 
Christenhusz & Chase, 2014) and are sister to the seed plants (Pryer et al., 2001). In a 
recent classification, ca. 280 genera in 45 families were recognized (Christenhusz et al., 
2011). Since then, two new families have been created; Hemidictyaceae (Christenhusz 
& Schneider, 2011) and Arthropteridaceae (Liu et al., 2013) and changing generic limits 
informed by phylogenetic studies have resulted in an increase in the number of genera 
to 287 genera (Appendix 2.1). 
 
Higher-level classification of ferns and their allies was unstable until the first molecular 
phylogenies were published in the mid-1990s (Wolf et al., 1994; Gastony & Rollo, 
1995; Hasebe et al., 1995; Pryer et al., 1995; Wolf, 1995). Since then, numerous 
phylogenetic studies based on DNA sequences or combined molecular and 
morphological data have either densely sampled genera or families (e.g. Hennequin et 
al., 2003 (Hymenophyllum);  Rouhan et al., 2004 (Elaphoglossum); Hauk et al., 2003 
(Ophioglossaceae); Korall et al., 2007 (Cyatheaceae)) or sought a robust backbone for 
the fern phylogeny by sampling exemplar species of higher taxa (Pryer et al., 2001; 
Pryer et al., 2004; Qiu et al., 2006; Schuettpelz et al., 2006; Qiu et al., 2007; Schneider 
et al., 2009; Rai & Graham, 2010). The latter have consistently shown ferns comprise 
five major extant lineages, horsetails, psilotophytes (whisk ferns), ophioglossoid ferns, 




placed horsetails and whisk ferns together with Lycopodiales and Selaginellales, the 
“fern allies” (Bidin, 1986; Parris & Latiff, 1997). As a result, the focus of phylogenetic 
enquiry and phylogenetically informed classifications has become the monophyletic 
‘monilophyte’ or ‘fern’ clade (Christenhusz et al., 2011; Lehtonen, 2011; Christenhusz 
& Chase, 2014). Ongoing phylogenetic studies at family/genus level, or testing the 
backbone fern phylogeny by sampling exemplar species or higher taxa continues to 
generate new sequence data. Nevertheless, relationships between several major clades 
still remain unresolved and polyphyletic and paraphyletic genera are common in many 
lineages, so that generic delimitation within the important families still needs further 
investigation.  
 
Whist backbone and clade-specific phylogenies can be the basis of revised 
classifications, a need for large, densely sampled phylogenies to address broad 
evolutionary questions is increasingly recognized  (Smith et al., 2009; Legume 
Phylogeny Working Group, 2013; Särkinen et al., 2013; Antonelli et al., 2014; Qian & 
Zhang, 2014; Qian & Jin, 2015). New analytical approaches have been developed for 
reconstruction of extremely large phylogenetic trees using publically available 
molecular data; the so-called ‘supermatrix’ or ‘mega-phylogeny’ analyses (Driskell et 
al., 2004; de Queiroz & Gatesy, 2007; Smith et al., 2009; Lehtonen, 2011; Lewis et al., 
2013; Qian & Zhang, 2014; Qian & Jin, 2015). Massive molecular data sets can be 
retrieved from databases such as Genbank, combined into a single, large and 
comprehensive matrix, and used to infer phylogenies to address large-scale evolutionary 
questions. A mega-phylogeny for ferns exists. Lehtonen (2011) generated a phylogeny 
representing more than one-fifth of extant global fern diversity representing 2656 taxa 




likelihood analyses. Nevertheless, several phylogenetic relationships still could not be 
completely resolved and many comparative studies often require more species than are 
available in previous phylogenies (Pearse & Purvis, 2013). For instance, for community 
ecology, some species in which ecologist are interested is not available in such trees, 
making difficult to test any hypotheses in macroevolutionary studies (Pearse & Purvis, 
2013). Furthermore, many species names in previous ferns megaphylogeny also were 
not currently accepted names, since the names applied to terminal taxa were those used 
on genbank.  
 
2.1.1  Objectives 
 
Lehtonen’s (2011) study is the benchmark for fern megaphylogeny. The primary 
objective of this study is to update Lehtonen’s megaphylogeny by adding all the 
available data for the same regions;  rbcL, rps4, atpA, and atpB. Chloroplast regions 
were selected in this study since they have been widely used in the majority of fern 
phylogenetic studies. Furthermore, these genes are variable enough to provide good 
resolution across the taxonomic diversity of fern taxa (Lehtonen, 2011; Prado et al., 
2007). In the five years since his work, many additional sequences have been generated, 
but to date, there has been no update published. The objective of this study is to 
generate a more densely sampled tree which can be used for further analysis in Chapter 
4 and Chapter 5. In order to generate a phylogeny fit for purpose, it is also necessary to 
sequence de novo some medicinal ferns not represented in Genbank. 
 
Ultimately, the tree would be made available so it could be used in other evolutionary 
research on ferns, such as in ecological and community phylogenetic and 




changes are made. Standardization of species nomenclature is essential when the study 
involves sequence data deposited over a period of time when many nomenclature 
changes have taken place. Genbank names are not currently accepted names, and this 
limits the utility of any phylogeny with names following Genbank. Hence, a second 
objective is that the nomenclature will be updated, rather than using names as available 
on Genbank, to produce a more user-friendly phylogeny.  
 
The topology of the phylogeny will be checked by comparison to existing phylogenetic 
hypotheses. This ensures the phylogeny is fit for future use, and does not include any 
anomalous relationships. This study also aims to investigate whether there are 
taxonomic or geographic biases in the availability of sequence data for the ferns, and to 
suggest a sampling strategy to address these biases. 
 
2.2 Materials and Methods 
 
2.2.1  Data assembly and taxonomic sampling 
 
Four chloroplast protein-coding genes, rbcL, rps4, atpA, and atpB, were selected for this 
study. These are genes which have been used extensively to infer fern phylogeny in 
recent years (Pryer et al., 2001; Pryer et al., 2004; Schneider et al., 2004; Schuettpelz et 
al., 2006; Schuettpelz & Pryer, 2007; Lehtonen, 2011). All sequence data available by 
November 2014 were downloaded for the root node “Moniliformopses’ from Genbank 
using Geneious Basic (http://www.geneious.com/download). These data were then 





For each gene region, hybrid taxa and unidentified species (species identified to genus 
level only e.g., Adiantopsis sp. MLP-2011-1) were eliminated. If multiple or duplicate 
sequences were available for the same taxon, only one sequence, the longest most 
complete one was retained. In total, 3713 fern sequences including ten generated de 
novo for this study (Section 2.2.2) were accepted and six outgroups, one lycophyte and 
five seed plants, were included in the analysis (Appendix 2.2). 
 
A list of accepted names of ferns in the Genbank (NCBI) list was updated since many 
species names did not follow the latest fern taxonomy and nomenclature. At family and 
genus levels, the NCBI list was restructured based on Christenhusz et al. (2011) 
(Appendix 2.1), with some minor changes in family and generic classification to reflect 
more recent studies (Appendix 2.3). At species level, names in the NCBI list were 
checked and matched with the currently accepted name based on the three international 
authority plant databases; Tropicos (2016), Catalogue of Life (2016) and IPNI (2005) in 
order to apply revised synonymy and to standardize spelling of plant names. If the taxon 
name appeared two or more times with different authors in Tropicos (2016) or 
Catalogue of Life (2016), the taxon name used was the one in the publication linked to 
Genbank’s sequence record.  
 
2.2.2  DNA isolation and amplification 
 
New sequences were generated to make the phylogeny fit for further analysis in Chapter 
4. The species sequenced are detailed in Table 2.1. Genomic DNA was extracted from 
0.3 to 0.5 g of leaf tissue from herbarium or silica-gel dried material using a 





Table 2.1 List of generated sequences included in the phylogenetic analysis. 
Taxon Collection site/Location Voucher 
specimen number 
Alsophila latebrosa Taman Paku pakis, UKM, Malaysia MM001 (UKMB) 
Alsophila contaminans Taman Paku pakis, UKM, Malaysia MM003 (UKMB) 
Cheilanthes tenuifolia Taman Paku pakis, UKM, Malaysia MM004 (UKMB) 
Dicranopteris curranii New Guinea MK13594 (UC) 
Diplazium cordifolium Taman Paku pakis, UKM, Malaysia MM005 (UKMB) 
Gleichenia vulcanica New Guinea ML2530 (UC) 
Hypolepis repens Las Casas de la Selva, Puerto Rico Every24 (RNG) 
Lygodium flexuosum Taman Paku pakis, UKM, Malaysia MM006 (UKMB) 
Lygodium longifolium Taman Paku pakis, UKM, Malaysia MM007 (UKMB) 
Sphaeropteris moluccana Taman Paku pakis, UKM, Malaysia MM002 (UKMB) 
 
The rbcL gene region was amplified using the primers shown  in Table 2.2. The PCR 
amplification was conducted in 20 µl reactions containing 19 µl of PCR Mastermix 
(0.75 μL of each primer at 10 μM, 0.5 μL of 2.5 μg/μL BSA solution, 0.2 μL 5% 
DMSO, 6.8 μL purified water and 10 μL Biomix Red) and 1 µl of template DNA (~ 10-
200 ng). The PCR protocol included 5 min initial denaturation (94o C), and followed by 
33 cycles of 45 sec denaturation (94oC), 30 sec annealing (45oC), and 2 min elongation 
(72oC) with a final elongation step of 5 min (72oC). PCR products were cleaned with 
the QIAquick PCR Purification Kit (Qiagen) following the manufacturer’s protocol with 
a final elution of 30 μL EB buffer. All purified PCR products were sent to Source 
Bioscience (Oxford, United Kingdom) to be sequenced. Contiguous sequences were 
assembled using the SeqMan program (DNASTAR, Lasergene). All sequences were 





Table 2.2 All the primers used in this study are from Schuettpelz and Pryer (2007). 
Region Name Sequence 5' - 3' 





  ESRBCL654RS GAARCGATCTCTCCAACGCAT 
 
2.2.3  Sequence alignment and phylogenetic analysis 
 
Sequences for each dataset were aligned in MUSCLE (Edgar, 2004) under default 
settings. The alignments then were checked and edited manually using BioEdit 7.25 
(Hall, 1999). The 5′ and 3′ ends containing high proportions of missing data were 
trimmed using TrimAI (Capella-Gutiérrez et al., 2009).  
 
The four alignments were concatenated to form a multigene matrix using Mesquite 2.74 
(Maddison & Maddison, 2001). Two methods, Maximum Likelihood (ML) and 
Bayesian Inference (BI) are currently the most widely used methods to infer large 
phylogenetic relationships. These methods introduce an evolutionary-model based on 
statistical methods which have the potential to search and evaluate different possible 
trees. However, running BI over a thousand species can take a very long time compared 
with ML using shortcuts, as recent improvements of the RaxML algorithm provide 
reasonable time for large dataset to be analysed (Roquet et al., 2012). Therefore, 
phylogenetic analysis for the combined four gene dataset in this study was conducted 
under the Maximum Likelihood (ML) criterion and the GTRGAMMA Model in 
RaxMLv7.2.8 (Stamatakis et al., 2008) implemented in the CIPRES web-portal. Branch 





2.2.4  Assessment of taxonomic bias in data availability 
 
To explore taxonomic sampling biases, the number of species in the dataset and the 
estimated diversity for each order and family were recorded. In most cases, estimates of 
species numbers for each order and family followed Smith et al. (2006), except where 
family limits had changed since this treatment. Estimated diversity for these families 
was recalculated based on more recent publications. General regression for all analyses 
were carried out in Microsoft Excel 2007 using log-transformed values for total number 
of taxa represented in the phylogeny as the dependent (y) variable, and total estimated 
diversity as the independent (x) variable.  
 
An audit of fern nucleotide sequence data against the current taxonomy held in the 
dataset was also conducted to identify genera for which no nucleotide sequence data 
from any genomic regions were available in Genbank. These genera were compiled 
based on the list of accepted names of fern genera (Appendix 2.1). The geographical 
range information derived from published papers was also added to the list of missing 
genera. 
 
2.3 Results and Discussion 
 
2.3.1 Availability of sequence data and nomenclatural updates 
 
Five coding regions, rbcL, atpA, atpB, rps4 and matK, were most often used for 
phylogeny reconstruction. The most frequently sequenced gene region was rbcL with 
7627 sequences available, followed by rps4 (3480), atpB (2311) and atpA (1016) 
(November, 2015). The matK region, with 922 sequences, was the least represented. 




amplification and alignment (Kress et al., 2005). Furthermore, rbcL has been shown to 
be useful in addressing phylogenetic relationships at a variety of taxonomic levels for 
ferns (Gastony & Rollo, 1995; Hasebe et al., 1995; Dubuisson, 1997; Lu et al., 2007; 
Prado et al., 2007). rbcL was one of the two regions selected as core barcoding regions 
(CBOL Plant Working Group, 2009). In contrast, matK, the other region selected as 
core barcode, is much less frequently sequenced. matK is embedded within a trnK 
intron and can be amplified using primers targeting the flanking trnK exons. Difficulties 
in amplication due to absence of  the flanking trnK exons in 90% of fern species (Duffy 
et al., 2009; Li et al., 2011) is probably one of the reasons why matK is less available in 
Genbank compared to other regions. The implications of different gene sequence 
availability across land plants are felt in the representation of ferns in land plant 
megaphylogenies. For example, Zanne et al. (2014) sampled seven regions (18S rDNA, 
26S rDNA, ITS, matK, rbcL, atpB, and trnL-F) but included only 518 fern species far 
fewer than the 3713 included. 
 
This number, 3719 including outgroup taxa, remained after removing the multilple 
accessions of the same taxon and unidentified taxa. The numbers of characters and taxa 
for each alignment and for the final matrix are shown in Table 2.3. The matrix of all 
taxa by four genes had 7875 missing gene sequence entries (53% missing data) and 
nearly half of the sampled taxa were represented by single gene (45%). Only 11% 
represented by all four genes. Most taxa were represented by the rbcL gene (94%) 
which has been shown to resolve some difficult problems in the phylogeny of green 
plants, even without other data (Chase et al., 1993; Smith et al., 2009). Though half of 




reconstructed robustly in such cases, if enough characters are included in the analysis 
(Wiens, 2003; Philippe et al., 2004; Wiens, 2006). 
 
Table 2.3 Alignment details in this study.  
Dataset Characters (bp) Taxa 
rbcL 1426 3477 
rps4 427 1570 
atpB 1278 1065 
atpA 1505 889 
Combined 4636 3719 
 
The phylogeny in this study updates Lehtonen’s (2011) megaphylogeny by 
incorporating 1057 more species from publically available databases. Hence, the 
taxonomic sampling employed here was broader than the previous best-sampled fern 
phylogenetic analysis and can be used to test the monophyly of currently accepted 
genera and families. It also makes 60 nomenclatural updates at generic level (Appendix 
2.3) and 480 updates from Genbank names following recent publications, so that the 
tree presented uses currently accepted names of species. There were 26 unresolved  
names applied to accessions in Genbank. For the purposes of interpretation, the 
sequences were considered to represent genera according to the most recent treatment. 
For example, the unresolved name Parathelypteris beddomei is considered here to 
represent a species of Amauropelta based on Almeida et al., (2016) (Appendix 2.2.). 
Furthermore, our finding also found that Parathelypteris beddomei is nested within in 
Amauropelta clade.  
 
Changes in taxonomic names for ferns result from major changes in fern classification 
in recent studies. As large-scale name changes are still ongoing, especially in several 
controversial genera, large databases such as Genbank are prone to accumulate 




on analysis of a massive amount of sequence data that are currently publically available, 
it is vulnerable to the outdated name or synonomy issue. We considered it important to 
update the taxon names based on clearly cited publications. Genera or other higher taxa 
may appear non-monophyletic in the supermatrix tree, especially to non-taxonomists, 
when species are not updated with the current accepted name. For instance, in the 
previous supermatrix study, Hymenophyllum exiguum (Hymenophyllaceae) was not 
updated with the current accepted name even though there was already a taxonomic 
revision of this family (Ebihara et al., 2006). This species was embedded in 
Didymoglossum apparently rendering the genus paraphyletic. By using the accepted 
names in this study, it will make the investigation of the monophyly of currently 
accepted genera and families much easier. As an alternative to the approach taken here, 
a single source of accepted names could be used, for instance, the Taxonomic Name 
Resolution Service or TNRS, an application for correcting and standardizing taxonomic 
names. Using a single source of accepted names and software of this kind may facilitate 
the further interpretation and use of the phylogeny since the software can also be used to 
interrogate other databases. On the other hand, the single sources of taxonomic data that 




2.3.2 Phylogenetic analyses and tree topology 
 
The concatenated dataset for 3719 terminals included 4636 characters, of which 3496 
were variable and 2981 were parsimony informative (Dataset F1). The resulting 
phylogeny included  47 families and 273 genera of ferns, and is presented here as a 




collapsed (Figure 2.2) and as a tree file (Dataset F2). At the outset, it was not expected 
that the phylogeny would have a more resolved or better supported backbone than the 
several phylogenies using exemplars and many more regions to reconstruct higher level 






















































Figure 2.1 Phylogram of ferns based on maximum likelihood analysis. The early divergences are expanded in the inset (a) and all 





























































Figure 2.2 Maximum likelihood phylogeny.Maximum likelihood bootstrap values are indicated next to nodes, and  nodes are collapsed to show families. Bootstrap values ≥90 are abbreviated (*) and bootstrap values ≥ 
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Overall, the phylogeny is consistent with the prevailing view of fern higher level 
relationships (Hasebe et al., 1995; Pryer et al., 2001; Pryer et al., 2004; Schneider et al., 
2004; Schuettpelz et al., 2006; Schuettpelz & Pryer, 2007; Lehtonen, 2011). In the early 
divergences within ferns, the controversial family Equisetaceae is found resolved  as 
sister to Marattiaceae (BS=62) and the osmundaceous ferns are well supported as sister 
to the rest (BS=99) consistent with previous fern phylogenetic studies (Pryer et al., 
2001; Pryer et al., 2004; Schneider et al., 2004; Wikström & Pryer, 2005; Schuettpelz et 
al., 2006; Schuettpelz & Pryer, 2007). However, this finding contradicts some recent 
studies based on nuclear and mitochondarial loci, that discovered strong support for 
Equisetales as sister to the rest of ferns (Knie et al., 2015; Rothfels et al., 2015). These 
patterns suggest that multigene datasets incorporating nuclear and mitochondrial 
sequence could improve support, and resolve uncertainties in monilophyte phylogeny. 
Therefore, it is critical to test plastid phylogeny with nuclear and mitochondrial genes 
on further fern phylogeny studies toward a more complete understanding of ferns 
relationships. Our analysis identified the schizaeiod ferns (Lygodiaceae, Anemiaceae 
and Schizaeaceae) as a well-supported (BS=81) sister to a large clade, the so-called 
‘core leptosporangiates’ that consist of heterosporous, tree and polypod ferns. Within 
polypods, most of the clades are well supported, but several relationships among them 
are poorly supported (BS<50). The majority of the families in the polypods are 
separated into two large eupolypod clades; ‘eupolypods I’ and ‘eupolypods II’ 
corresponding with previous studies (Schneider et al., 2004; Lehtonen, 2011). 
Pteridaceae is resolved as sister to the whole of the eupolypod clade, congruent with the 
previous published study of Schuettpelz and Pryer (2007), however this relationship is 
poorly supported (BS=26). Most short backbone internodes, particularly in eupolypods 




inference. The ‘ancient rapid radiations’, long branches that are intercalated with short 
internal nodes, are also a prominent feature in previous fern phylogenetic studies 
(Schuettpelz & Pryer, 2007; Lehtonen, 2011). That multigene studies provide improved 
support at deeper nodes is exemplified by the study by Rai and Graham (2010) using a 
large set of plastid genes (17 genes) but relatively few exemplar taxa to represent fern 
lineages. Increasing the number of gene regions in this phylogeny could improve the 
poor resolution or low support in the deeper nodes. However, data mining in Genbank 
for more regions for large-scale fern phylogeny reconstruction will generate matrices 
with a high proportion of missing data. In the context of supermatrix analyses, these 
missing data will result in a decline in support values (Sanderson & Wojciechowski, 
2000). In addition, some analytical shortcuts in large datasets with high proportions of 
missing data present serious computational challenges that may compromise some 
approaches and results (Lehtonen, 2011). In any case, for many applications of 
phylogeny, phylogenetic uncertainty in the backbone has relatively little impact on 
analysis outcomes, at least compared to uncertain placement of missing species (Rangel 
et al., 2015). 
 
Family-level relationships and family delimitations in this study are also largely 
consistent with the recently published linear fern classification based on phylogeny 
(Christenhusz & Schneider, 2011; Christenhusz et al., 2011). All families are 
monophyletic in our study, except Tectariaceae. The position of Arthropteridaceae 
nested within Tectariaceae does not correspond to the currently accepted family sensu 
Liu et al. (2013). The sampling of Arthropteridaceae and Tectariaceae in previous 
studies has not revealed this relationship. Liu’s study included eight species of Tectaria 




classification is attributed to denser sampling not problems with our phylogenetic 
reconstruction. Overall, 41 out of 47 families have high bootstrap support (BS=>95).  
 
Most of the clades recovered here are consistent with currently accepted generic limits 
and exceptions have been previously reported. In Ophioglossaceae, Ophioglossum 
lusitanum is grouped together with Helmintostachys zeylanica as in Lehtonen (2011) 
while in Gleicheniaceae, Gleichenia is not resolved as monophyletic although other 
genera in this family are resolved as monophyletic. Dennstaedtia is found to be strongly 
paraphyletic (BS=100), due to the inclusion of the monophyletic Microlepia as in 
previous studies (Schuettpelz & Pryer, 2007; Lehtonen, 2011). 
 
In Pteridaceae, numerous of the pteridoid genera are monophyletic including Adiantum  
which was not well resolved in previous studies (Prado et al., 2007; Schuettpelz & 
Pryer, 2007; Schuettpelz et al., 2007; Bouma et al., 2010). However, generic limits need 
reconsideration where polyphyly seems to be rampant in several of the largest genera 
within this family. Eight genera, Anogramma, Monogramma, Doryopteris, Cheilanthes, 
Notholaena, Pellaea, Paragymnopteris and Aleuritopteris, are found not monophyletic; 
all these genera have already been highlighted as problematic in previous studies (Prado 
et al., 2007; Schuettpelz & Pryer, 2007; Schuettpelz et al., 2007; Rothfels et al., 2008; 
Bouma et al., 2010; Lehtonen, 2011). 
 
Increased sampling with updated nomenclature in this study supports recent generic 
reclassifications. The placement of Pleocnemia in Dryopteridaceae is consistent with 
the current study by  Liu et al. (2014). Dracoglossum, previously placed in 




with the study by Christenhusz et al. (2013) which suggested that Dracoglossum should 
be placed in Lomariopsidaceae. Several genera in this study such as Amauropelta 
(including some Parathelypteris species), Steiropteris, Coryphopteris (including some 
Parathelypteris species), Oreopteris, Metahelypteris, Cyclogramma, Macrothelypteris, 
Phegopteris, Pseudophegopteris and Stegnogramma are shown to be monophyletic, 
these results also support current generic limits in Thelypteridaceae proposed by 
Almeida et al. (2016), contradicting Lehtonen’s megaphylogeny (Lehtonen, 2011) 
which showed a polyphyletic Thelypteris. However, the Cyclosorus clade is still 
polyphyletic and requires further attention.  
 
Within Polypodiaceae, most genera are resolved as monopyletic, including 
Zygophlebia, contradicting previous studies which found Zygophlebia nested within 
Enterosora, or sister to it (Sundue et al., 2010; Sundue et al., 2014). Delimitation of 
Lepisorus changed when Paragramma was placed in synonymy with Lepisorus 
(Hennipman et al., 1990). In this study, Paragramma longifolia (Lepisorus longifolius) 
is resolved as the sister to all Lepisorus, congruent with the previous phylogeny 
sampling fewer lepisoroids (Kreier et al., 2008; Wang et al., 2010a; Wang et al., 2010b) 
thus supporting the acceptance of Paragramma as a genus. There are still many genera 
found to be polyphyletic, such as Grammitis, Oreogrammitis and Radiogrammitis. 
These genera were also polyphyletic in a recent less inclusive study (Sundue et al., 
2014). 
 
The majority (99%) of sequence data in this study was retrieved from Genbank, and it is 
well known that some erroneous identifications are present in Genbank. Several species 




three notable misplaced samples are Vandenboschia speciosa found sister to the core 
leptosporangiates and Taenitis pinnata  and Thelypteris augescens are found embedded 
in Pteris clade. When blasted in NCBI, none of these problematic sequences find 
sequence similarity with their congeners, which suggest a wrong identification or 
laboratory error for these sequences. Furthermore, poor sequence alignment also may 
contribute to incorrect placement of taxa. The detailed analysis of alignment conditions 
was not further explored here because of the complexity of assessing length variation in 
many thousands of sequences. For future work, these problematic species should be 
pruned from the tree. Duplicate or more sequences for sequence entries should also be 
included, rather just one sequence per taxon, to increase the possibility of detecting any 
erroneous identification or laboratory error and to highlight putatively non-
monophyletic species. 
 
2.3.3 Assessment of taxonomic bias in missing data 
 
This study includes 3713 out of the 9490 fern species recognised by Smith et al. (2006) 
and in more recent publications, representing 39% of the total diversity. This is a major 
increase in the number of species sampled in comparison with the previous fern 
megaphylogeny of Lehtonen (2011). This improvement will facilitate a variety of 
further analysis at the species level. Overall, the taxonomic coverage of individual 
orders and families varied greatly (Table 2.4 and Table 2.5). At ordinal level, 
Osmundales, Equisetales, Ophioglossales and Salviniales were best sampled with more 
than 60% of taxa sampled. Three orders, Gleicheniales, Schiziaeales and Cyatheales had 





Table 2.4 Taxonomic coverage and residual analysis at order-level. Estimated diversity per order were recorded following recent publications in 
family level (Christenhusz et al., 2011). Residual values are –ve for orders sampled less than ferns overall; a positive value indicates orders 
sampled more. 
 
Order Taxa included in this present study Estimated diversity % taxa in tree Residuals 
Equisetales 19 23 83 0.2 
Ophioglossales 50 80 63 0.1 
Psilotales 5 12 42 -0.2 
Marattiales 74 150 49 0.0 
Osmundales 19 20 95 0.2 
Hymenophyllales 204 600 34 -0.1 
Gleicheniales 41 140 29 -0.2 
Schizaeales 44 155 28 -0.2 
Salviniales 55 91 60 0.1 
Cyatheales 173 663 26 -0.2 
Polypodiales 3029 7556 40 0.2 









Table 2.5 Taxonomic coverage and residual analysis at family-level. Taxonomy follows 
Christenhusz et al., (2011) with updates following Christenhusz & Schneider, (2011),  Rothfels 
et al., (2012) and Liu et al., (2013). Estimated diversity for each family were recorded based on 
several publications; 1Smith et al., (2006), 2Des Maraies et al., (2003), 3Lehtonen et al. (2012),   
4 Korall et al. (2006), 5Rothfels et al. (2013),6Rothfels et al., (2012),7Nooteboom 
(2012),8Christenhusz et al. (2013),9Hovenkamp and Miyamoto (2005), 10Moran et al. (2014), 
11Hovenkamp and Ho (2012). Residual values are –ve for families sampled less than ferns 
overall; a positive value indicates families sampled more. 
Families 
Taxa included in 
this present study 
Estimated 
diversity 
% taxa in tree 
Residuals 
Equisetaceae 2 19 23 83 0.2 
Ophioglossaceae1 50 80 63 0.1 
Psilotaceae1 5 12 42 -0.2 
Marattiaceae1  74 150 49 0.1 
Osmundaceae1 19 20 95 0.2 
Hymenophyllaceae1 204 600 34 0.0 
Gleicheniaceae1 32 125 26 -0.2 
Dipteridaceae1 5 11 45 -0.1 
Matoniaceae1 4 4 100 0.1 
Lygodiaceae1 15 25 60 0.0 
Schizaeaceae1 10 30 33 -0.2 
Anemiaceae 1 19 100 19 -0.4 
Marsileaceae1 42 75 56 0.1 
Salviniaceae1 13 16 81 0.1 
Thyrsopteridaceae1 1 1 100 0.0 
Loxsomataceae1 2 2 100 0.1 
Culcitaceae1  2 2 100 0.1 
Plagiogyriaceae1 10 15 67 0.0 
Cibotiaceae1 9 11 82 0.1 
Cyatheaceae1  133 600 22 -0.2 
Dicksoniaceae1 14 30 47 -0.1 
Metaxyaceae1 2 2 100 0.1 
Lonchitidaceae 3 2 2 100 0.1 
Saccolomataceae1 4 12 33 -0.3 
Cystodiaceae4 1 1 100 0.0 
Lindsaeaceae1 104 200 52 0.1 
Dennstaedtiaceae1 46 170 27 -0.2 
Pteridaceae1 602 950 63 0.3 
Cystopteridaceae5 32 38 84 0.2 
Aspleniaceae1 255 700 36 0.1 
Diplaziopsidaceae6 4 6 67 0.0 
Thelypteridaceae1 196 950 21 -0.2 
Woodsiaceae6 21 35 60 0.1 
Rhachidosoridaceae6  4 7 57 -0.1 
Onocleaceae6  6 10 60 0.0 
Blechnaceae1 118 200 59 0.2 
Athyriaceae6  205 600 34 0.0 
Hypodematiaceae7 7 15 47 -0.1 
Dryopteridaceae1 574 1700 34 0.1 
Lomariopsidaceae8  9 40 23 -0.4 
Nephrolepidaceae9  19 29 66 0.1 
Tectariaceae10 84 290 29 -0.1 
Oleandraceae11  6 20 30 -0.3 
Davalliaceae1 29 65 45 0.0 
Polypodiaceae1 689 1500 46 0.2 
Hemidictyaceae6 1 1 100 0.0 













Of the 47 families presented here, five small families and three monotypic families were 
fully sampled while the largest families such as Dryopteridaceae and Polypodiaceae 
stand out with more than 30% of the known diversity sequenced respectively (Table 
2.5). Despite the density of sampling in this study, several larger families remained 
poorly sampled. For instance, Thelypteridaceae is a widespread family with ca. 950 
species worldwide (Smith et al., 2006). Several relationships within this family, 
particularly in the christelloid clade (e.g. Christella and Sphaerostephanos) are still not 
fully resolved as in previous studies (Almeida et al., 2016)  though only 21% of these 
species are represented (Table 2.5). Therefore, improved understanding of the genera 
within this family as well as other problematic genera is still needed, by adding more 
additional taxa in sampling in order to make a robust assessment to the monopyly and 
also to clarify the generic delimitation. Futhermore, increasing sampling of taxa in a 
phylogenetic analysis will result in more accurate estimates of overall phylogeny by 
dispersing homoplasy across the tree and eventually reducing the effect long branch 
attraction (Pollock et al., 2002; Heath et al., 2008).  
 
Regression analyses indicated the presence of a strong linear positive relationship 
between the number of sampled taxa in this study against total estimated diversity by 
order and family level with an R2 of 95% and 96%, respectively (Figure 2.3 and Figure 
2.4). The directions of the residuals (positive and negative) indicate whether a family or 
order are over or under-sampled (Table 2.4 and Table 2.5). Compared with the 39% 
overall density of sampling, there are several lineages at the family level that are over-
presented such as Pteridaceae, Osmundaceae and Cystopteridaceae while 
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Figure 2.3 Relationship between the total estimated diversity at order level and the 
















Figure 2.4 Relationship between the total estimated diversity at family level and the 
species in this study. 
 
 





















































It is necessary to sample all ca. 287 accepted genera to move towards a phylogeny of 
ferns fully sampled at species level. In order to achieve this goal, a list of accepted 
names of fern genera was compiled based on Christenhusz et al. (2011) and was 
updated to take account of subsequent taxonomic generic changes. This study indicated 
that there are only three small genera and six monotypic genera from six families 
representing 15 species for which no nucleotide sequence data is available from any 
genomic region up to November 2015 (Table 2.6). Among these, generic level sampling 
gaps are mostly in Polypodiaceae where three monospecific genera remain unsampled. 
The missing genera are mainly from tropical regions, notably South East Asia. There 
are two genera, Nephopteris and Oenotrichia for which sequence data have been added 
to Genbank during preparation of this chapter which are not included in the phylogeny.  
One genus, Arthrobotrya for which sequence data is available in Genbank was not 
included in the phylogeny as it only represented by a region, rps4-trnS. 
 
Table 2.6 Accepted names of fern genera based on Christenhusz et al. (2011) for which 
there is no sequence data deposited in Genbank (November 2015). Their geographic 
distribution and the number of species is indicated. 
 
Family Accepted name 
(Generic) 
Number of species in the genus and its 
geographical distribution 
Dryopteridaceae Dryopolystichum 1sp; New Guinea to Solomons 
 Stenolepia 2 sp; Malesia 
Lindsaeaceae Xyropteris 1 sp; Borneo and Sumatera 
Lomariopsidaceae Thysanosoria 1sp; Indonesia 
Tectariaceae Aenigmopteris 5 sp; Malaysia, Indonesia, Philippines and 
New Guinea 
Pteridaceae Tryonella 2 sp; Brazil 
Polypodiaceae Luisma 1sp; Columbia 
 Paraselliguea 1 sp; Borneo 





One factor that might negatively influence the assemblage of fern nucleotide data in 
Genbank is authors reporting on DNA sequences yet intentionally failing to deposit 
their sequences in Genbank (Noor et al., 2006). Another possible explanation might be 
unsuccessful molecular work (due to difficulties of extracting and sequencing) or 
problems in collecting species or identifying them. These finding suggest that sampling 
from existing herbarium and targeted field work for underpressented species or missing 
species in unsampled genera, especially in Southeast Asia, a priority region, need to be 




With the advent large sequence databases such as Genbank as a rich repository of 
phylogenetically relevant information at the molecular level, many attempts are being 
made to reconstruct large phylogenetic trees that may include from hundreds to 
thousands of sequences. Generally, four primary factors that will affect the accuracy of 
molecular phylogenetic estimates; i) selection of appropriate target gene for analysis; ii) 
collection of enough sequence data; iii) the use of accurate of analytical methods and iv) 
adequate taxon sampling for the group interest (Judd et al., 1999). 
 
The utilities of molecular data over the past decades have provided a better 
understanding of fern classification (Christenhusz et al., 2011). Lehtonen (2011) 
generated fern megaphylogeny based on four genes and 2656 fern taxa, inferring the 
first supermatrix-based fern pylogeny. Nevertheless, the taxonomy and nomenclature in 
the previous fern megaphylogeny are outdated to some degree and several types or 
errors exist in the phylogeny. Hence, this present study here provides the most 




taxa than previously, thus representing over one-third of the extant global fern diversity. 
The taxonomy and nomenclature in this fern megaphylogeny also was updated 
according to the recent revision of the fern classification from the current publications 
and has a potential to be used in addressing other evolutionary research, such as 
ecological, biogeographical and community phylogenetic questions particularly those 
seeking for a pattern of phylogenetic properties (e.g. phylogenetic relatedness). In the 
context of this thesis, the phylogeny will be used to better understand the selection and 
use of ferns in herbal medicine systems. 
 
However, in terms of taxonomic understanding for fern classification, some genera need 
still need to be the focus of further work for their generic redefinition, such as pteridoid 
genera and several larger families in eupolypods. Several internal nodes also were not 
well supported, as expected, given several known issues. Molecular phylogenetic data 
sets have been increasing and there has been a growing effort to use as much available 
sequence data as possible to construct very large trees. Furthermore several program 
such as MUSCLE (Edgar, 2004) together with phylogenetic analysis programs such as 
RAxML (Stamatakis et al., 2008) have made it possible to assemble and analyze larger 
data sets than ever before. A more stable tree topology may be achieved by overcoming 
uneven sampling of lineages and loci. In conclusion, the megaphylogeny of ferns 
presented here provided a much wider view for future studies. Inclusion of missing 
lineages, increasing number of loci with addition of nuclear markers and and taxon 
sampling are critically needed, specifically those poorly sampled in hyperdiverse 
families in order to refine generic delimitation. Adding fuller sampling of extinct clades 
may hold greatest promise for resolving the overall pattern of fern phylogeny (Rothwell 




genes not only improve the tree topology but also enable moving even closer to a full 






















































Since ethnobotanical data are scattered in various publications and in different 
languages with limited accessibility, initiatives are needed to collect data into a 
centralized database for easy reference (Gaikwad et al., 2011). A database of this kind 
will eventually facilitate further studies by other researchers. Many researchers around 
the world have been involved in compiling traditional knowledge of medicinal plants, 
and many studies have been published in the form of dissertations or theses, in journals, 
proceedings, articles, books or monographs and technical reports (Mat-Salleh & Latiff, 
2002). There is no recent, comprehensive synthesis of ferns used medicinally. 
 
Ferns (monilophytes) are found in most terrestrial habitats, but most species are found 
in the wet tropics (Benniamin, 2011; Chin, 2005; Winter & Amoroso, 2003). Almost all 
parts of ferns, including the stems, rhizomes, leaves, young fronds and shoots can be 
used in some way, for example as a source of food and beverages, fertilizer, for 
ornament, material for crafts or building and not least as medicines (Chin, 2005; 
Mannan et al., 2008; Srivastava, 2007; Winter & Amoroso, 2003). Ferns may be 
particularly important in the Chinese system of medicine (Kimura & Noro, 1965) and 
other indigenous system of medicine (Pan et al., 2014). A number of fern species have 
been reported in traditional pharmacopoeias and are continuously used in herbal 
medicine in many countries (Puri, 1970). A critical review may reveal more medicinal 




2000 years (Chin, 2005; Benniamin, 2011). A recent study conducted in Brazil showed 
that low recording of ferns as medicine can be attributed to inadequate data collection, 
but also to the perception that these plants are inferior to flowering plants in their 
therapeutic value. However, when appropriate data collection methods are used, the 
proportion ferns used medicinally is as high as the proportion flowering plants used 
medicinally (dos Santos Reinaldo et al., 2015). 
 
Medicinal plants comprise a rich source of compounds with a variety of 
pharmacological activities. As many ferns have been used as folk medicine, some of 
them have become the focus of research concerning their bioactive constituents. 
Numerous compounds especially phenol and phenolic glycosides such as tannins, 
coumarins and their glycosides, quinones, flavonoids and related compounds, alkaloids, 
terpenoids and steroids have been isolated from fern species, suggesting they are an 




To date, all information regarding the medicinal uses of ferns is scattered in various 
publications, including digital resources. The first objective of this project is to compile 
data on medicinal use of fern species throughout the globe into a single comprehensive 
literature source. This ‘Medicinal Ferns Database’ will facilitate access to data, and can 
be used for further analysis. By gathering a large quantity of information, therapeutic 





Secondly, pharmacological and biological activities (e.g., anthelmintic activity, 
antitumor activity, antimicrobial, anti-inflammatory activity and antioxidative activity) 
will be compiled for all medicinal species in this study. This database might therefore 
be used to evaluate the likely efficacy of these traditional medicines. 
 
3.2  Materials and methods 
 
3.2.1  Database structure 
 
A database for medicinal uses of ferns data has been constructed using Microsoft 
Access 2007, since it is the most economic relational database solution suitable for 
small databases or academic purposes. Eventhough the older version of Microsoft 
Access was used, there is no limit in term of the data storage as well as the input 
functionality as the data entry forms and queries functionality in this study are quite 
basic. Twenty three data fields excluding the identification key have been defined and 














The database is being maintained directly using the Microsoft Access 2007 application. 
This includes the development and maintenance activities and data entry. Four main 
interfaces were created to enable data entry into the database, which are referred to as 
forms in Microsoft Access terminology. The four main forms are shown in the screen 

















































3.2.2  Sourcing data  
 
Ethnobotanical field surveys focussed on ferns are scarce, so in addition to the 21 
publications focussed on ethnopteridology we identified, use reports were sourced from 
general surveys. Journals, books, reports from national, regional and international 
organizations, and online databases were scrutinized and the information related to ferns 
extracted. An extensive search for literature/articles including information about 
ethnomedicinal uses of plants was made using Google Scholar, PUBMED and ISI Web 
of Science. The key words “ethnobotany”, “ethnobotanical”, “ethnomedicinal”, 
“ethnopharmacological”, “medicinal” and “medicinal plant” were used independently or 
in combination with the term “ferns” or “pteridophytes”. All the sources, including  
Figure 3.3 Form for data entry for references. These are the sources of each reference type 




books, were examined for information about the ferns used medicinally. For each 
source it was recorded whether the findings were substantiated by citing herbarium 
specimens. Whether vernacular names or specified uses (therapeutic application, plant 
part used, mode of application) were provided was recorded for each source.  
 
From the sources identified, use reports were compiled, where a use report is the 
species’ scientific name and all the associated data originating from one publication for 
that name (one row in Appendix 3.1). The associated information included therapeutic 
application, plant part used, mode of preparation and application and vernacular name. 
For each report, the country/region where the report originated was recorded; reports 
were assigned to botanical continents following Brummitt et al. (2001).  
 
The three additional fields for the species with documented ethnomedicinal use were as 
follows. The IUCN Red List 2015 was used to record the conservation status of all the 
medicinal ferns recorded here. The pharmacological and toxicological studies of these 
species also were recorded (Appendix 3.2). To document these properties in the 
database, a critical analysis of existing pharmacological literature was made, by 
searching for the accepted name and most common synonyms along with the following 
terms; “pharmacological”, “anthelmintic activity”, “antitumor activity”, 
“antimicrobial”, “anti-inflammatory activity”, “antiviral activity”, “antioxidative 
activity” and “bioactivity” and “toxicological”  in combination with species name or 







3.2.3  Standardizing data  
 
The nomenclatural history of ferns has been unstable, so the scientific names in the 
literature were often not those currently accepted. For this study, family and generic 
classification followed  Christenhusz et al. (2011) with some minor changes based on 
more recent studies (Christenhusz & Schneider, 2011; Rothfels et al., 2012; Liu et al., 
2013). When a species name in a publication was considered a synonym of a currently 
accepted name, we use the current accepted name to resolve synonymy and correct 
spelling errors. All names, including the authors’ names used here have been checked 
against Tropicos (2016) and Catalogue of Life (2016). Appendix 3.1 reports both names 
as used in the source publication and the currently accepted name.  
 
Therapeutic applications were recorded as in the source, and then grouped into 14 
categories (Heinrich et al., 1998); cardiovascular problems/blood purity (CB), 
dentistry/mouth (DM), gastro-intestinal (GI), gynaecology/fertility (GF), neurological 
conditions (NC), ophthalmology (OP), musculo-skeletal (MS), skin 
conditions/dermatology (SD), otorhinolaryngology (OT), respiratory/pulmonary (RP), 
urinary conditions (UC), poisonous animal bites (PA), general health problem (GR) and 





Table 3.1 Circumscription of therapeutic application categories. The 14 therapeutic application categories follow Heinrich et al. (1998). 
The therapeutic applications as described in the source publication are assigned to Heinrich’s categories. 
Therapeutic application categories Therapuetic application as described in the source 
Cardiovascular problems/blood purity (CB) 
 
Blood purification/purifier/depurative, high/low blood pressure, heart strength, cardio/ heart problem, cardiac infection, 
cardioac problem, circulatory disorder, hematocarthartic,  hypocholesterolemia, chest pain,  angina pectoris, spleen 
treatment, antihemorragic, venous problem,  arteriosclerosis, depurative of blood, hyperlipidemia, hypertension. 
Dentistry/mouth (DM) 
 
Bleeding gums, toothache/odontalgia, mouth sore, mouth blister, mouth infection, dental neuralgia,  
Periodontitis/pyorrhea, mouth infection, tongue blemish, tongue ulcer, unhealthy tongue, dentirifice. 
Gastro-intestinal (GI) 
 
Stomach problem (stomachache/stomach pain, stomach ulcer/peptic ulcer, stomach cancer, stomach acidity, stomach 
cramp)  gastric,anthelmintic/vermifuge/vermicide, diarrhea,dysentery,emetic/vomiting/nausea, carminative, dyspepsia, 
indigestion, digestion problem, diabetes, constipation, intestinal problem, jaundice, appendicitis, liver problem, nausea, 
hepatitis, enteritis, colitis, laxatives/purgative, hepatic disease, aperient, hemorrhoids, pancreas problem, hematemesis. 
Gynecology/fertility (GF) 
 
Gynecological problem, women problem, white discharge/leucorrhea, syphilis, gonorrhea, menstrual promoters, 
menstrual problem, menstrual pain/ dysmenorrhea,  uterine contractors, uterus problem, ovarian cyst, emmenagogue, 
menorrhagia, uterine hemorrhage, female haemorrhage, abortion, delivery pain, male/female fertility, venereal diseases, 
prostate problem, aphrodisiac, child birth problem, facilitate childbirth, mastitis, contraceptive, postpartum recovery. 
Neurological conditions (NC) 
 
Epilepsy, sedative, convulsion, sciatica pain, insomnia, sleep disorder, antidepressant, encephalitis, nervous system 
problem, spastic, meningitis, mental problem, amnesia, neuralgia. 
Ophthalmology (OP) Eye problem/opthalmic, ophthalmia,  sore eyes, indolent ulcer, eye infection, conjunctivitis. 
Musculo-skeletal (MS) 
 
Fracture in bone, body pain,waist pain, joint pain, muscle pain, muscle problem,  rheumatism, sprain cramps, abdominal 
pain, knee aching, bone injuries/problem, arthritis, backache, lumbago, gout, arthralgia, rickets. 
Skin conditions/dermatology (SD) 
 
Any skin disease/problem, skin wound and cut, swelling, skin irritation, skin rashes, skin itching, skin ulcer, astringent, 
dandruff, scalp, hair growth,  hair problem, hair loss, boils, eczema, emmolient, scabies, seborrheic dermatitis, leprosy, 
burn and scalds, bruise, carbuncle, leucoderma, scald, abscess, nail separation. 
Poisonous animal bites (PA) Scorpion-sting, snakebite, insect bite, honeybee sting. 
Otorhinolaryngology (OT) 
 
Catarrh, ear infection/problem, nose problem, nosebleed, sinusitis, throat infection, deafness, pharyngitis, tinnitus,  
laryngopharyngitis,  nasopharyngeal infection. 
Respiratory/pulmonary (RP) 
 
Respiratory disorders, lung problem, cough (antitussive), cold, bronchitis problem, asthma, expectorant, tuberculosis, 
phthisis, haemoptysis, pneumonia. 
Urinary conditions (UC) 
 
Kidney problem/disorders, kidney inflammation, kidney swelling, kidney stones, diuretic, urinary problem/ cystitis, 
urethritis, urolithiasis, urinary calculus, renal problem, renal calculus, bladder complaints, hematuria,   nephritis. 
General health problem (GR) 
 
Fever, anodyne, health tonic (for body strength), headache, antioxidant, antibacterial, antiviral, antifungal, febrifuge, 
sickness, food poisoning, general pain, fatigue. 













































Figure 3.4 Parts of a fern. The terminology used here for plant part categories is 
illustrated. 
 
As the nomenclature for the parts of ferns is sometimes confused, plant parts used were 
recorded exactly as in the source, then standardized (Figure 3.4; Table 3.2). Modes of 
preparation and application as reported in the literature were also standardized (Table 










Table 3.2 Plant part use categories. Each plant part as reported in the source literature is 
assigned to one of nine categories. 
 
Plant part categories Part used as reported in the source 
Aerial part                                                                                                 Aerial part, frond and rhizome, frond and stem  
Frond                                                                                                            Frond, leaf and stem,
Leaflet/pinnae Leaf, pinna, pinnule, leaf and spore 
Whole plant Whole plant, all parts of the plant 
Stalk Stem, stipe, hard part, leaf stalk, nodal lump, 
petiole, pith, rachis 
Spore Sorus, seed, spore, inflorescence, cone, strobilus, 
spike 
Rhizome or root Rhizome, root, tuber 
Crozier Crozier, bud, shoot, sprout 




Table 3.3 Categories of modes of preparation and application. Each mode as reported in 





Modes of application categories Preparation or application reports in literatures 
Decoction Decoction, extraction, boiling 
Infusion 
 
Tea, tisane, soaked with water, drink /drink with other 
herbs, mixed with cow milk 
Tincture Tincture, add with wine, soaked with wine 
Maceration 
 

















Paste, applied on skin/head/hair/teeth/gum, poultice, 
pounded, pressed on the body, crushed (external 
application), powdered, powder mixed water, oil or 
other, cataplasm, grinding, mashed, pulverized, 
milling, blended, external application 
Filteration, juice, squeezed 
Skin wash, steam bath, scrub, bath, hand wash, body 
wash, gargle 
Eaten as vegetables or mixed with sugar, onion, 
garlic, herbs, coconut, betel, porridge, fried with  
butter, toasted, pill, soup, chewed, cooked, grilled, 
oral application 
Smoke, smoke inhalation,  put on fire 
Oil, ointment, oleolite, lotion, burn in oil 




3.2.4 Summarising data  
 
The full data set, describing all use reports and including reference to pharmacological 
and toxicological studies, is presented in Appendix 3.1 and Appendix 3.2. The reports 
compiled were explored in several ways to identify the most frequently reported 
families, genera, species and uses, the spatial distribution of fern use, the conservation 
status of the species used and the availability of pharmacological data for each species. 
 
3.3. Data Summary 
 
3.3.1 Use of ferns documented in literature  
 
In total, 3220 use-reports were compiled. We sourced our use reports from 258 
publications comprising 239 journal articles and 16 books, and from three online 
databases. Three books and 18 other publications  (8% of published sources) reported 
only ferns (Appendix 3.1). Most of the publications (98%) included information about 
therapeutic applications, but plant parts used (91%) and mode of application (76%) 
were less often detailed. Across all sources, 75% cited herbarium specimens and 84% 
gave local names. The three databases were Ngā Tipu Whakaoranga: Maori Plant Use 
Database (2016) , Plants For a Future (2012)  and Raintree-Tropical Plant Database 
(1996) ; two are global databases, and one, the Maori Plant Use Database, had a 
restricted geographic focus. Of the 16 books, 11 presented regional accounts and five 
were multi-countries. Most of the 3220 use reports compiled here came from journal 
articles (2059; 64%), followed by 856 (27%) from books and the remaining 305 (9%) 





Reports varied in their information content, sometimes depending on whether they were 
primary or secondary sources. All of the databases and books were secondary sources, 
as were 12% of the journal articles. Overall, the percentage of reports providing other 
associated information were as follows: 54% local names; 99% therapeutic applications; 
56% mode of preparation/application; 75% plant parts used; 94% locality of use. We 
found usage the reports with localities were, in general, derived from ethnobotanical 
field studies that recorded the site of data collection. Secondary sources rarely report 
locality data and for 5% of use reports not even the country where use takes place is 
recorded. For example, some data extracted from PROSEA recorded use as taking place 
in “South East Asia”. Of the 3220 reports, just 46% cited herbarium specimens. The 
collection of voucher specimens is generally thought to be crucial for correct 
identification of a species. Incorrect identification devalues a database, with negative 
implications for analyses using those data. Some metanalyses will only include primary 
data including a methodology for data collection and an explicit statement that voucher 
specimens were compared to herbarium material or examined by experts (de Medeiros 
et al., 2013). Despite the paucity of vouchered specimens, we show that our large 
dataset reveals patterns in the use of ferns, providing novel insight into fern use 
globally.  
 
3.3.2 Distribution of fern use records 
 
Table 3.4 shows the continental distribution of the medicinal fern reports, species and 
sources. Asia-Tropical includes more than three times as many reports as the next most 
report-rich continent, Southern America. These spatial patterns are also found when 
countries from which use reports originate are considered. Use record originates from 




by Malaysia (219 use reports and 50 species) and China (193 use reports and 77 
species). 
 
Table 3.4 Reviewed literatures based on continents. 
Continents 






Asia-Tropical 1643 204 95 
Southern America 400 118 49 
Asia-Temperate 339 100 38 
Europe 298 34 57 
Africa 177 57 29 
Pacific 93 38 9 
Australasia 52 25 4 
Northern America 40 18 12 
 
 
dos Santos Reinaldo et al. (2015) suggested ferns were poorly represented in 
ethnobotanical surveys because they are unrecorded by existing methods of survey, and 
because they are less commonly used, at least in Brazil. Without studies comparable to 
Dos santos Reinaldo et al.’s in different countries, it is impossible from the literature 
survey to explain the strong spatial patterns in fern use recovered here. We cannot 
account for differences in field data collection methods, for biases in reporting of fern 
use and for biases in our survey methods. Ferns comprise approximately 9600 species 
worldwide (Smith et al., 2006) with almost half of the number are known from South-
East Asia (Winter & Amoroso, 2003). Furthermore, fern communities are highly rich in 
wet tropical regions especially in South-East Asia and neotropical region (Mehltreter et 
al., 2010). Thus, it is not surprisingly when ferns in this study are more apparent in 
these regions as proportion of ferns species are rich in these two continents. 
 
Overall, ferns are genuinely well-represented in ethnomedicinal plant selections in 




might be that some Asian countries are rich with fern species especially in China that 
comprised of 2600 fern species (Lu, 2007) while India with more than 1200 species 
(Dixit, 1984) and Malaysia with more than 1000 species of ferns (Parris & Latiff, 1997). 
These total number of species represent more than 50%  of the global ferns species 
which might explains why the number of medicinal ferns is high in these area. 
Furthermore, the use of herbal medicine is quite popular in India and China where 
Ayurvedic medicine and Chinese herbal medicine are originated which also  include 
ferns in their therapies (Nadkarni, 1996; Ching, 2007). Beside that, China, India and 
Malaysia are among top five countries using plants for medicinal purposes (Schippmann 
et al., 2002). The ethnobotanists especially in India are also interested in ferns, for 
instance, 57% of papers that are only specific on ferns are originated from here. These 
factors might be the reason behind the inflation of reporting of fern use in Asia-
Tropical, or maybe exist simply because of the greater importance of ferns in this 
region.  
 
3.3.3 Taxonomic diversity 
 
A total of 454 taxa (442 species, seven subspecies, five varieties) belonging to 121 
genera in 36 families were recorded as having medicinal uses in different parts of the 
world. A detailed overview of all species with associated information included 
therapeutic application, plant part used, mode of preparation and application, vernacular 
name, continent for each record and  IUCN Red list status are given in Appendix 3.1. 
The name listed in Appendix 3.1 has been updated according to the current accepted 
nomenclature and are arranged in alphabetic order according to family. This total 
amount contributed to about 5% of total estimated of extant fern diversity (Smith et al., 




lot of traditional knowledge of medicinal fern species has not yet been really explored. 
On the other hand, the 454 medicinal taxa in this study demonstrate that we have good 
source of promising plants that should be studied in detail.  
 
In term of conservation, two species in this study; Blechnum eburneum Christ. is listed 
as vulnerable (VU) and Culcita macrocarpa C. Presl as near threatened (NT). It is not 
possible to estimate the real threat for all these medicinal species as there is still many 
medicinal species lacking a global assessment. Aside from overexploitation, 
introduction of invasive species and urban development, by far, forest fragmentation is 
the most important threat to fern communities (Paciencia & Prado, 2005). Deforestation 
has negative impact since trees provide shade for understory ferns and are hosts for 
epiphytic species (Mehltreter et al., 2010). According to Sodhi et al. (2004), the rapid 
rate of deforestation in Southeast Asia, the highest in the tropics, would result loss of 
42% of its biodiversity by 2100. This current rate of habitat fragmentation and 
deforestation would lead to a worrying situation due to the high diverse fern species in 
tropical region (Winter & Amoroso, 2003; Ranker & Haufler, 2008). Various types of 
action can be taken to the conservation and sustainable use of medicinal plants such as 
protection of species by conservation of their natural habitat (in situ) or by cultivation of 
individual species outside form their natural habitats as in botanical garden or 
horticultural institutions (Mehltreter et al., 2010). At the same time, public awareness 






The 20 most commonly medicinally-used families and genera are presented in Figure 
3.5. Of a total 36 families-used, Pteridaceae has the highest number of medicinal taxa 
(92 taxa; 20%), followed by Polypodiaceae (91; 20%), Dryopteridaceae (47; 10%), 
Aspleniaceae (30; 7%), Thelypteridaceae (21; 5%) and Cyatheaceae (20; 4%). These six 
families together represent 66% of the medicinal taxa, while the remaining 34% of the 
taxa belonged to 30 families that are represented by less than 15 taxa. It seems that 
Pteridaceae and Polypodiaceae contribute the highest number of medicinal species. The 
Polypodiaceae and Pteridaceae are among of the most diverse group of extant ferns that 
include approximately 1200 spp. and 950 spp., respectively, with a nearly worldwide 
distribution (Smith et al., 2006). The genera with the highest number  of medicinal taxa 
are Adiantum (32) followed by Asplenium (30), Dryopteris (24) and Pteris (19) while 
the other genera were represented with less than 15 taxa. Adiantum  and Asplenium not 
only have cosmopolitan distribution (Bir, 1963; Boonkerd & Pollawatn, 2013) but also 
have long been used medicinally. For instance, out of 34 Adiantum species found in 
China ("Flora of China:Volume 2," 1994), half of this number have been used in 
Traditional Chinese Medicine to cure human ailments (Wu, 1990). The species most 
frequently cited in this survey are Adiantum capillus veneris L. (272 use-reports in 66 
publications), Equisetum arvense L. (113 use reports in 42 publications), Asplenium 
ceterach L. (49 use reports in 27 publications), Equisetum ramosissimum ssp. 
ramosissimum Desf. (66 use reports in 22 publications), while Adiantum philippense L., 
Asplenium trichomanes ssp. trichomanes L., Lygodium flexuosum (L.) Sw., and 







Figure 3.5 Most commonly used families (left) and genera (right) reported in the 
reviewed literatures with number of medicinal taxa. 
 
Many medicinal plants are cultivated close to home/in homegardens, which serve as 
‘medicine cabinets’ (Agelet et al., 2000; Ssegawa & Kasenene, 2007). Several genera in 
the most used families such as Adiantum, Pteris, Drynaria and Platycerium, are widely 
cultivated in many homegardens (Winter & Amoroso, 2003; Chin, 2005; Mannan et al., 
2008).   
 























































The criteria used when selecting plants for traditional medicine can include 
morphological characters such as shape and colour (Bennett, 2007), or organoleptic 
properties including taste and smell (Ankli et al., 1999; Leonti et al., 2002; Molares & 
Ladio, 2009). Examples of morphological and organoleptic selection are apparent in the 
ferns. For example, the hair-like, delicate stalk of Adiantum (Maidenhair) was thought 
useful  for the treatment of hair problems (May, 1978). Indigenous women of the 
Guarani of Misiones (Argentina) believe they will have a large family by eating ferns of 
Pecluma and Pleopeltis that are characterized by their prolific production of small 
fronds (Keller et al., 2011). Several species of Polypodium (Polypodiaceae) also have a 
liquorice flavour and contains small amounts of ostadin, a steroid saponin 3000 times as 
sweet as sucrose (Prance & Keller, 2015).  
 
3.3.4 How ferns are used 
 
Of the 3220 use reports, there were about 500 that described the therapeutic application 
of the species used. Figure 3.6 summarises the therapeutic applications recorded. 
Gastro-intestinal ailments, mainly stomach ailments and pains, including other diseases 
that related with stomach, small or large intestine and accessory organs of digestions, 
were most frequently reported (206 taxa , 45% of the total taxa). The high frequency of 
fern use for treating gastro-intestinal ailments suggests ferns may not be used differently 
to medicinal plants in general. Many studies of whole medicinal floras also report 
gastro-intestinal applications as the most frequent therapeutic application (Heinrich et 
al., 1998; Novais et al., 2004; Benítez et al., 2010). Poor sanitation amongst some poor 
communities in the tropics reliant on medicinal plants might explain the high frequency 
of gastro-intestinal problems reported. Skin and dermatological problems is the second 




used) followed by gynecology/fertility problems (141 taxa; 31%), 
respiratory/pulmonary illness (90 taxa; 20%), urinary conditions (82 taxa; 18%), general 
health (120 taxa; 26%) and musculo-skeletal (111 taxa; 24%). The reporting of all other 
therapeutic applications is much less, with fewer than 110 therapeutic applications and  





Figure 3.6 Summary of  species use-reports by therapeutic application. Categories; 
gastro-intestinal (GI), skin conditions/dermatology (SD), gynaecology/fertility (GF), 
respiratory/pulmonary (RP), urinary conditions (UC), general health problem (GR), 
musculo-skeletal (MS), other/unclassified (OU), cardiovascular problems/blood purity 
(CB), poisonous animal bites (PA), otorhinolaryngology (OT), neurological conditions 
(NC), dentistry/mouth (DM) and ophthalmology (OP).  
 
 
Many species are reported to have multiple uses. Analysis of the data also revealed that 
half of the total medicinal species are used to treat many different medical problems and 
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to more than one category of while the other cited medicinal species (193 taxa, 42%) 
were used to treat only single therapeutic application categories.  
 
The plant parts used for medicinal purposes and method of  preparation and application 
are shown in Figure 3.7 (a) and (b). The part used and method of preparation and 


















Figure 3.7 Fern use: Plant part used and mode of preparation and application. (a) 
Percentage of plant parts used of total used-reports of medical remedies, (b) Percentages 
























































































All parts of the fern sporophyte are used medicinally, but the rhizome or root are most 
frequently used (689 reports for 184 taxa). Leaflets/pinnae (581 reports for 151 taxa), 
fronds (533 reports for 168 taxa), the whole plant (287 reports for 95 taxa), aerial parts 
(226 reports for 42 taxa) and the stalk (94 reports for 43 taxa) also find significant use. 
The croziers and spores are less frequently mentioned (each fewer than 32 reports, 1.3% 
or less of the reports). Four use reports referred to sap, four to scales, two to gum, and 
one each for slimy tissue and pulp. Field surveys of ethnomedicinal plant use refer to 
the use of fruits, seeds, wood bark or flowers, structures not present in ferns. However, 
many general surveys  report the preferential  use of rhizomes, roots or leafy parts (Di 
Stasi et al., 2002; Giday et al., 2003; Shrestha & Dhillion, 2003; Okello & Ssegawa, 
2007; Teklehaymanot & Giday, 2007). It is possible that, in ferns as in plants generally, 
roots are significant sources of bioactive chemicals and this underlies their selection and 
use (Robinson, 1974). Since ferns in tropical rainforests are mostly moderately sized 
with short, erect fronds (Page, 1979), they are easily collected and stored.  
 
Of the 11 categories of preparation and application, decoction is the most frequently 
reported (Figure 3.7b). The mode of preparation and application of medicinal plants 
could vary both according to the cultures using them and the plant group being used; it 
is beyond the scope of this study to assess whether decoction is used for preparing ferns 
more or less than for medicinal plants in general. The high frequency of decoction may 
be a result of the frequent of rhizome/root parts. Decoction may be popularised because 
of the belief that the longer the plant is boiled the higher the efficacy of the remedy 
(Speck, 1941), though in some situations the cost of preparing a decoction may be 
limiting (Daswani et al., 2011). Pastes, infusions and juices are the next most important 
forms of use, and chewing or eating ferns for medicinal purposes is also common. The 




accounting for less than 1% of reported preparations/applications. Most ailments and 
pains were usually treated with a single plant. In 25 cases, mixtures of two or more 
different plant species are used to prepare a remedy for ailments. For example, in India, 
fresh rhizome of Alsophila gigantea is mixed with Piper nigrum together with cows’ 
milk (Singh & Singh, 2012). Since the majority of our reports are from Asia, where 
written systems that emphasise multi-herbal mixtures originated, we might expect more 
reports of mixtures including ferns in our data set. Ethnobotanical studies are rarely 
focused on herbal mixtures, so the frequency of fern use of mixtures could be under-
reported.  
 
3.3.5  Ferns in pharmacology and toxicology 
 
The review of the pharmacological  and toxicological properties of medicinally-used 
ferns and their phytochemistry highlights the tension between therapeutic and 
deleterious effects of medicinal plants exemplified in the ferns. Out of 454 taxa in this 
study, 189 (42%) had pharmacological properties reported in the literature and 81 taxa 
(18%) had been the focus of a toxicological study (Appendix 3.2).  
 
This finding, while preliminary, suggests that there are still many medicinal ferns 
species not been investigated regarding their biological activities and only little 
information on toxicological impacts to human healths have been reported. Other 
studies have shown that ferns are rarely the focus of such research (Santos et al., 2010). 
However, the majority of the medicinal species that find the highest number of use 
reports are rather well known in terms of their bioactivity, with at least two studies, or 
as many as 30 in Pteridium aquilinum (Table 3.5). Notably, the toxic nature of 




activity has been the focus. The scale of the public health problem associated with toxic 
properties might be considerable and further research is needed (Chapter 5).  
 
 
Table 3.5 Most frequently cited medicinal species showing the numbers of reports of 
their pharmacological and toxicological properties. 






Adiantum capillus-veneris  272 16 0 
Equisetum arvense  113 12 0 
Lygodium flexuosum  82 8 0 
Equisetum ramosissimum ssp. 
ramosissimum 
66 4 0 
Adiantum philippense  62 10 0 
Pteridium aquilinum 58 4 26 
Asplenium ceterach 49 2 0 
Asplenium trichomanes ssp. 
trichomanes 
41 2 0 
 
 
Drynaria roosii Nakaike, known as ‘Gu Sui Bu’ in China, received most attention in 
pharmacological experimental studies with 20 papers found, more than any other 
species, although we found only four studies reporting its traditional use (Table 3.6). 
This might reflect the large number of pharmacological studies of plants in the Chinese 
Pharmacopeia, but also the relative lack of studies of Chinese traditional use in the 
English language, abstracted scientific literature. Drynaria roosii is frequently used 
clinically to treat bone fractures, arthritis, osteoporosis and rheumatism in China (Li et 
al., 2006) and in the Chinese Pharmacopoeia, it is cited for treating kidney problems in 
Traditional Chinese Medicine (Chinese Pharmacopoeia Commission, 2005). Its 
potential in treating bone fractures, bone reconstructions and deafness has been 
demonstrated; several studies report flavonoid and phenylpropanoid compounds such as 
as epicatechin, naringin and neoeriocitrin have osteoprotective effects (Wang et al., 




Table 3.6 Medicinal species that are most frequently studied for their pharmacological 







Drynaria roosii 20 12 4 
Adiantum capillus-veneris  16 272 66 
Diplazium esculentum 13 23 12 
Drynaria quercifolia 13 65 19 
Blechnum orientale 13 42 16 
Adiantum philippense 10 62 21 
Equisetum arvense  12 113 42 
 
 
Adiantum capillus-veneris L. was also well studied pharmacologically, with 16 papers 
found (Table 3.6). The literature reveals the presence of flavonoids such as astragalin 
(kaemp- ferol 3-glucoside), isoquercitrin (quercetin 3-glucoside), kaempferol 3-
glucuronide, querciturone (quercetin 3-glucuronide), nicotiflorin (kaempferol 3-
rhamnoglucoside) and rutin (quercetin 3-rhamno glucoside) (Akabori & Hasegawa, 
1969; Pourmorad et al., 2006), different classes of triterpenoids (Nakane et al., 1999; 
Reddy et al., 2001; Nakane et al., 2002), phenyl propanoids (Imperato, 1982b, 1982a), 
steroids (Marino et al., 1989), alicyclic acids (Minamikawa & Yoshida, 1972) and lipids 
(Sato & Furuya, 1983). Extracts of this species have also been reported  to possess 
many pharmacological activities, such as antiurolithic (Ahmed et al., 2013), 
antimicrobial (Banerjee & Sen, 1980; Mahran et al., 1990; Singh et al., 2008; Parihar et 
al., 2010; Alipour & Khanmohammadi, 2011), antifungal (Guha et al., 2005) and 
antioxidant (Pourmorad et al., 2006) activities which could justify its traditional use in 
13 therapeutic application categories. For example, alcohol extracts of the rhizome have 
been shown to be antimicrobial when it inhibited the proliferation and metabolism 
activity of rifampicin-resistant pulmonary tuberculosis cells (Tan & Xiang, 2002) which 
could explain its traditional use in the treatment of respiratory problems (Perry & 




urinary infections (Pieroni et al., 2002; Winter & Amoroso, 2003; Hanlidou et al., 2004; 
Everest & Ozturk, 2005; Hamayun et al., 2006; González-Tejero et al., 2008; Lee et al., 
2008; Upreti et al., 2009; Altundag & Ozturk, 2011; Mati & de Boer, 2011; Cornara et 
al., 2014).  
 
In addition to Drynaria roosii  and Adiantum capillus-veneris, other medicinal species 
have been the focus of pharmacological investigations (Table 3.6, Appendix 3.2). To a 
certain extent, the data from pharmacological investigations validated the applications 
of these medicinal species in traditional medicines and provided the association  
between the ethnomedicinal uses and bioactivity evaluations. For instance, the species 
used for diarrhea and urinary tract infection have antimicrobial activities (Equisetum 
arvense; Radulović et al., 2006), species used for the treatment of skin diseases have 
antidermatophytic activities (Drynaria quercifolia; Nejad & Deokule, 2009) and species 
used for wound healing have antioxidant activities (Blechnum orientale; Lai et al., 
2010). A review by Zhu et al. (2011) revealed no approved drugs from fern species, and 
no fern bioactivities undergoing clinical drug trials. The only species in the preclinical 
trial drugs list is Thelypteris torresiana (Thelypteridaceae), which is being tested for 
anticancer activity (Zhu et al., 2011). Protoapigenone, a natural flavonoid, isolated from 
this species exhibited significant cytotoxic activity against several types of human 
cancer cells using both in vitro and in vivo models (Lin et al., 2005; Chang et al., 2008a; 
2008b; Chiu et al., 2009; Hunyadi et al., 2011; Chen et al., 2013) which demonstrated a 
prospective future of anticancer drug development. Although there is comparatively 
little data in the literature on the pharmacological investigations of ferns that are used in 
traditional medicine (Appendix 3.2), numerous compounds especially flavonoids, 




compounds have become the focus of intensive research concerning their 
pharmacological properties due to the potential of bioactive agents (Tomsik, 2014; Cao 
et al., 2017). These pharmacological data suggest there maybe more leads amongst the 
ferns.  
 
3.4.  Conclusion 
  
Compilation and scrutiny of the ‘Medicinal Ferns Database’ has shown the diversity of 
medicinal ferns throughout the globe and has revealed the many fern species used 
medicinally in various cultures worldwide. In conclusion, more than 400 fern species 
are found to treat different ailments by people throughout the globe and some may 
appear to have the potential for new drug discovery. As ferns comprise about 9,000 to 
12,000 species (Smith et al., 2006; Lehtonen, 2011; Christenhusz & Chase, 2014), only 
a small proportion (5%) are known to have medicinal use as opposed to between 12% of 
medicinal species of flowering plants (Schippmann et al., 2002). This study shows 58% 
and 82% of medicinal ferns species have not been the focus of pharmacological and 
toxicological effects respectively (Appendix 3.2).  
A lot of online databases are found to be directing their focus to specialized content 
such as traditional medicine systems, regional uses, disease-specific and phytochemical 
information and most of the existing independent databases are variable in their content 
with regional or cultural focus. Ningthoujam et al. (2012) found specialized databases 
have some advantages as compared to comprehensive ones. The United Nations 
Industrial Development Organization (UNIDO) recommended that a comprehensive 
medicinal plant database should contain information in terms of botanical aspects along 




chemotaxonomic, market and other relevant aspects (Ningthoujam et al., 2012). With 
the exception of large, publically funded projects, the comprehensive approach seems to 
be impractical as the data collection from a wide geographical area in multiple 
disciplines into a single database might create the risk of possible inconsistencies. 
However, to avoid unnecessary duplication of research or inconsistencies, a 
comprehensive database can be achieved by optimization of data and development of 
data standards for better management and sharing networking (Gaikwad et al., 2011; 
Ningthoujam et al., 2012). For example, the using of multiple terms such as; rhizomes, 
rootstock and rizoma in various literature that carry the same meaning or referring to the 
same part of the plant can be confusing to the public users, thus a standard term must be 
used throughout the study to avoid such confusion. Hence, continuing updates to 
include more information such as chemical compound data or biogeography of fern 
species in the database will be developed in the future and the potential to be made as 
public or online database will be explored. Data collection is not only crucial in 
conserving traditional knowledge, but also contributes towards evaluation of the likely 














Chapter  4. The limits of phylogenetic predictivity in 
bioprospecting: phylogenies do not reveal 




The use of plants in the treatment and prevention of disease has been practiced for 
thousands of years in many countries, for example China (Chang et al., 1986) and India 
(Kappor, 1990). It is estimated that about 53,000 medicinal species (Schippmann et al., 
2002) are used to provide healthcare for 80% of the world population especially in 
developing countries (Hamann, 1991; Van Wyk & Wink, 2004; Gurib-Fakim, 2006). 
Given the extensive traditional knowledge of these plants’ medicinal use, it may be 
possible to make a tremendous contribution to bioprospecting by targeting traditionally-
used medicinal plants for drug discovery. However, only a small proportion of plants 
have been investigated and screened for their biological activity (Gurib-Fakim, 2006).  
 
Screening plants as candidates for drug discovery programs can be either through 
“random” collection or through investigating the leads of prior ethno-pharmacological 
knowledge (Lewis & Elvin-Lewis, 1995; Fabricant & Farnsworth, 2001). However, the 
progress of focusing drug discovery by ethnobotanical data is not consistent, and the 
popularity of this approach has fluctuated (Saslis-Lagoudakis et al., 2012). This 
approach also has been critized because traditionally-used medicinal plants may be used 
predominantly ritually and not for bioactivity. Therefore, they would not yield 
interesting chemicals that are efficacious, thus resulting in disappointing outcomes 




biodiversity loss, with recent estimations indicating more than 20% of the world’s 
plants threatened with extinction (Brummitt & Bachman, 2010), faster and better 
systematic approaches to find new-plant derived drugs are more necessary than ever 
before. Some of the species that are threatened with extinction may well include plants 
with significant medicinal value or might yield novel bioactive compounds with the 
potential therapeutic use. The early identification of these valuable species can help 
researchers find the same compound in other plants. 
 
In recent years, new methodological approaches have renewed interest in 
bioprospecting, specifically by investigating the phylogenetic patterns of plant 
therapeutic uses or bioactivities across medicinal floras. This approach correlates 
phylogenetic analyses based on DNA sequence information from plants with medicinal 
data or chemical properties by examining the relatedness between the particular group 
of species (eg. medicinal species) on the phylogeny. In the earliest study in 2006, 
Lukhoba et al. found an interesting trend whereby most traditionally-used medicinal 
species of Plectranthus (Lamiaceae) were found within the same large phylogenetic 
clade. One year later, using a more quantitative method, a study by Forest et al. (2007) 
reported that the medicinal plants in the Cape of South Africa were significantly 
phylogenetically clustered. In an analysis aimed at identifying target species for drug 
discovery, the distribution of alkaloids with specific activity was found significantly 
constrained by phylogeny when Rønsted et al. (2008) succesfully mapped bioactivity on 
to phylogenetic trees within a plant genus, Narcissus. A similar situation also was 
observed by Zhu et al. (2011) when they revealed that nature-derived drugs were 
derived mostly from drug-productive families and tended to be clustered rather than 




phylogenetic clustering of traditionally-used or bioactive species. In 2011, Saslis-
Lagoudakis et al. investigated the pattern of ethnomedicinal usage in Pterocarpus 
(Leguminosae) and detected significant clustering of species in certain usage categories 
on the phylogeny. Another study conducted by Saslis-Lagoudakis et al. (2012) also 
revealed strong phylogenetic signal in traditionally-used medicinal plants. Medicinal 
plants were overpresented in certain branches of the phylogenetic tree when 
traditionally used species from three different regions, Nepal, New Zealand and the 
Cape of South Africa, were investigated. Interestingly, the ‘hottest’ branches contained 
more than 60% more traditionally used plants than expected. Most recently, Ernst et al. 
(2016) found that the plants used medicinally in the Euphorbia are significantly 
phylogenetically clustered, as were traditional uses inferred to be anti-inflammatory 
applications, though traditional therepautic applications were not. 
 
Considering all of this evidence, it seems that there is a correlation between species’ 
evolutionary history and the diversity of services (eg. medicinal uses and chemical 
properties). An evolutionary predictive tool for prioritizing specific lineages to be 
investigated is underpinned by the observation that phylogenetically closely related 
species generally share similar biochemical properties. However, studies to date are 
relatively few, so it is difficult to generalise about expectations at different hierarchical 
levels and in different plant groups (Table 4.1). Most of the previous studies have been 
carried out on Angiosperms, no studies have been focused on other groups and this 








Table 4.1 Phylogenetic studies of traditional use of plants for medicine. Level of sampling indicates hierarchical level of which examplars 
were sampled, for example, one exemplar per genus was sampled by Forest et al. (2007).  
*Lukhoba et al., 2006 1, Forest et al., 2007 2, Saslis-Lagoudakis et al., 20113, Saslis-Lagoudakis et al., 2012 4, Yessoufou et al., 2015 5, 
6Ernst et al. (2016) 







Plectranthus: A review of ethnobotanical uses 1 Genus (Plectranthus) Species Global distribution of genus in 
Tropical Africa, Asia and 
Australia 
Preserving the evolutionary potential of floras in 
biodiversity hotspots 2 
Angiosperm Genus South Africa   
The use of phylogeny to interpret cross-cultural 
patterns in plant use and guide medicinal plant 
discovery: an example from Pterocarpus 
(Leguminosae) 3 
Genus (Pterocarpus) Species Global distribution of genus in 
three regions, Neotropics, tropical 
Africa and Indomalaya 
Phylogenies reveal predictive power of traditional 
medicine in bioprospecting 4 
Angiosperm Genus Across three regions, Nepal, New 
Zealand and the Cape of South 
Africa 
Phylogenetic exploration of commonly used medicinal 
plants in South Africa 5 
Angiosperm Genus South Africa   
Evolutionary prediction of medicinal properties in the 
genus Euphorbia L. 6 




Studies of medicinal uses of ferns are available in different inhabited continents 
especially in Asia-Tropical region (Chapter 3). Different fern species throughout the 
globe have been or are presently utilized to treat various ailments as explained in 
Chapter 3. Ferns are numerous, they do find medicinal use traditionally and so they are 
potentially valuable. The phylogeny (Chapter 2) and the database of fern medicinal use 
(Chapter 3) represent an opportunity to advance medicinal fern research by 




The primary objective of this chapter is to explore phylogenetic methods as applied to 
medicinal ferns. By using the robust megaphylogeny of the ferns (Chapter 2) and the 
global database of medicinal ferns use (Chapter 3), the use of ferns is investigated at a 
range of spatial scales, from global, to continental and regional/national scales. In this 
chapter, I will subsample the available data to encompass the range of different 
hierarchical levels of phylogeny reconstruction and sampling, and also investigate 
spatial scales so that the pattern revealed for ferns can be compared to all patterns 
revealed for Angiosperms to date. Patterns amongst fern species that are used 
medicinally will be investigated with the expectation that lineages rich in medicinal 
ferns will be discovered which eventually might provide a framework for further 
prediction. With an increasing number of studies revealing lineages rich in medicinally-
used flowering plants, this phylogenetically-guided approach will be used on ferns for 







4.2 Materials and methods 
 
Nine analyses were carried out (Table 4.2). The ethnomedicinal dataset and phylogeny 
were prepared for these analyses as follows. 
 
Table 4.2 Taxonomic scope and level of sampling for nine analyses performed. 
Ethnomedicinal information and phylogeny were processed to represent different 
hierarchical levels and spatial scales.  
No Taxonomic scope of sampling Hierarchical level of 
sampling 
Geographical extent of 
sampling 
1. All ferns Species Global 
2. Family (Pteridaceae) Species Global 
3. Genus (Adiantum) Species Global 
4. Eusporangiate ferns (Early 
diverging species) 
Species Global 
5. All ferns Generic Nepal 
6. All ferns Generic New Zealand 
7. All ferns Generic South Arica 
8. All ferns Generic Asia-Tropical 
9. All ferns Generic Global 
 
 
4.2.1 Ethnomedicinal data 
 
Information on the medicinal uses of ferns for each species throughout the globe was 
collected and recorded as in Chapter 3 (Appendix 3.1). Overall, a total of 454 taxa (442 
species, seven subspecies, five varieties) belonging to 121 genera in 36 families were 
recorded as having medicinal uses in different parts of the world.  
 
Asia-Tropical was selected for continental level study since this continent is rich in 
medicinal fern species as reported in Chapter 3. Three different regions/nations; Nepal, 
New Zealand and South Africa were chosen in parallel with studies by Saslis-





Therapeutic applications for all studies were grouped into 14 categories (Chapter 3). 
These are; cardiovascular problems/blood purity (CB), dentistry/mouth (DM), gastro-
intestinal (GI), gynaecology/fertility (GF), neurological conditions (NC), 
ophthalmology (OP), musculo-skeletal (MS), skin conditions/dermatology (SD), 
otorhinolaryngology (OT), respiratory/pulmonary (RP), urinary conditions (UC), 
poisonous animal bites (PA), general health problem (GR) and other/unclassified (OU). 
 
4.2.2 Tree preparation 
 
The phylogeny of ferns reconstructed at the species level (Chapter 2) was the basis of 
the phylogenies for this study. Nine new phylogenies were reconstructed to carry out 
analyses as outlined in Table 4.2. For analysis 1, the species level tree previously 
generated (Chapter 2) has been modified by adding manually 55 fern taxa for which 
genetic data was unavailable. Their placement in polytomies on the phylogeny was 
based on their taxonomic affinities (Appendix 4.1). Mesquite (Maddison & Maddison, 
2001) was used to manipulate the phylogenies. Overall, sampling reached a total of 
3768 of fern taxa representing approximately 40% of the global fern diversity.  
This most inclusive species-level tree was pruned to make generic level trees. One 
exemplar species from each genus was selected at the global, continental, and 
regional/national levels. The distribution of genera included in the continental and 
regional/national levels studies were checked againt the Global Biodiversity 
Information Facility (GBIF; www.gbif.org). Thus, 185 out of 271 genera were selected 
for Asia-Tropical, 94 genera for Nepal, 66 genera for New Zealand and 90 genera for 
South Africa. In addition, due to synonymy problems and changes in fern nomenclature, 
additional sources were also used to confirm the generic checklist for each country 




Dodsworth, 1989) South Africa (Roux, 2001). Phylogenies were pruned in the R 
environment version 3.3.1 (https://www.r-project.org/). All the scripts are available in 
the Appendix 4.2. Prior to analysies, phylogenies were further pruned to remove 
outgroup taxa and the phylogenis were also unrooted. 
 
4.2.3 Phylogenetic analyses and manipulations 
 
Metrics from phylogenetic community ecology were used to compare the ‘communities 
of taxa’ in this study. Generally, in phylogenetic community ecology, ‘communities of 
taxa’ are grouped by ecological zone or geographical zone, however ‘communities of 
taxa’ here were compiled based on the group of species traditionally-used for medicine 
and by therapeutic application categories. 
 
The ‘comstruct’ command in Phylocom v4.1 (Webb et al., 2008) was used to assess the 
significance of phylogenetic signal/structures for a ‘community of taxa’, which are a 
subset of the taxa in the phylogeny. It measures whether a group of species are 
significantly clustered on the phylogeny. In this analysis, the significance of 
phylogenetic signal for a group of species on the phylogeny is measured by calculating 
the mean phylogenetic distance (MPD) and mean nearest phylogenetic taxon distance 
(MNTD). MPD measures the phylogenetic distance between every pair of individuals 
drawn from the sample and compares the average. Mean nearest phylogenetic taxon 
distance (MNTD) measures the average distance from each individual in the sample to 

















Figure 4.1 Red lines indicate measured distances between taxa in this study. A: MPD 
measures the mean of the distances (length along phylogeny) between all possible pairs 
of sample taxa. B : MNTD measures the mean of the distances between each sample 
taxon and its most closely related sample taxon. 
 
 
These average distances were compared to MPD/MNTD values for randomly generated 
samples to provide p values for the significance of phylogenetic signal for the given 
sample. The p values were calculated by dividing the number of randomly generated 
samples that were more clustered on the phylogeny than the observed sample 
(rankLow) by the number of runs (1,000). The Net Relatedness Index (NRI) quantifies 
the overall clustering of taxa on a tree, and the Nearest Taxon Index (NTI) quantifies 
the extent of terminal clustering on a tree. Both were calculated for each dataset. 
Positive values (NRI/NTI > 0) indicate under-dispersed communities (phylogenetic 
clustering) whereas negative values  (NRI/NTI < 0) indicate over-dispersed 
communities (phylogenetic evenness). By using this method, the phylogenetic 
signal/structure for all samples can be assessed to provide an estimation of the relation 





















Figure 4.2 Two different scenarios (A and B) for the distribution of traditionally-used 
medicinal species of ferns on a hypothetical phylogeny. Three traditionally-used 
medicinal taxa are indicated with a frond symbol under scenarioA and B. The 
phylogenetic signal (phylogenetic clustering) in scenario A is strong as the phylogenetic 
distance within the medicinal taxa is small while there is a signal of phylogenetic 
evenness (overdispersal) in scenario B as the phylogenetic distance within the medicinal 





Investigation of the phylogenetic distribution of all taxonomic levels of medicinal use of 
ferns including their categories of uses with the ‘comstruct’ tool, are summarised in 








Table 4.3 Phylogenetic structure indicated by NRI and NTI values for medicinally-used medicinal ferns across different hierarchical levels and spatial scales, and 14 categories of use. Green cells indicate 
significant overdispersion, green cells with (-) indicate nonsignificant overdispersion whereas red cells with (+) indicate nonsignificant clustering. 
 









































- + + NA NA NA  - - + + + NA NA NA  - 
Dentistry/mouth 
 
- + + NA NA NA   - + + - NA NA NA +  
Gynaecology 
/fertility  
-  + - NA NA  -  - - - - NA NA - - 
Gastro-
intestinal  
- - - - + -    -  - - - - -  
General health 
problem  
- - -  + +   -   - - + + -  
Musculo-
skeletal  
- + + - NA NA - -  - + - - NA NA   
Neurological 
conditions  
+ + - NA NA +    + + - NA NA +   
Ophthalmology 
 
+ - + NA + NA   - + - - NA + NA  - 
Otorhinolaryn-
gology  
- - - NA NA NA - - - - - + NA NA NA - - 
Other 
/unclassified  
- - + NA NA NA  -  - + - NA NA NA - - 
Poisonous 
animal bites - - + NA NA NA NA + - - - + NA NA NA NA + - 
Respiratory 
/pulmonary  
+ - - - NA +    + -  - NA + -  
Skin conditions 
/dermatology  
- - - + + NA - -  - - - + + NA - - 
Urinary 
conditions  
- - + - NA NA - - - - + - - NA NA  - 




Overall, the NRI metric identified that ferns that are used medicinally were not 
phylogenetically clustered at any spatial or taxonomic scale. In other words, fern 
species that are used medicinally are not found in specific lineages, but are distributed 
throughout the phylogeny, suggesting an overall phylogenetic overdispersion of 
medicinally-used fern species. None of the 14 therapeutic application categories of use 
showed significant clustering. At all hierarchical levels, only phylogenetic distribution 
of medicinal uses at the species level (global) including eight categories of uses; 
cardiovascular problems/blood purity (CB), gastro-intestinal (GI), ophthalmology (OP), 
skin conditions/dermatology (SD), respiratory/pulmonary (RP), urinary conditions 
(UC), general health problem (GR) and other/unclassified (OU) were found to be 
strongly significantly overdispersed (P <0.001). The phylogenetic tree with strong 
significant overdispersal of medicinally-used fern species is presented in Figure 4.3. In 
summary, 36 out of 107 samples were shown to have significantly overdispersed 
phylogenetic distributions. A similar pattern was also found for all medicinally-used 
fern and categories of use when the phylogenetic structures were analysed using the 
NTI metric. Out of 107 samples, 27 showed significantly overdispersed distributions.  
 
There were some positive NRI and NTI values in almost majority samples in New 
Zealand samples and when the taxonomic scope of sampling narrowed down to certain 
therapeutic categories in Pteridaceae, Adiantum, eusporangiate lineage, Nepal, South 
Africa and Asia Tropical. However, none of this clustering was significant. Overall, 
these results indicate that medicinally-used fern species are overdispersed at deep and 














Figure 4.3 Fern phylogeny based on maximum likelihood analysis at the species level 
(global) indicating the distribution of medicinally-used fern species. Fern species that 












In recent years, phylogenetic comparative methods have emerged as promising tools for 
exploring correlations between phylogenetic diversity and useful attributes of medicinal 
plants (Lukhoba et al., 2006; Forest et al., 2007; Saslis-Lagoudakis et al., 2011; Saslis-
Lagoudakis et al., 2012; Yessoufou et al., 2015). Here, these analyses are applied to a 
previously unstudied group, the ferns. Surprisingly, despite the increased number of 
studies suggesting lineages rich in flowering plants used for medicinal purposes, the 
findings of this study showed that no such lineages can be identified for ferns. Indeed, 
the findings suggest a different pattern, one in which of medicinally used fern taxa are 
dispersed across all spatial and taxonomic scales. This pattern of overdispersion, 
whereby co-occuring species are phylogenetically more distantly related than expected 
by chance (Emerson & Gillespie, 2008), is seen both in deep-evolutionary lineages, as 
revealed by NRI, and at shallow levels, as revealed by NTI. The results thus indicate 
that medicinally-used fern taxa around the globe are spread along the phylogeny. 
 
This is the first time any global species-level phylogeny has been the focus of such 
study. Contrary to expectations, it is somewhat surprising when medicinally-used ferns 
overall are significantly phylogenetically overdispersed at deep and shallow 
phylogenetic levels. As this finding is not directly comparable to previous studies, 
patterns of the distribution of traditionally-used medicinal ferns were further 
investigated at genus level as in Lukhoba et al., (Plectranthus, 2006); Saslis-Lagoudakis 
et al., (Pterocarpus, 2011); Ernst et al., (Euphorbia, 2016). In addition, phylogenetic 
signal was also tested by investigating the species level sampling for one family. 
Pteridaceae was selected to represent the family level and Adiantum for the genus level. 




of medicinally-used species (Chapter 3) and are diverse groups of extant ferns with 
more than 40% and 60% of their taxa sampled in the phylogeny respectively (Chapter 
2). Nevertheless, there is still no evidence for phylogenetic clustering, instead both 
groups demonstrate the same overdispersed patterns. Phylogenetic patterns at species 
level also were further explored for early diverging, eusporangiate ferns, and the finding 
here is also of overdispersal of distribution of medicinal use. The results here are 
contrary to previous studies with species-level sampling at generic level, which found 
clustered medicinal usage (Lukhoba et al., 2006; Saslis-Lagoudakis et al., 2011; Ernst et 
al., 2016). In some cases, phylogenetic clustering were observed in Adiantum samples 
when the usage was organised into categories, however, none of this clustering was 
significant. It could be argued that the results for Adiantum sample might not be directly 
comparable to previous studies of genus level in terms of sample density or deficiencies 
of  use-reports data. Ernst et al. (2016) have 560 species in the phylogeny representing 
65 species with genus of which 12% are medicinal. Saslis-Lagoudakis et al. (2012) 
sampled 19 of the 25 species in the genus for phylogeny reconstruction and 76% were 
used medicinally. However, even though figures for Adiantum are comparable (32 of 
the 73 species) in the genus were represented, and more than 40% were used 
medicinally, a different pattern is emerging in ferns at this level.  
 
Generic-level phylogenetic studies of the medicinally-used plants in whole Angiosperm 
floras have also been given considerable attention by researchers. Thus, in this study, 
the predictive power of phylogeny in traditionally-used fern species was further 
explored at generic level. Following Saslis-Lagoudakis et al. (2012)’s study, 
phylogenetic signal in the medicinal use of ferns at generic level for the same regions; 




overall, especially in Nepal and South Africa, were overdispersed. All samples in New 
Zealand were found clustered based on NRI, nevertheless these findings were not 
significant. An investigation was made at the continental scale, for the Asia-Tropical 
region, because here 40% of fern genera are used medicinally. Interestingly, we 
consistently demonstrate phylogenetic overdispersion in this area. Finally, patterns of 
use at the global scale for medicinal ferns using a generic level phylogeny were 
explored; consistent with other scales, the global generic-level study showed 
overdispersion in distribution of medicinal use.  
 
The comparison of previous studies of the Angiosperms (Lukhoba et al., 2006; Forest et 
al., 2007; Saslis-Lagoudakis et al., 2011; Saslis-Lagoudakis et al., 2012; Yessoufou et 
al., 2015; Ernst et al., 2016) to the findings presented here have unequivocally 
demonstrated that ethnomedicinally-used ferns are not phylogenetically clustered in the 
same way as flowering plants are. Indeed, they are overdispersed. These results may be 
explained by the fact that ferns, which do not flower and lack seeds, are fundamentally 
different from Angiosperms (Chin, 2005) and suggest that the selection criteria for ferns 
and flowering plants have differed throughout their history of medicinal use. Thus, the 
finding presented here lead us to think that ferns and flowering plants overall are 
fundamentally different in terms of how they are selected for traditional medicinal use.  
 
Despite the increasing number of documented phylogenetic clustering patterns in 
Angiosperms, there is one other recent and as yet unpublished study which provides a 
rather different view suggestive of overdispersal at the family level. Estevao N. F. 
Souza (in prep.) revealed that traditionally-used plants of family Leguminosae in Brazil 




Angiosperms is considered in isolation, it shows overdispersed genera with medicinal 
use, comparable to the whole ferns. In this broader perspective, it seems as if ferns may 
be selected in the same way as genera of an Angiosperm family.  
 
Organoleptic properties seem to be one of the important criteria in the selection of 
plants as medicine (Leonti et al., 2002). Indigenous people in many cultures around the 
globe use smell and taste properties to characterize medicinal plants since medicinal 
plants tend to have distinctive taste or odor (Ankli et al., 1999; Leonti et al., 2002; 
Molares & Ladio, 2009). For instance, astringent and bitter taste properties were most 
frequently used in the treatment of gastrointestinal disorders such diarrhea or for 
expelling internal parasites (Leonti et al., 2002). Such attributes are directly associated 
with the presence of certain secondary plant metabolites (eg. bitter taste is often due to 
alkaloids). Thus, medicinal properties are not randomly distributed in Angiosperm 
phylogeny as closely related species share biochemistry (Fairbrothers et al., 1975; 
Rønsted et al., 2008; Rønsted et al., 2012). Whether organoleptic diversity of ferns is 
equivalent to organoleptic diversity in Angiosperms is unclear. The sweet and bitter 
tastes were quite often described in ferns (Mabberley, 2008; Keller et al., 2011; 
Harmaja, 2012), without mentioning other tastes commonly attributed to Angiosperms, 
which are more diversified in taste properties (eg. bitter, astringent, sweet, tasteless, 
spicy, acid (Ankli et al., 1999; Leonti et al., 2002)). Whether ferns are biochemically 
less diverse is also unclear. The insect-herbivory that drives chemical diversification in 
flowering plants is rather well known (Becerra et al., 2009; Agrawal & Weber, 2015). 
Cyanogen glycosides, phenoloids and ecdysteroids have been detected in several fern 
species as protection agents against herbivorous insects (Lafont et al., 2011; Vetter, 




they lack flowers and fruit, therefore, they have a relatively limited chemical defence 
repertoire compared to flowering plants (Cooper-Driver, 1978; Auerbach & Hendrix, 
1980; Cooper-Driver, 1985; Markham et al., 2006). A study by Rathinasabapathi et al. 
(2007) revealed that arsenic accumulation in Pteris vittata is an elemental defence 
against insect herbivory. Alternatives modes of defences against herbivores would 
account for low phytochemical variation across the ferns, as many ferns are arsenic 
accumulator (Ma et al., 2001; Francesconi et al., 2002; Zhao et al., 2002; Meharg, 2003; 
Du et al., 2005; Srivastava et al., 2006; Van et al., 2006; Rathinasabapathi et al., 2007; 
Zhang et al., 2008). Phylogenetic overdispersal in traditionally-used species in 
Adiantum may partly explained by the limited variation in chemical compounds as at 
least some species of Adiantum also able to accumulate arsenic (Srivastava et al., 2010).  
 
The Doctrine of Signatures concept has also been applied to the ferns even though they 
lack flowers and seeds. For instance,indigenous women of the Guarani of Misiones 
(Argentina) believe they will have a large family by eating ferns of the genera 
Pleopeltis and Pecluma that are characterized by their prolific production of small 
fronds (Keller et al., 2011) whereas Adiantum species are used to treat hair weakness or 
baldness due to the similarity between the fern leaf and human hair (May, 1978; Lev, 
2002; Dafni & Lev, 2003). Therefore, leaflet (pinnae) characteristics, especially the 
leaflets of bipinnate or tripinnate leaves, appear to play a role for selection in fern 
species. The morphology of leaf pinnation in ferns is homoplasious, occurring across 
distantly related lineages due to the convergent or parallel evolution during long 
evolutionary history of ferns (Little & Barrington, 2003; Ranker et al., 2004; Rothfels et 
al., 2008). The great morphological homoplasy within fern lineages may contribute to 




Doctrine of Signatures could drive fern selection and use, however, compared to 
flowering plants, ferns have fewer morphological and colour characteristics.  
 
Ecology also seems to play a role in species selection. For instance, weedy plants are 
more likely to be used in indigenous pharmacopoeias (Stepp & Moerman, 2001; 
Gazzaneo et al., 2005; Giday et al., 2009). Furthermore, families that are rich in weeds 
such as mints are more likely to be found in home gardens and the phylogenetic 
relatedness of traditionally-used plants might reflected their ‘weediness’. In contrast, for 
fern species, the epiphytic habit might be associated with selection for medicine. 
Drynaria roosii, Drynaria coronans, Davallia divaricata and Davallia solida which are 
called as ‘Gusuibu’ in the Chinese traditional medicine system are examples of the 
important medicinal ferns which have long been used in the treatment of bone injuries 
(Chang et al., 2007). Interestingly, all of these species are epiphytic (Benzing, 2008). 
Considering that about one third of leptosporangiate species grow as epiphytes on 
Angiosperm trees and the diversification of  of epiphytic ferns is not limited to only one 
clade but evolved several times in the ferns in many families (Schuettpelz & Pryer, 
2009), which may contribute to the pattern of overdispersal of traditionally used fern 
species in the phylogeny at species level.  
 
Generic complexes are suites of closely related plants interchangeably used for a 
particular purpose (Martin, 1995). They are common in medicinal use of flowering 
plants (Berlin et al, 1973; Pardo-de Santayana & Morales, 2010). It may be that turn-
over in species in a generic complex reflects turn over in space of availability of 
species. This could be named phylogenetic replacement, and this phenomenon would 




conceivably be hypothesised that widely distributed species may be contributing to a 
failure to recover shallow phylogenetic clustering in ferns overall. Fern species are 
overall more widespread than flowering plant species, so that actually the same fern can 
be used in many different places, so there is no turn-over in space. In Angiosperms, the 
pattern may be one of overdispersed clusters, but the clusters are sufficiently rich in 
species for the single statistic that reduces the complexity of relationships across the 
entire phylogeny (Borregaard et al., 2014) to a single figure reflecting clustering overall. 
If the “clusters at the tips” in Angiosperms are single or few species in the ferns, then 
the single statistic will record an overall pattern of overdispersal. Just as community 
ecology needs more sophisticated metrics to tease apart the complex patterns of clade 
over-representation, methodological refinement is needed to exploit phylogenetic 




Ferns comprise ca. 9000 species (Smith et al., 2006), and account for about 3% of 
globally-known vascular plants (Christenhusz & Byng, 2016) and could be an important 
source of new medicines if continued commitment is devoted to the search for new 
medicinal plants. Whilst all the previous studies were focusing on Angisoperms for 
ethnomedicinal patterns, investigation on the generality of phylogenetic patterns by 
exploring evolutionary relationships between fern species that are used medicinally was 
shown here for the first time.  
 
Evidence for phylogenetic overdispersion was found consistently at every taxonomic 
level and spatial scale investigated. This results are not encouraging to identify 




in Saslis-Lagoudakis et al. (2012). Here, I have shown that the ethnomedicinal selection 
of ferns is not comparable to selection of flowering plants. Neither the MPD nor the 
MNTD have shown significant clustering at any taxonomic hierarchical level. Instead, a 
pattern of significant overdispersal of traditionally used fern species is observed. This 
finding suggests that, overall, fern diversity is better sampled by traditional medicine 
than angiosperm diversity, where medicinal plants are found on selected lineages 




























Chapter  5. Phylogenetic prediction of public health risk 




The use of plants in the treatment and prevention of disease has been practiced for 
thousands of years. The continued use of medicinal plants in traditional cultures may be 
because of their perceived magical or symbolic importance. There may be no scientific 
proof of efficacy, but beliefs are passed verbally from one generation to the next 
generations by elders and shamans, and plant use is therefore considered to be safe and 
effective (Van Wyk & Wink, 2004; Chin, 2005; Van Wyk & Wink, 2015). Although 
many plants that are used medicinally are often perceived ‘natural’ and are believed to 
be safe to use, their ‘naturalness’ does not guarantee that they are harmless. Intensive 
research concerning phytochemical and pharmacological activities focused on many 
medicinal plants has shown some constituents of medicinal plants are potentially toxic, 
mutagenic, carcinogenic, clastogenic and teratogenic (Akintonwa et al., 2009; Kuete, 
2014; Van Wyk & Wink, 2015; see Box 1 for definitions). This raises concerns about 














Box 1: Definitions  
 
Precise definition * of terms used to describe specific forms of toxicity used in this 
chapter: 
 
Toxic - a poisonous susbtance that can damage an organism. 
Mutagenic - having the ability to cause a permanent change in an organism's genes. 
Carcinogenic - used to refer to a substance that causes cancer. 
Clastogenic - capable of causing breakage of chromosomes. 
Teratogenic - used to refer to a substances that causes malformation of an embryo. 
 






Several fern species that are used medicinally are known to damage animal and human 
health. It has been demonstrated that some fern species contain a variety of toxic 
secondary metabolites, of which the best known is Ptaquiloside (PTA). PTA is 
mutagenic, clastogenic and carcinogenic (Van der Hoeven et al., 1983; Niwa et al., 
1983(a); Tomšík, 2014). This compound was first isolated in 1983 and was determined 
to be a norsesquiterpene glucoside of the illudane type containing a reactive 
cyclopropane ring, and readily soluble in water (Niwa et al., 1983(b)) (Figure 5.1). This 
molecule produces pterosin B under acidic conditions and an unstable dienone under 
alkaline conditions which is believed to be the ultimate carcinogen (Smith & Seawright, 
1995; Vetter, 2009, 2011). Consumption of contaminated meat or milk from cattle 
grazing on plants that contain PTA and spore inhalation, as well as direct consumption 
of  PTA-containing species as a food or herbal remedy are the potential sources of 
exposure to this poisonous and carcinogenic constituent (Alonso-Amelot, 1996; Simán 















Heavy metal contamination in soil is an another toxicological risk to human health 
which has been continued to gain global attention. Several heavy metals are 
carcinogenic to humans. Exposure is via contaminated soil, the food chain (soil-plant-
human or soil-plant-animal-human), or contaminated ground water (McLaughlin et al., 
2000). Some heavy metals such as iron (Fe), zinc (Zn), chromium (Cr), copper (Cu), 
manganese (Mn) and Nickel (Ni) are essential to human health in small amounts (Chen 
et al., 1995), however, some others, such as lead (Pb), cadmium (Cd), chromium (Cr) 
and arsenic (As) become toxic in excess of certain concentrations (Singh & Kalamdhad, 
2011).  
 
Many species of plants are able to to absorb heavy metals from soils and accumulate 
them. A plant that is capable of taking up large quantities of contaminants from soils, so 
the level of heavy metals in the plant is higher than in the soils, is known as a 
hyperaccumulator. More precisely, a hyperaccumulator is defined as a plant that able to 
accumulate more than 100 mg/kg-1 Cd, 1,000 mg/kg-1 As/Co/Cu/Pb/Ni or 10,000 
mg/kg-1 Mn/Zn in its above-ground parts (Brooks, 1998). To date, more than 400 
Angiosperm species have been identified as heavy metal hyperaccumulators of As, Cd, 
Co, Cu, Mn, Ni, Pb, Sb, Se, Tl and Zn (Rascio & Navari-Izzo, 2011) of which about 
three-quarters are nickel (Ni) hyperaccumulators (Baker et al., 1999). The majority of 
plants that hyperaccumulate arsenic are ferns, and arsenic hyperaccumulation was first 
reported in Pteris vittata (Ma et al., 2001). Long term exposure to arsenic causes health 
problems, and arsenic poisoning (arsenicosis) is a major health problems in some 
countries especially in Asia (Tseng, 1999). Atherosclerosis, cancers in various organs, 
especially the skin, lung, bladder, liver, skin lesions, neurological effects, 




documented to be associated with arsenic exposure in some epidemiological studies 
(Rahman et al., 1999; Tseng, 1999; Smith et al., 2000). Mining activity is one of the 
important sources of exposure to arsenic or other heavy metals and abandoned mining 
areas are often colonized by natural vegetation or replanted. If the species are 
hyperaccumulators used as foods or medicine, this causes a serious health risk, 
especially for those people living on contaminated land and relying more on natural 




Several species in different families of ferns are toxic or carcinogenic because of PTA 
or arsenic hyperaccumulation. However, not all ferns contain PTA or are arsenic 
hyperaccumulators. Thus, the purpose of this chapter is to review the literature on the 
toxicological properties, either PTA or arsenic accumulation, in ferns, especially in 
medicinally-used species, and also to explore the phylogenetic distribution of these 
toxic elements using the robust megaphylogeny of the ferns (Chapter 2). 
 
To understand evolution of toxic compounds, PTA and arsenic hyperaccumulation in 
fern species, it is necessary to know not only the character states in extant ferns but also 
in their ancestors. Ancestral state reconstruction is increasingly popular; by optimising 
the character states of living organisms onto phylogenies, it serves as a method for 
testing hypotheses about evolution of any character traits (Pagel et al., 2004; Goldberg 
& Igić, 2008; Litsios & Salamin, 2012). For example, if all members of a monophyletic 
group have PTA, it can be concluded that their last common ancestor most probably 
contained PTA. More importantly in this study,  if there are missing data, the ancestral 
occurrence of PTA could be used to predict which ferns had these properties. With more 




(Chapter 3), predicting or recognised which clades or groups of ferns contain PTA or 
hyperaccumulate arsenic has important implications for health. 
 
5.2 Materials and methods 
 
5.2.1  Sourcing data describing toxicity  
 
Toxicological literature for all fern species, including non-medicinal and medicinal 
species was made using Google Scholar with the following terms; “Ptaquiloside” and 
“arsenic accumulation” in combination with the term “ ferns” and “pteridophytes”. 
 
5.2.2 Sourcing data describing use as food and medicine 
 
All the species that have been screened for their PTA and arsenic accumulation were 
then matched with the medicinal use that have been recorded in Chapter 3. At the same 
time, searches were made for PTA-containing and arsenic hyperaccumulating species, 
to see whether they have been recorded as having food use. For the subset of the 
medicinal species and species that are used as food that were identified as toxic, the 
plant parts eaten or used were recorded. 
 
5.2.3 Predicting the taxonomic distribution of toxicological and carcinogenical species 
 
Initially, predictions for the species used were made based on their taxonomic 
distribution, but an explicit phylogenetic approach was also taken. The taxonomic 
approach was made by identifying all the species that are used medicinally which are 
known to contain PTA or arsenic hyperaccumulation. All the use reports and number of 




number of their congeners and confamilial species that were not screened for PTA or 
arsenic hyperaccumulation were calculated and recorded. 
 
The maximum likelihood (ML) phylogeny of ferns reconstructed at the species level 
(Chapter 2) was used in this chapter. This phylogenetic tree represents a total of 3719 of 
fern taxa, including the outgroup was used for mapping the distribution of PTA 
compound and arsenic hyperaccumulator. Two maximum likelihood ancestral 
reconstructions, one of PTA and the other of arsenic hyperaccumulation, were 
undertaken using Mesquite (Maddison & Maddison, 2001). The characters of PTA and 
arsenic hyperaccumulation were coded as presence or absence characters and missing 
data were coded as “?”. The “Trace Character Over Tree” option was employed to 
reconstruct the ancestral state. The tree was then visualized as ‘Balls and Sticks” 
representation. In the case of arsenic hyperaccumulation, the investigation was limited 
to family Pteridaceae, since literature survey found there are no arsenic 
hyperaccumulators outside of this family. 
 
5.3 Results and discussions 
 
5.3.1 Known toxic species and their medicinal and food use 
 
Studies of the toxicology of ferns have been published. The possibility of using ferns in 
phytoremediation has also resulted in several studies of heavy metal hyperaccumulation. 
This chapter reviews the toxicological and carcinogenical studies in ferns and 
distribution of arsenic hyperaccumulators. In general, assessments of the toxicity and 
carcinogenicity of fern species focusing on arsenic PTA and arsenic accumulation were 
very few, with only 1.5% of the global fern diversity investigated (Appendix 5.1 and 




Out of 58 species that have been investigated for the PTA, 41 have been recognized to 
contain a potent carcinogenic compound, ptaquiloside (PTA) or its analogue, pterosin B 
with 23 out of these having medicinal use and some of them serving as food in many 





Table 5.1 List of toxic and carcinogenic species used for food or medicine. P indicates  a species with PTA and A indicates an arsenic hyperaccumulating species. Country indicate the 
countries for which there are use reports either as a food (F) or medicine (M). 
Species  Toxin Country and Use for food (F) and medicine (M) Part used for food (F) or medicine (M) 
Aleuritopteris farinosa  
(Cheilanthes farinosa) 
P India (M), Ethiopia (M) Rhizome (M), Frond (M) 
Cibotium barometz  P China (F), India (M), Malaysia (M), Japan (M), Philippines (M), Vietnam (M) Rhizome (F, M), Frond (M) 
Cyclosorus aridus  
(=Christella arida) 
P India (M), Papua New Guinea (M) Leaves (M) 
Cyclosorus dentatus  
(=Christella dentata) 
P DR Congo (M), Africa (F) Young leaves (F), Whole plant (M) 
Diplazium esculentum 
(=Callipteris esculenta) 
P Malaysia (F,M), Indonesia (M), China (M), Taiwan (M), Philippines (F), India (F,M), Bangladesh (M), Nepal (F, 
M), Nigeria (F), Africa (M) 
Frond (F, M), Rhizome (M), Young leaves 
(F,M) 
Dryopteris cochleata  P Nepal (F), India (M) Young leaves (F), Frond (M), Whole Plant 
(M) 
Dryopteris juxtaposita P Pakistan (M) Frond (M) 
Histiopteris incisa  P DR Congo (F), New Zealand (M) Leaves (F), Frond (M) 
Hypodematium crenatum P India (M) Rhizome (M), Leaves (M) 
Hypolepis punctata P India (M), China (M) Frond (M), Leaves (M) 
Hypolepis tenuifolia P Taiwan (M) Frond (M) 
Myriopteris myriophylla  
(=Cheilanthes myriophylla) 
P Peru (M) Leaves (M) 
Onychium japonicum P India (M), Taiwan (M), China (M) Leaves (M), Spore (M 
Pityrogramma calomelanos P and A Malaysia (M), India (M), Philippines (M), South Africa(M), Bangladesh (M), Nepal (M), Peru (M), Indonesia 
(M) 
Frond (M), Rhizome (M) 
Polystichum squarrosum  P Nepal (F), India (M) Rhizome (M), Young leaves (F) 
Pteridium aquilinum  P Japan (F), Korea (F), China (F,M),  Angola (F),Cameroon (F), Dr Congo (F), Gabon (F), Madagascar (F), 
Nigeria (F), South Africa (F,M), Greece (M), India (M), Europe (M), Thailand (M), Papua New Guinea (M), 
Italy (M), Bosnia (M), Kosovo (M), Mexico (M), Portugal (M) 
Frond (F, M), Crozier (F, M), Crozier (F,M), 
Aerial Part (M), Leaves (F,M) 
Pteridium aquilinum var. 
arachnoideum 
(=Pteridium arachnoideum) 
P Argentina (M) Frond (M) 
Pteridium aquilinum var. 
latiusculum  
P Japan (F), China (F, M), Korea (F) Frond (F), Rhizome (F), Crozier (M) 
Pteridium esculentum  P New Zealand (F, M), Australia (M) Frond (M), Rhizome (F, M), Crozier (M) 
Pteridium revolutum  
(=Pteridium aquilinum subsp. 
wightianum) 
P China (F), India (M) Frond (F), Rhizome (F, M) 
Pteris aspericaulis P and A Nepal (M) Rhizome (M) 
Pteris biaurita P and A Nepal (F,M), India (M) Frond (M), Young Leave (F), Young leaves 
(F) 
Pteris cretica P and A India (M), China (M), Pakistan (M) Frond (M), Leaves (M), Whole Plant (M) 
Pteris longifolia A China (M) - 
Pteris multifida A India, China (M), Vietnam (M) Rhizome (M), Frond (M) 
Pteris quadriaurita P and A Nepal (M), Africa (M), India (M) Rhizomes (M), Leaves (M) 
Pteris wallichiana  P China (F, M), India (M), Papua New Guinea (M) Frond (M), Leaves (F, M) 




The majority of PTA-containing species are members of the genus Pteridium. PTA has 
been recorded in seven families (Athyriaeae, Cibotiaceae, Dennstaedtiaceae, 
Dryopteridaceae, Hypodematiaceae, Pteridaceae and Thelypteridaceae) but most of the 
investigated species that contain this carcinogenic compound are belong to the 
Dennstaedtiaceae or Pteridaceae (Appendix 5.1).  
 
On the other hand, a range of fern species accumulate arsenic from the soil (Appendix 
5.2).  Of the 102 species identified as able to accumulate arsenic, 62% are found to have 
medicinal use and some of them are used as a vegetable. Several studies indicating 
species were hyperaccumulators were conducted at arsenic-contaminated sites (Ma et 
al., 2001; Visoottiviseth et al., 2002; Van et al., 2006). However, Zhao et al. (2002) 
found the same species exhibited hyperaccumulation from uncontaminated soils. It 
seems that the hyperaccumulating trait in ferns is constitutive, regardless of whether 
species grow in contaminated soils or not (Zhao et al., 2002; Wang et al., 2007; 
Bundschuh et al., 2014). Since the distribution of arsenic in soils may vary with soil 
type  (Smith et al., 1998), only hyperaccumulator species are further discussed in detail 
in this study. Collection of the hyperacumulating species in any environment, not only 
polluted environments, poses potential risk of toxicity as this metal can affect biological 
activities as a carcinogen and mutagen. Arsenic hyperaccumulator species are limited to 
the family Pteridaceae. Almost all the hyperaccumulator species are placed in genus 
Pteris, however, some of the Pteris species also are not hyperaccumulators. Of 12 
hyperaccumulating species, eight are used medicinally in different cultures (Table 5.1).  
 
Twenty-six species are identified and still being used in traditional medicine in different 




contain PTA or are able to accumulate arsenic in large amounts (Table 5.1). Notably, 
five species; Pityrogramma calamelonaos, Pteris aspericaulis, Pteris biaurita, Pteris 
cretica and Pteris quadriaurita which belong to Pteridaceae not only contain PTA but 
are also arsenic hyperaccumulators. Even more alarming, all these five species have 
significant medicinal use despite known toxicological properties. 
 
In those species studied to date, the toxic compound, either PTA or arsenic, can be 
found in all parts of plants especially in croziers and fronds (Rasmussen et al., 2003; 
Srivastava et al., 2006). Rasmussen et al. (2003) revealed that the highest concentrations 
of PTA in ferns were found in fronds while Ma et al. (2001) showed fronds accumulate 
more arsenic than other parts. Rhizomes and fronds are the plant parts most often served 
as a vegetable or used in traditional medicine (Table 5.1). Ferns are widespread, found 
in many enviroments, including in alkaline soils where the arsenic is more extractable 
and can therefore accumulate to increase risk among consumers. 
 
Despite the reports of toxic compounds, the majority of species with known toxicity 
remain importance in ethnopharmacopeias. For instance, Aleuritopteris farinosa 
(Cheilanthes farinosa) which has been reported to contain PTA, also has been used in 
folk medicine in India to treat stomach ache and menstrual problems (Jain et al., 2005; 
Mannan et al., 2008; Benniamin, 2011). This species is rich in flavonoids (Erdtman et 
al., 1966) and has been shown to pose strong anti-inflammatory and anti-nociceptive 
properties due to the presence of active ingredients  such as rutin, cinnamic acids, 
caffeic acid and its quinic acid derivative, chlorogenic acid (Yonathan et al., 2006). 
Nevertheless, the use of whole plant extracts from ferns as food or herbal remedies 
should be approached with caution and future research also needs to clarify which 




Pteridium aquilinum, including subspecies and varieties, is a notable species in this 
survey, exemplifying significant medicinal and food use despite known toxicological 
properties (Table 5.1). The detrimental effects of this invasive species on livestock have 
been appreciated since the 18th century and it has since been shown to be a cause of 
thiamine deficiency, bladder tumours, and acute haemorrhagic disease in horses, pigs 
and in cattle and sheep respectively (Fenwick, 1989; Shahin et al., 1999). The presence 
of PTA, a reactive norsesquiterpenoid glucoside, has been demonstrated to contribute to 
the toxicity of bracken (Van der Hoeven et al., 1983; Yamada et al., 2007). The 
carcinogenic properties of PTA are not only responsible for animal disease, but believed 
to constitute a risk to human health either through environmental exposure or 
consumption. A close association was found between the consumption of bracken and 
human gastric cancer (Alonso-Amelot & Avendaño, 2002). More than 20 toxicological 
studies of P. aquilinum were identified in this survey, so the toxicity of P. aquilinum is 
well known. Despite a long history of research establishing a link between human 
cancers and consumption (Kamon & Hirayama, 1975; Marliere et al., 1999), many 
reports of medicinal use in this study are fairly contemporary; 8 of the 58 use reports 
were less than 5 years old, and 50 less than 10 years old (Chapter 3). Arguably, 
processing methods that detoxify the plants might be used; or, since carcinogens are 
slow-acting, the link between consumption and negative health effects may not be 
made. PTA is water soluble and decomposes under acidic or alkaline conditions (Hirono 
& Weisburger, 1986). In order to remove the bitter taste for food use, P. aquilinum is 
soaked in water for a few hours prior to cooking, greatly reducing the level of PTA. 
However, we find 17 reports of decoction of  P. aquilinum used medicinally (Chapter 
3), where decoction might be expected to maximize expose to PTA. Just as use of 




ethnobotanical and metabolomic research to assess public health risks (Michl et al., 
2013), more research on P. aquilinum including subspecies and varieties should be also 
prioritized. If the risk of exposure to PTA is proven, public health interventions are 
needed. 
 
Diplazium esculentum is one of the examples of an edible fern that is popular and 
commonly consumed in Asia (Table 5.1). The young frond of this species was found to 
contain PTA (Somvanshi et al., 2006) and an earlier study by Kumar (2004) discovered 
that this species caused mild pathologic effects in rats and induced mortality in guinea 
pigs. In a more recent study, Roy and Chaudhuri (2015) discovered this species may 
also induce immune dysfunction by altering cytokine balance in mice. However, a study 
by Junejo et al. (2015) found that the leaf extract of this species is non-toxic in their 
acute oral toxicity test and safe to be used for medicinal purposes. Even though the 
findings from previous studies are contradictory, further studies are still needed, so the 
public health risk associated with eating this fern as a vegetable can be determined.  
 
Another notable species, Pteris vittata, is well-studied due to its remarkable capacity for 
arsenic hyperaccumulation. Even though this species has received extensive attention 
since discovery as the first arsenic hyperaccumulator in ferns (Ma et al. 2001), it is still 
used as traditional medicine. More than ten use reports in seven different studies, 
particularly in India, have been recorded (Chapter 3) clearly showing that Pteris vittata 
has been extensively used to treat several ailments. Abou-Arab and Abou Donia (2000) 
investigated the heavy metal levels during processing of Egyptian medicinal plants and 
found that boiling the plant in water leads to the extraction of higher amounts of the 
metal from the plant than immersing it in the hot water. One unanticipated finding here 




method might concentrates heavy metals and might ultimately lead to the death of the 
people using this remedy. 
 
Even though this study emphasizes hyperaccumulator species, non-hyperaccummulator 
species should never be overlooked as many fern species that able to accumulate arsenic 
also are used as traditional medicine and as a vegetable. Exposure to arsenic even at low 
concentration may also cause a variety of human health problems if the comsumption 
was on long term basis (Kaltreider et al., 2001).  
 
With only 1.5% of all fern species screened so far, and only 1% of the species with 
medicinal use investigated, further screening is urgently needed. Until resources are 
directed to this end, it is necessary to predict the extent of the problem. In terms of  
predicting the public health risk from a species that is not screened yet, three approaches 
were taken here; 1) Taxonomic distribution of known toxic species used medicinally. 2) 
Using phylogeny and ancestral reconstruction to explore and trace evolution of toxicity 
in ferns and 3) Mapping the distribution of toxic species at family level using 
phylogeny. 
 
5.3.2 Predicting health risk using taxonomic distribution 
 
As several species in the fern group have been shown to have toxic and carcinogenic 
properties, their close relatives might be also have the potential to have these toxic 
properties. Thus, understanding the taxonomic distribution of these species could 
provide a basis to estimate risk and at the same time to help to identify which groups 
should be the focus of further screening. Table 5.2 shows that many species in the same 
genera and families as PTA-containing species are used medicinally, but have not been 




Table 5.2 Many PTA-containing species are used medicinally. Many of their congeners 
and confamilial species are used, but not screened for PTA. If PTA follows a taxonomic 
distribution, the exposure of PTA through medicinal fern use could be more significant 
than suggested by the known use of 23 PTA-containing species. 
Medicinal 
genera known to 
contain  PTA 
Species, and number of use reports 
(number of publications source reports 
drawn) 
Number of congeneric 
species with medicinal 
use for which PTA 
status is unknown 
 
Athyriaceae (10 species with medicinal use and unknown PTA status) 
Diplazium D. esculentum 23(12) 6 
Cibotaceae (no confamilial with medicinal use) 
Cibotium  C. barometz 24(9) 0 
Dennstaedtiaceae (4 species with medicinal use and unknown PTA status) 
Pteridium  P. aquilinum 58(21)  
0 
P. aquilinum var. arachnoideum 1(1) 
P. aquilinum var. latiusculum 2(1) 
P. esculentum 15 (4)                                  
P. revolutum 6(1) 
Histiopteris H. incisa 1(1) 0 
Hypolepis H. punctata 3(2) 
1 
H. tenuifolia 1(1) 
Dryopteridaceae (44 species with medicinal use and unknown PTA status) 
Dryopteris  D. cochleata 20(7);  
22 
D. juxtaposita 1(1) 
Polystichum P. squarrosum 1(1) 7 
Hypodematiaceae (no species with medicinal use and unknown PTA status) 
Hypodematium  H. crenatum 5(3) 0 
Pteridaceae (83 species with medicinal use and unknown PTA status) 
Aleuritopteris A. farinosa 10 (5) 5 
Myriopteris M. myriophylla 1(1) 1 
Onychium O. japonicum 3(2) 1 
Pityrogramma P. calomelanos 42(13) 1 
Pteris P. aspericaulis 4 (1) 
12 
P. biaurita 4 (3) 
P. cretica 5(5) 
P. quadriaurita 5(5) 
P. wallichiana 7(4) 
Thelypteridaceae (19 species with medicinal use and unknown PTA status) 
Cyclosorus C. dentatus 3(1) 
12 





Meanwhile Table 5.3 shows that many species in Pteridaeae, particularly in genus 
Pteris are used medicinally, but not been screened for arsenic hyperaccumulation. If 
arsenic hyperccumulation follows a taxonomic distribution, the exposure of arsenic 
hyperaccumulation through medicinal fern use could be more significant than suggested 
by the known use of 8 arsenic hyperaccumulating species. 
 
Table 5.3 List of  hyperaccumulating species that are used medicinally. 
Medicinal genera 
known as arsenic 
hyperaccumulators 
Species, and number of use reports 
(number of publications source reports 
drawn) 
Number of congeneric 
species with medicinal 





Pteridaceae (78 species with medicinal use and  
unknown hyperaccumulating status) 
 
Pityrogramma P. calomelanos 42(13) 1 
Pteris P. aspericaulis 4 (1) 
10 
P. biaurita 4 (3) 
P. cretica 5(5) 
P. longifolia 1(1) 
P. quadriaurita 5 (5) 
P. multifida 13(5) 
P. vittata 13(7) 
 
 
Overall, Tables 5.2 and 5.3 show that of the 14 genera known to include species PTA or 
hyperaccumulating arsenic, three genera, Dryopteris, Pteris and Cyclosorus include 
more than ten species that are toxic and used medicinally. These must be priority genera 
for screening, and their use raises concern. Other genera of concern ( ≥ five medicinal 
species in a genus know to include toxic species) are Diplazium, Polystichum and 
Aleuritopteris. The exposure of PTA or arsenic hyperacumulator through the medicinal 




compound. For instance, more than 75 species that are used medicinally in family 
Pteridaceae and more than 40 medicinal species in Dryopteridaceae have been not 
screened yet for their toxicological and carcinogenical properties.  
 
There are limitations to the taxonomic approach taken here. One is that considering 
genera and family units, and what is known about them in isolation, means information 
we have on how genera or families are related is not taken into account. Another 
limitation is that it is difficult to take into account information about the absence of 
toxicity. The phylogenetic approach explicitly considers relatedness which is usable for 
making predictions and eventually able to identify species that do not contain PTA or 
arsenic hyperaccumulation. 
 
5.3.3 Predicting health risk using phylogenetic approach 
 
Firstly, distribution of toxic properties was investigated using ancestral reconstruction. 
Trait evolution can be examined by using ancestral reconstruction by mapping 
particular traits onto a molecular phylogeny (Simpson, 2010). As several fern species 
have been identified in different genera and families, this approached was used to 
predict and investigate any patterns of distribution of PTA-containing or arsenic 
hyperaccumulating species in related families that are not uncovered by taxonomic 
approach.  
 
Our analyses showed almost all of the ancestral character states of deep nodes 
representing the most recent common ancestor three or more species are equivocal for 
PTA and arsenic hyperaccumulation. A possible explanation for these results may be 
the high proportion of missing and limited data.  Therefore, further work to include 




Since all arsenic hyperaccumulator species belong to family Pteridaceae, thus, it would 
interesting to explore the phylogenetic prediction between the hyperaccumulating and 
non-hyperaccumulating species in this family. We predict that more arsenic 
hyperaccumulating species will be found, however, equivocal nodes seem the norm in 
this phylogeny too, since only a small proportion of species have been tested for arsenic 
accumulation to date (Appendix  5.3).  
 
Overall, based on the ancestral reconstruction approach, most of the traits were 
insufficiently known to predict clades with toxic properties. However, the data 
tentatively suggest these traits might not be conserved through fern evolution. Further 
investigation for many species of ferns is needed in order to point clearly to where we 
should look for more toxic species. Furthermore, further screening can be focused on 
the close relatives PTA containing or hyperaccumulating species. 
 
Because ancestral reconstruction is influenced by the large proportion of missing data, 
we also mapped presence of toxic properties onto the phylogeny at family level. The  
phylogenetic distribution of the properties is summarised in Figure 5.2. The 
phylogenetic relationships within the Polypodiales clade are of broader interest, 















































Figure 5.2 Phylogenetic tree for ferns showing the distribution of families posing risk to health. (a) PTA. Families with species 
containing PTA are shown in red and families in green have been shown to include species that  do not contain PTA (b) Arsenic 
hyperaccumulation. Hyperaccumulating species belong only to the Pteridaceae shown in brown. Several families in green have been 
shown to include species which do not hyperaccumulate arsenic. * indicate families that include both PTA-containing species and 
non-PTA-containing species along with hyperaccumulating and non-hyperaccumulating species. 
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As shown in Figure 5.2 (a), it is apparent that PTA-containing species are all located  in 
the core leptosporangiate ferns (Cyatheales and Polypodiales). Six families containing 
PTA are concentrated in Polypodiales clade where some of the families are closely 
related to each other suggesting more hyperaccumulator species might occur in this 
clade. In contrast, arsenic hyperaccumulator species are more concentrated in the 
Pteridaceae family within the order Polypodiales, however, other families that are 
closely related and other families in the same order do not exhibit hyperaccumulation 
and neither do primitive ferns such as Psilotales and Equisetales (Figure 5.2 (b)).  These 
patterns suggest that these toxic and carcinogenic properties are phylogenetically 
conserved to some extent in ferns. A similar phylogenetic pattern in heavy metal 
hyperaccumulation including arsenic is seen in Brassicaceae, (Krämer, 2010). 
Interestingly, Pteridaceae are unique by having toxic and carcinogenic properties from 
both PTA and arsenic hyperaccumulation. However, due to time constraints on 
laboratory work, toxicological screening was not carried out in this study. Therefore, 
further investigation and experiment on toxicity tests should be prioritized for this 
family.  
 
Several questions remain unanswered at present. It seems that PTA and arsenic 
hyperaccumulation arrived relatively late in terms of fern evolution as these characters 
are not exhibited by some exemplars of primitive ferns. In order to develop full picture 
of  the evolutionary origin of these toxicities in ferns, screening of more primitive 
species is necessary. Despite toxicity caused by PTA and arsenic hyperaccumulation 
being absent in earlier-evolving, these linegaes lacking PTA and arsenic 
hyperaccumulation are not necessarily safe. For instance, Equisetum (Horsetail) 




of silicates which can produce digestive problems when used in the long term (Pohl, 
1955; Cullina, 2008; Sandhu et al., 2010). This enzyme is also present in bracken  and 




The presence of unacceptably toxic compounds in medicinal or edible plants is a 
concern because of immediate health problems and genetic damage which can be 
heritable. This study shows a number of ferns have been used in traditional medicine or 
serve as food in different parts of the globe and many of them have been shown to have 
to these toxic and carcinogenic properties. Surprisingly, some of them are well known 
to be toxic. Traditional use despite scientific demonstration of toxicity is known for 
other plants. For example, Aristolochia indica consumption leads to urinary tract cancer 
and is still widely available in Bangladeshi herbal markets where those buying it are 
unaware of  its toxicity (Michl et al., 2013). Other examples, include Poliomintha 
longiflora (Mexican Oregano) known to contain acutely toxic compounds (Deciga-
Campos et al., 2007) and still widely used for culinary and medicinal purposes, while 
38 species in Traditional Chinese Medicine (TCM) and numerous indigenous plants in 
North America have been reported to contain toxic pyrrolizidine alkaloids (PAs) which 
could be responsible for initiating a range of slowly developing chronic diseases 
(Roeder, 2002; Roeder et al., 2015). In this context, the risk of these toxic properties in 
food or herbal remedies for humans must not be ignored. Further assessment into 
biological and toxicological properties of less well-known species is crucial, in order to 
assess the real potential of these medicinal species and also to ascertain their safety for 
human use. Upon confirmation of the species toxicity, awareness needs to be raised not 




authorities. The findings here also indicate that studies about the health risks associated 
with fern species are limited and provides a framework for the further exploration of 
toxicity in ferns. The scale of the public health problem associated with PTA or arsenic 
hyperaccumulation might be a considerable and further investigation and 





























Chapter  6. General conclusion and future perspectives 
 
This thesis, “Molecular Systematic Studies of Extant Ferns (Monilophytes) with 
Emphasis on Medicinal Use of Ferns”, highlights the power of the phylogeny of ferns 
and meta-analysis of the ethnobotanical data to explore the evolutionary patterns 
amongst fern species that are used medicinally at different ranges and scales as well as 
the access of the distribution of toxic in medicinally-used fern species. 
 
6.1 Challenges faced in carrying out this work 
 
The biggest challenges faced in this study was the existence of several names for the 
same taxon. This occurred in part because of the lack of dissemination of taxonomic 
information in the past, as a result of limited communication facilities. This problem 
existed when two or more researchers from different countries were not aware of the 
same taxon that they described is actually of the same species (Mohamed Said et al., 
1999). The phenomenon of synonymy has made it difficult to assemble the uses of 
particular species. Different names have been used for the same species and thus it has 
been difficult to collate information about the ethnobotanical uses of ferns. The lack of 
an up to date, authoritative synonymized checklist is a significant barrier to synthesize 
knowledge on plant uses from the diverse and fragmented data sources available 
(Lukhoba et al., 2006). Major challenges in this study began when sequence data were 
gathered from Genbank to reconstruct the supermatrix. Compilation of a large number 
of data from Genbank poses a great challenge due to the source organism nomenclature 
and taxonomic classifications in Genbank being inadequately curated, so changes in 




2011; Christenhusz & Chase, 2014). Furthermore, some species name in Genbank were 
misspelled. In order to validate the current accepted name of the species and also to 
resolve any related taxonomic problems, the spelling and nomenclature of all species 
were checked manually following recent studies. Since all the taxonomy and 
nomenclature for each chapter in this study is linked to each other, standardization of 
nomenclature for all chapters is very important to provide a consistent view of the data 
available in a particular field. At the species level, it is desirable to use a single  
internationally recognized data portal of plant taxonomic information such as 
TROPICOS (2016), nevertheless recognizing nomenclature can still be imperfect  
especially where names do not appear in the first source. For instance, Microsorum 
grossum is not listed in TROPICOS (2016), thus the updated nomenclature of this 
species was checked in other sources such as Catalogue of Life (2016) and World Ferns 
(Hassler & Schmitt, 2015). Even though the nomenclature updated in this study might 
not be completely perfect, it has been improved in many aspects from the previous fern 
megaphylogeny (Lehtonen, 2011). In the face of these challenges, it is important to be 
able to interact with a taxonomist specialist, but ultimately the ease of the work depends 
on the quality and completeness of the databases.  
 
We managed to reconstruct the most comprehensive molecular phylogeny for ferns to 
date, however, we still lack sequence data of many important species, especially those 
that have been used in traditional medicine, and this may limit its utility in some 
contexts. Therefore, additional sampling is required for medicinal species that are not 
available in Genbank. This global phylogenetic study posing other challenges in the 
data assembly due to the limited field opportunity and the difficulty of getting  




The study is also limited by the small proportion of medicinal data for fern species in 
ethnobotanical surveys due to lack of ethnobotanical studies focusing on ferns 
compared to Angiosperms (Benjamin & Manickam, 2007; Rout et al., 2009). This 
resulted in more time used to identify fern species in general ethnobotanical literature. 
 
There are several challenges in using the community phylogenetic software, Phylocom 
v4.1, (Webb et al., 2008) which are mostly due to the documentation or user guide not 
being user friendly. Some commands or features stated in the documentation work only 
in an Apple IOS environment, but not in Microsoft Windows. Several errors were found 
during software execution, most which were overcome by changing and structuring 
input files. Inability to address this software bug deterministically leads to unsafe 
speculation in software execution. 
 
6.2 How robust is the work 
 
This study uses published data, and as such depends on the availability of quality data. 
Three elements were the basis of the study described here, the phylogeny, the use 
database and the database of toxicity. Together, these three shed light on the extent of 
fern use, patterns of fern use and possible health risks of fern use.  However, 
deficiencies in each of the three elements brought together here should be considered, as 
possibly limiting the interpretation of the analyses. 
 
Our large-scale fern tree of life demonstrated that it was possible to estimate a well-
corroborated, taxon rich phylogeny directly from analyses of a supermatrix. Although 
not all nodes were well supported and some relationships relatively poorly resolved, this 




able to render a more a clear generic delimitation in several families. With the advent of 
next-generation sequencing (NGS) technologies in recent years, improvement in high-
throughput, time-saving and affordability has helped resolve most of the problematic 
relationships in flowering plants, thus, resolving remaining problematic deep level 
questions in ferns in the near future would much easier (Schuster, 2007; Soltis et al., 
2010; McCormack et al., 2013). Nevertheless, since the tree in this study has 
sufficiently dense taxonomic sampling at species level, and I have shown it serves as a 
valuable framework for comparative research. It may be also useful for other practical 
applications in many areas of biology (Heath et al., 2008; Lu et al., 2014).  
 
Ethnobotanic data are scattered in various publications in different languages with 
limited accessibility and application, and some of the medicinal plants databases are 
written in various languages especially sources from China or other countries that do 
not converse in English (Ningthoujam et al., 2012). Therefore, there are likely to be 
some geographical biases in the data collected here. Another issue that might undermix 
the robustness of the ethnobotanical database is the incorrect identification of species 
recorded as used. My study revealed 54% of the use data is not associated with 
herbarium specimens, and field identification by non-experts may be inaccurate. 
Voucher specimen for herbarium collection are an essential components of any research 
project by providing valuable tools for assisting researchers in confirming the identity 
of an unknown plant (Culley, 2013). Therefore, the absence of voucher specimens of a 
research project, may influence the quality of data analyses as there is no proof of the 
species identity. Data quality in ethnobotanical meta-analysis is a recognized problem 
(Albuquerque & Medeiros, 2012). We might expect the identification associated with 




known, so one weakness of the use of published data is that it might report false 
negative where the compound tested for is just below recorded threshold.  
 
6.3 Priorities for future work  
 
Extensive literature review in this study indicates that fern species are used in 
traditional medicine. However, not many ethonobotanical studies include fern species 
and they have not been recorded as having medicinal uses as frequently as 
Angiosperms. There are several factors contributing to the low representation of fern 
species in traditional pharmacopoeias, but fern use is revealed if it is the explicit focus 
of ethnobotanical survey (dos Santos Reinaldo et al., 2015). Thus, ethnobotanical 
survey with the most appropriate data collection method focusing on ferns is crucial and 
should be conducted in the future. This step is important to update the inventory of 
existing ferns that are used as traditional medicine with respect to the number of ferns 
yet to be explored. Furthermore, considering the rapid destruction of natural habitats 
and the ongoing loss of biodiversity, especially in tropic regions (Achard et al., 2002; 
Sodhi et al., 2004; Hansen et al., 2013), unrecorded species potentially become extinct 
before their medicinal potential can be sufficiently explored. Ethnobotanical studies 
have indicated other uses of ferns (Keller et al., 2011), therefore, the approach taken in 
this thesis (Chapter 4) need not be restricted to the study of medicinal of use but also 
can be applied  to the investigation of patterns of ferns used in food, as pesticide, 
fertilizer and material for construction. 
 
The wide use of fern species in traditional medicine may contribute to the health of 
millions of people throughout the globe as well as to livelihoods through trade of herbal 




be associated with health hazards (Chan, 2003; Haq, 2004; George, 2011), toxicological 
information on ferns is still limited. Medicinal plants contain a complex mixture of 
hundreds chemical compounds (Ross, 2007), thus it is difficult  to map all the complex 
interactions and synergies that might be taking place between all the numerous 
chemicals found  in plants. In order to access the real risk and potential of ferns that are 
used in traditional medicine, further research is needed in preparation of pure 
compounds (Sasidharan et al., 2011; Duarte & Rai, 2015) as well as the assessment of 
their toxicity (Coghlan et al., 2012; Ifeoma & Oluwakanyinsola, 2013). Emphasis on 
extensive screening programmes for biological activities and toxicity not only provide 
complete understanding of the effects of these plants to human health, but may also 
contribute to the discovery of novel compounds for pharmaceutical industry (Fabricant 
& Farnsworth, 2001; Fennell et al., 2004; Balunas & Kinghorn, 2005; Mitra et al., 
2016). Awareness in public health education also should be intensified and scientific 
findings with regards to the possibility of plants containing toxic, heavy metal 
contamination or undeclared drugs compounds should be publicized (Street et al., 
2008). New toxicological data from the toxicological investigation of medicinally-used 
ferns could provide new evolutionary insights into the phylogenetic distribution of toxic 
species indicating the extent to which the phylogeny can predict the health risks 












Abou-Arab, A., & Abou Donia, M. (2000). Heavy metals in Egyptian spices and 
medicinal plants and the effect of processing on their levels. Journal of 
Agricultural and Food Chemistry, 48(6), 2300-2304.  
 
Achard, F., Eva, H. D., Stibig, H. J., Mayaux, P., Gallego, J., Richards, T., & 
Malingreau, J. P. (2002). Determination of deforestation rates of the world's 
humid tropical forests. Science, 297(5583), 999-1002. 
 
Agelet, A., Bonet, M. À., & Vallés, J. (2000). Homegardens and their role as a main 
source of medicinal plants in mountain regions of Catalonia (Iberian Peninsula). 
Economic Botany, 54(3), 295-309.  
 
Agrawal, A. A., & Weber, M. G. (2015). On the study of plant defence and herbivory 
using comparative approaches: How important are secondary plant compounds. 
Ecology Letters, 18(10), 985-991. 
 
Ahmad, I., Aqil, F., & Owais, M. (2006). Modern Phytomedicine: Turning Medicinal 
Plants into Drugs. Weinheim: John Wiley & Sons. 
 
Ahmed, A., Wadud, A., Jahan, N., Bilal, A., & Hajera, S. (2013). Efficacy of Adiantum 
capillus veneris Linn in chemically induced urolithiasis in rats. Journal of 
Ethnopharmacology, 146(1), 411-416.  
 
Akabori, Y., & Hasegawa, M. (1969). Flavonoid pattern in the Pteridaceae II. Botany 
Magazine, 82(973), 294-297.  
 
Albuquerque, U. P., & Medeiros, P. M. (2012). Systematic reviews and meta-analysis 
applied to ethnobiological research. Ethnobiology and Conservation, 1(6), 1-8. 
 
Alipour, M., & Khanmohammadi, O. (2011). Antibacterial activity of plant extracts 
against oral and skin pathogens. African Journal of Microbiology Research, 
5(19), 2909-2911.  
 
Almeida, T. E., Hennequin, S., Schneider, H., Smith, A. R., Batista, J. A. N., Ramalho, 
A. J., Proite, K., & Salino, A. (2016). Towards a phylogenetic generic 
classification of Thelypteridaceae: Additional sampling suggests alterations of 
neotropical taxa and further study of paleotropical genera. Molecular 
Phylogenetics and Evolution, 94, 688-700.  
 
Alonso-Amelot, M. E. (1996). Bracken ptaquiloside in milk. Food and Chemical 
Toxicology, 11(34), 1187.  
 
Alonso-Amelot, M. E., & Avendaño, M. (2002). Human carcinogenesis and bracken 
fern: a review of the evidence. Current Medicinal Chemistry, 9(6), 675-686.  
 
Altundag, E., & Ozturk, M. (2011). Ethnomedicinal studies on the plant resources of 




Akintonwa, A., Awodele, O., Afolayan, G., & Coker, H. A. (2009). Mutagenic 
screening of some commonly used medicinal plants in Nigeria. Journal of 
Ethnopharmacology, 125(3), 461-470.  
 
Ankli, A., Sticher, O., & Heinrich, M. (1999). Yucatec Maya medicinal plants versus 
nonmedicinal plants: Indigenous characterization and selection. Human 
Ecology, 27(4), 557-580.  
 
Antonelli, A., Condamine, F. L., Hettling, H., Nilsson, K., Nilsson, R. H., Oxelman, B., 
Sanderson, M. J., Sauquet, H., Scharn, R., & Silvestro, D. (2014). 
SUPERSMART: Ecology and evolution in the era of big data. PeerJ PrePrints, 
2, e501v1.  
 
Auerbach, M. J., & Hendrix, S. D. (1980). Insect–fern interactions: macrolepidopteran 
utilization and species–area association. Ecological Entomology, 5(2), 99-104.  
 
Baker, A., McGrath, S., Reeves, R., & Smith, J. (1999). Metal hyperaccumulator plants: 
A review of the biological resource for possible exploitation in the 
phytoremediation of metal-polluted soils. Phytoremediation of  Contaminated 
Soil and Water, 6, 85-107.  
 
Balick, M. J., & Cox, P. A. (1996). Plants, People, and Culture: The Science of 
Ethnobotany. New York: Scientific American Library. 
 
Balunas, M. J., & Kinghorn, A. D. (2005). Drug discovery from medicinal plants. Life 
Sciences, 78(5), 431-441.  
 
Banerjee, R., & Sen, S. (1980). Antibiotic activity of pteridophytes. Economic Botany, 
34(3), 284-298.  
 
Barnes, P. J., Belvisi, M. G., Mak, J. C., Haddad, E. B., & O'Connor, B. (1995). 
Tiotropium bromide (Ba 679 BR), a novel long-acting muscarinic antagonist for 
the treatment of obstructive airways disease. Life Sciences, 56(11), 853-859. 
 
Barnes, P. M., Powell-Griner, E., McFann, K., & Nahin, R. L. (2004). Complementary 
and alternative medicine use among adults: United States, 2002. Advance Data, 
(343), 1-19. 
 
Becerra, J. X., Noge, K., & Venable, D. L. (2009). Macroevolutionary chemical 
escalation in an ancient plant–herbivore arms race. Proceedings of the National 
Academy of Sciences, 106(43), 18062-18066.  
 
Benítez, G., González-Tejero, M. R., & Molero-Mesa, J. (2010). Pharmaceutical 
ethnobotany in the western part of Granada province (southern Spain): 
Ethnopharmacological synthesis. Journal of Ethnopharmacology, 129(1), 87-
105.  
 
Bennett, B. C. (2007). Doctrine of signatures: An explanation of medicinal plant 




Benjamin, A., & Manickam, V. S. (2007). Medicinal pteridophytes from the Western 
Ghats. Indian Journal of Traditional Knowledge, 6(4), 611-618. 
 
Benniamin, A. (2011). Medicinal ferns of North Eastern India with special reference to 
Arunachal Pradesh. Indian Journal of Traditional Knowledge, 10(3), 516-522. 
 
Benzing, D. H. (2008). Vascular Epiphytes: General Biology and Related Biota. 
Cambridge: Cambrigde University Press.  
 
Berlin, B., Breedlove, D. E., & Raven, P. H. (1973). General principles of classification 
and nomenclature in folk biology. American Anthropologist, 75(1), 214-242. 
 
Bernstein, J. H. (1996). Higher-order categories in Brunei Dusun ethnobotany: The 
folk-classification of rainforest plants. In D. S. Edward, W. E. Booth, & S. C. 
Choy (Eds.), Tropical Rainforest Research — Current Issues (pp. 435–450). 
Netherlands: Kluwer Academic Publishers. 
 
Bidin, A. A. (1986). Paku-Pakis Di Sekeliling Kita. Kuala Lumpur: Dewan Bahasa dan 
Pustaka. 
 
Bir, S. S. (1963). Evolution in the Indian members of the genus Asplenium Linn. 
Memoirs of the Indian Botanical Society, 4, 41-50. 
 
Boonkerd, T., & Pollawatn, R. (2013). Note on Adiantum hispidulum (Pteridaceae), a 
new record species to fern flora of Thailand. Songklanakarin Journal of Science 
and Technology, 35(5), 513-516.  
 
Borregaard, M. K., Rahbek, C., Fjeldså, J., Parra, J. L., Whittaker, R. J., & Graham, C. 
H. (2014). Node‐based analysis of species distributions. Methods in Ecology and 
Evolution, 5(11), 1225-1235.  
 
Bouma, W. L., Ritchie, P., & Perrie, L. R. (2010). Phylogeny and generic taxonomy of 
the New Zealand Pteridaceae ferns from chloroplast rbcL DNA sequences. 
Australian Systematic Botany, 23(3), 143-151.  
 
Brooks, R. R. (1998). Plants that Hyperaccumulate Heavy Metals: Their Role in 
Phytoremediation, Microbiology, Archaeology, Mineral Exploration and 
Phytomining. New York: CAB International. 
 
Brownsey, P., & Smith-Dodsworth, J. (1989). New Zealand Ferns and Allied Plants. 
Auckland: David Bateman Ltd. 
 
Brummitt, R. K., Pando, F., Hollis, S., & Brummitt, N. (2001). World Geographical 
Scheme for Recording Plant Distributions (2nd ed.). Pittsburgh: Hunt Institute 
for Botanical Documentation. 
 
Brummitt, N., & Bachman, S. (2010). Plants Under Pressure—A global Assessment: 
The First Report of the IUCN Sampled Red List Index for Plants. Kew: Royal 





Bull, L. B. (1955). The histological evidence of liver damage from pyrrolizidine 
alkaloids. Australian Veterinary Journal, 31(2), 33-40. 
 
Bundschuh, J., Holländer, H. M., & Ma, L. Q. (2014). In-Situ Remediation of Arsenic-
Contaminated Sites. Leiden: CRC Press. 
 
Caldas, E. D., & Machado, L. L. (2004). Cadmium, mercury and lead in medicinal 
herbs in Brazil. Food and Chemical Toxicology, 42(4), 599-603.  
 
Calixto, J. (2000). Efficacy, safety, quality control, marketing and regulatory guidelines 
for herbal medicines (phytotherapeutic agents). Brazilian Journal of Medical 
and Biological Research, 33(2), 179-189.  
 
Cao, H., Chai, T., Wang, X., Morais-Braga, M. F. B., Yang, J. H., Wong, F. C., Wong, 
R, Yao, H., Cao, J., Cornara, L., Burlando, B., Wang, Y., Xiao, J., & Burlando, 
B. (2017). Phytochemicals from fern species: Potential for medicine 
applications. Phytochemistry Reviews, 16(3), 379-440. 
 
Capella-Gutiérrez, S., Silla-Martínez, J. M., & Gabaldón, T. (2009). trimAl: A tool for 
automated alignment trimming in large-scale phylogenetic analyses. 
Bioinformatics, 25(15), 1972-1973.  
 
Catalogue of Life: 27th February 2016. (2016). Retrieved November, 2015, from 
http://www.catalogueoflife.org/col/ 
 
CBOL Plant Working Group. (2009). A DNA barcode for land plants. Proceedings of 
the National Academy of Sciences, 106(31), 12794-12797.  
 
Chai, T. T., Panirchellvum, E., Ong, H. C., & Wong, F. C. (2012). Phenolic contents 
and antioxidant properties of Stenochlaena palustris, an edible medicinal fern. 
Botanical Studies, 53(4), 439-446. 
 
Chan, K. (2003). Some aspects of toxic contaminants in herbal medicines. 
Chemosphere, 52(9), 1361-1371.  
 
Chan, P. C., Haseman, J. K., Prejean, J., & Nyska, A. (2003). Toxicity and 
carcinogenicity of riddelliine in rats and mice. Toxicology Letters, 144(3), 295-
311. 
 
Chang, H. C., Huang, G. J., Agrawal, D. C., Kuo, C. L., Wu, C. R., & Tsay, H. S. 
(2007). Antioxidant activities and polyphenol contents of six folk medicinal 
ferns used as “Gusuibu”. Botanical Studies, 48(4), 397-406.  
 
Chang, H. M. M., But, P. P. H., Sih-Cheng, Y., Lai-Ling, W., & Yeung, S. C. S. (1986). 
Pharmacology and Applications of Chinese Materia Medica: Volume 1. 
Singapore: World Scientific Publishing Co Pte. 
 
Chang, H. L., Su, J. H., Yeh, Y. T., Lee, Y. C., Chen, H. M., Wu, Y. C., & Yuan, S. S. 
F. (2008a). Protoapigenone, a novel flavonoid, inhibits ovarian cancer cell 




Chang, H. L., Wu, Y. C., Su, J. H., Yeh, Y. T., & Yuan, S. S. F. (2008b). 
Protoapigenone, a novel flavonoid, induces apoptosis in human prostate cancer 
cells through activation of p38 mitogen-activated protein kinase and c-Jun NH2-
terminal kinase 1/2. Journal of Pharmacology and Experimental 
Therapeutics, 325(3), 841-849. 
 
Chase, M. W., Soltis, D. E., Olmstead, R. G., Morgan, D., Les, D. H., Mishler, B. D., 
Duvall, M. R., Price, R. A., Hills, H. G., Qiu, Y. L., Kron, K. A., Rettig, J. H., 
Conti, E., Palmer, J. D., Manhart, J. R., Sytsma, K. J., Michaels, H. J., Kress, W. 
J., Karol, K. G., Clark, W. D., Hedren, M., Gaut, B. S., Jansen, R. K., Kim, K. 
J., Wimpee, C. F., Smith, J. F., Furnier, G. R., Strauss, S. H., Xiang, Q. Y., 
Plunkett, G. M., Soltis, P. S., Swensen, S. M., Willimas, S. E., Gadek, P. A., 
Quinn, C. J., Eguiarte, L. E., Golenberg, E., Learn, G. H., Jr., Graham, S. W., 
Barret, S. C. H., Dayanandan, S., & Albert, V. A. (1993). Phylogenetics of seed 
plants: An analysis of nucleotide sequences from the plastid gene rbcL. Annals 
of the Missouri Botanical Garden, 80(3)528-580. 
 
Chen, M. D., Lin, P. Y., Tsou, C. T., Wang, J. J., & Lin, W. H. (1995). Selected metals 
status in patients with noninsulin-dependent diabetes mellitus. Biological Trace 
Element Research, 50(2), 119-124.  
 
Chen, T., Mei, N., & Fu, P. P. (2010). Genotoxicity of pyrrolizidine alkaloids. Journal 
of Applied Toxicology, 30(3), 183-196. 
 
Chen, Y. J., Cheng, Y. J., Hung, A. C., Wu, Y. C., Hou, M. F., Tyan, Y. C., & Yuan, S. 
S. F. (2013). The synthetic flavonoid WYC02-9 inhibits cervical cancer cell 
migration/invasion and angiogenesis via MAPK14 signaling. Gynecologic 
oncology, 131(3), 734-743. 
 
Chin, W. Y. (2005). Ferns of the Tropics. Singapore: Times Editions. 
 
Chinese Pharmacopoeia Commission. (2005). Chinese Pharmacopoeia (Vol1-3). 
Beijing : Chemical Industry Press. 
 
Ching, F. M. (2007). Chinese Herbal Drug Research Trends. New York: Nova Science 
Publishers. 
 
Christenhusz, M. J. M. (2007). Dracoglossum, a new Neotropical fern genus 
(Pteridophyta). Thaiszia, Journal of Botany, 17, 1-10.  
 
Christenhusz, M. J. M., & Chase, M. W. (2014). Trends and concepts in fern 
classification. Annals of Botany, 113(4), 571-594.  
 
Christenhusz, M. J. M., Jones, M., & Lehtonen, S. (2013). Phylogenetic placement of 
the enigmatic fern genus Dracoglossum. American Fern Journal, 103(2), 131-
138.  
 
Christenhusz, M. J. M., & Schneider, H. (2011). Corrections to Phytotaxa 19: Linear 




Christenhusz, M. J. M., Zhang, X. C., & Schneider, H. (2011). A linear sequence of 
extant families and genera of lycophytes and ferns. Phytotaxa, 19(1), 7-54. 
 
Christenhusz, M. J. M., & Byng, J. W. (2016). The number of known plants species in 
the world and its annual increase. Phytotaxa, 261(3), 201-217.  
 
Chiu, C., Chang, H., Chuang, D., Chang, F., Chang, Y., Cheng, Y., Cheng, Y., Tsai, M., 
Chen, W., Lee, S., Wang, C., Chen, J., Wang, H., Chen, C., Liu, Y., & Wu, Y. 
(2009). Fern plant-derived protoapigenone leads to DNA damage, apoptosis and 
G2/M arrest in lung cancer cell line H1299. DNA and Cell Biology, 28(10), 501-
506 
 
Coghlan, M. L., Haile, J., Houston, J., Murray, D. C., White, N. E., Moolhuijzen, P., & 
Bunce, M. (2012). Deep sequencing of plant and animal DNA contained within 
traditional Chinese medicines reveals legality issues and health safety concerns. 
PLoS Genetics, 8(4), e1002657. 
 
Cooper-Driver, G. (1978). Insect‐fern associations. Entomologia Experimentalis et 
Applicata, 24(3), 310-316.  
 
Cooper-Driver, G. (1985). Anti-predation strategies in pteridophytes—a biochemical 
approach. Proceedings of the Royal Society of Edinburgh. Section B. Biological 
Sciences, 86, 397-402. 
 
Cornara, L., La Rocca, A., Terrizzano, L., Dente, F., & Mariotti, M. G. (2014). 
Ethnobotanical and phytomedical knowledge in the north-western Ligurian 
Alps. Journal of Ethnopharmacology, 155(1), 463-484.  
 
Cox, P. A., & Balick, M. J. (1994). The ethnobotanical approach to drug discovery. 
Scientific American, 270(6), 82-87. 
 
Cragg, G. M. (1998). Paclitaxel (Taxol®): A success story with valuable lessons for 
natural product drug discovery and development. Medicinal Research Reviews, 
18(5), 315-331. 
 
Culley, T. M. (2013). Why vouchers matter in botanical research. Applications in Plant 
Sciences, 1(11), 1300076. 
 
Cullina, W. (2008). Native Ferns, Moss, and Grasses: From Emerald Carpet to Amber 
Wave, Serene and Sensuous Plants for the Garden. Boston: Houghton Mifflin 
Harcourt. 
 
Dafni, A., & Lev, E. (2003). The doctrine of signatures in present day Israel. Economic. 
Botany, 56(4), 328-334. 
 
Daswani, P. G., Ghadge, A. A., & Birdi, T. J. (2011). Preparation of decoction of 
medicinal plants: A self-help measure? The Journal of Alternative and 





Déciga-Campos, M., Rivero-Cruz, I., Arriaga-Alba, M., Castañeda-Corral, G., Angeles-
López, G. E., Navarrete, A., & Mata, R. (2007). Acute toxicity and mutagenic 
activity of Mexican plants used in traditional medicine. Journal of 
Ethnopharmacology, 110(2), 334-342. 
 
de la Torre, L., Cerón, C. E., Balslev, H., & Borchsenius, F. (2012). A biodiversity 
informatics approach to ethnobotany: Meta-analysis of plant use patterns in 
Ecuador. Ecology and Society, 17(1), 15. 
 
de Medeiros, P. M., Ladio, A. H., & Albuquerque, U. P. (2013). Patterns of medicinal 
plant use by inhabitants of Brazilian urban and rural areas: A macroscale 
investigation based on available literature. Journal of Ethnopharmacology, 
150(2), 729-746.  
 
de Queiroz, A., & Gatesy, J. (2007). The supermatrix approach to systematics. Trends 
in Ecology & Evolution, 22(1), 34-41.  
 
Des Marais, D. L., Smith, A. R., Britton, D. M., & Pryer, K. M. (2003). Phylogenetic 
relationships and evolution of extant horsetails, Equisetum, based on chloroplast 
DNA sequence data (rbcL and trnL‐F). International Journal of Plant Sciences, 
164(5), 737-751. 
 
Di Stasi, L. C., Oliveira, G. P., Carvalhaes, M. A., Queiroz-Junior, M., Tien, O. S., 
Kakinami, S. H., & Reis, M. S. (2002). Medicinal plants popularly used in the 
Brazilian tropical Atlantic forest. Fitoterapia, 73(1), 69–91. 
 
Dixit, R. D. (1984). A Census of the Indian Pteridophytes. Howrah: Botanical Survey of 
India. 
 
dos Santos Reinaldo, R. C. P., Santiago, A. C. P., Medeiros, P. M., & Albuquerque, U. 
P. (2015). Do ferns and lycophytes function as medicinal plants? A study of 
their low representation in traditional pharmacopoeias. Journal of 
Ethnopharmacology, 175, 39-47.  
 
Doyle, J. J., & Dickson, E. E. (1987). Preservation of plant samples for DNA restriction 
endonuclease analysis. Taxon, 715-722.  
 
Driskell, A. C., Ané, C., Burleigh, J. G., McMahon, M. M., O'Meara, B. C., & 
Sanderson, M. J. (2004). Prospects for building the tree of life from large 
sequence databases. Science, 306(5699), 1172-1174.  
 
Du, W., Li, Z. a., Zou, B., & Peng, S. (2005). Pteris multifida Poir., a new arsenic 
hyperaccumulator: Characteristics and potential. International Journal of 
Environment and Pollution, 23(4), 388-396. 
 
Dubuisson, J. Y. (1997). rbcL sequences: A promising tool for the molecular 
systematics of the fern genus Trichomanes (Hymenophyllaceae)? Molecular 





Duarte, M. C., & Rai, M. (Eds.). (2015). Therapeutic Medicinal Plants: From Lab to 
the Market. Boca Raton: CRC Press. 
 
Duffy, A. M., Kelchner, S. A., & Wolf, P. G. (2009). Conservation of selection on matK 
following an ancient loss of its flanking intron. Gene, 438(1), 17-25.  
 
Ebbell, B. (1937). The Ebers Papyrus. The Greatest Egyptian Medical Document. 
London: Oxford University Press. 
 
Ebihara, A., Dubuisson, J. Y., Iwatsuki, K., Hennequin, S., & Ito, M. (2006). A 
taxonomic revision of Hymenophyllaceae. Blumea-Biodiversity, Evolution and 
Biogeography of Plants, 51(2), 221-280. 
 
Edgar, R. C. (2004). MUSCLE: multiple sequence alignment with high accuracy and 
high throughput. Nucleic Acids Research, 32(5), 1792-1797.  
 
Emerson, B. C., & Gillespie, R. G. (2008). Phylogenetic analysis of community 
assembly and structure over space and time. Trends in Ecology & Evolution, 
23(11), 619-630. 
 
Erdtman, H., Novotný, L., & Romanuk, M. (1966). Flavonols from the fern Cheilanthes 
farinosa (forsk.) Kaulf. Tetrahedron, 22, 71-74. 
 
Ernst, M., Saslis-Lagoudakis, C. H., Grace, O. M., Nilsson, N., Simonsen, H. T., Horn, 
J. W., & Rønsted, N. (2016). Evolutionary prediction of medicinal properties in 
the genus Euphorbia L. Scientific Reports, 6, 30531. 
 
Everest, A., & Ozturk, E. (2005). Focusing on the ethnobotanical uses of plants in 
Mersin and Adana provinces (Turkey). Journal of Ethnobiology and 
Ethnomedicine, 1(1), 6.  
 
Fabricant, D. S., & Farnsworth, N. R. (2001). The value of plants used in traditional 
medicine for drug discovery. Environmental Health Perspectives, 109(Suppl 1), 
69-75.  
 
Faith, D. P. (1992). Conservation evaluation and phylogenetic diversity. Biological 
Conservation, 61(1), 1-10. 
 
Fairbrothers, D., Mabry, T., Scogin, R., & Turner, B. (1975). The bases of Angiosperm 
phylogeny: Chemotaxonomy. Annals of the Missouri Botanical Garden, 765-
800.  
 
Fennell, C., Lindsey, K., McGaw, L., Sparg, S., Stafford, G., Elgorashi, E., Grace, O., 
& Van Staden, J. (2004). Assessing African medicinal plants for efficacy and 
safety: Pharmacological screening and toxicology. Journal of 
Ethnopharmacology, 94(2), 205-217.  
 
Fenwick, G. (1989). Bracken (Pteridium aquilinum)—toxic effects and toxic 





Firn, R. D. (2003). Bioprospecting–why is it so unrewarding? Biodiversity & 
Conservation, 12(2), 207-216. 
 
Flora of China: Volume 2. (1994).   Retrieved March, 2016, from 
http://www.efloras.org/ 
 
Forest, F., Grenyer, R., Rouget, M., Davies, T. J., Cowling, R. M., Faith, D. P., 
Balmford, A., Manning, J. C., van der Bank, M., & Reeves, G. (2007). 
Preserving the evolutionary potential of floras in biodiversity hotspots. Nature, 
445(7129), 757-760.  
 
Francesconi, K., Visoottiviseth, P., Sridokchan, W., & Goessler, W. (2002). Arsenic 
species in an arsenic hyperaccumulating fern, Pityrogramma calomelanos: A 
potential phytoremediator of arsenic-contaminated soils. Science of the Total 
Environment, 284(1), 27-35.  
 
Fraser-Jenkins, C., Kandel, D., & Pariyar, S. (2015). Ferns and Fern-Allies of Nepal. 
Vol. 1. Kathmandu: National Herbarium and Plant Laboratories Department of 
Plant Resources, Ministry of Forests and Soil Conservation. 
 
Gaikwad, J., Wilson, K., Kohen, J., Vemulpad, S., Jamie, J., & Ranganathan, S. (2011). 
Combining ethnobotany and informatics to discover knowledge from data. In M. 
K. Rai, D. Acharya & J.L. Rios (Eds.), Ethnomedicinal Plants: Revitaization of 
Traditional Knowledge of Herbs (pp. 444-457). New Hampshire: Science 
Publishers.  
 
García-Rico, L., Leyva-Perez, J., & Jara-Marini, M. E. (2007). Content and daily intake 
of copper, zinc, lead, cadmium, and mercury from dietary supplements in 
Mexico. Food and Chemical Toxicology, 45(9), 1599-1605. 
 
Gastony, G. J., & Rollo, D. R. (1995). Phylogeny and generic circumscriptions of 
cheilanthoid ferns (Pteridaceae: Cheilanthoideae) inferred from rbcL nucleotide 
sequences. American Fern Journal, 85(4), 341-360.  
 
Gazzaneo, L. R. S., De Lucena, R. F. P., & de Albuquerque, U. P. (2005). Knowledge 
and use of medicinal plants by local specialists in an region of Atlantic Forest in 
the state of Pernambuco (Northeastern Brazil). Journal of Ethnobiology and 
Ethnomedicine, 1(1), 1-9. 
 
George, P. (2011). Concerns regarding the safety and toxicity of medicinal plants-An 
overview. Journal of Applied Pharmaceutical Science, 1(06), 40-44. 
 
Giday, M., Asfaw, Z., Elmqvist, T., & Woldu, Z. (2003). An ethnobotanical study of 
medicinal plants used by the Zay people in Ethiopia. Journal of 
Ethnopharmacology, 85(1), 43-52.  
 
Giday, M., Asfaw, Z., Woldu, Z., & Teklehaymanot, T. (2009). Medicinal plant 
knowledge of the bench ethnic group of Ethiopia: An ethnobotanical 





Goldberg, E. E., & Igić, B. (2008). On phylogenetic tests of irreversible evolution. 
Evolution, 62(11), 2727-2741.  
 
Goodman, J., & Walsh, V. (2001). The Story of Taxol: Nature and Politics in the 
Pursuit of an Anti-Cancer Drug. Cambridge: Cambridge University Press. 
 
González-Tejero, M. R., Casares-Porcel, M., Sánchez-Rojas, C. P., Ramiro-Gutiérrez, J. 
M., Molero-Mesa, J., Pieroni, A., Giusti, M., Censorii, E., De Pasquale, C., 
Della,  A., Paraskeva-Hadijchambi, D., Hadjichambis, A., Houmani, Z., El-
Demerdash, M., El-Zayat, M., Hmamouchi, M., & ElJohrig, S. (2008). 
Medicinal plants in the Mediterranean area: Synthesis of the results of the 
project Rubia. Journal of Ethnopharmacology, 116(2), 341-357. 
  
Govaerts, R. (2001). How many species of seed plants are there? Taxon, 50(4), 1085-
1090. 
 
Gu, R., Wang, Y., Long, B., Kennelly, E., Wu, S., Liu, B., Ping L., & Long, C. (2014). 
Prospecting for bioactive constituents from traditional medicinal plants through 
ethnobotanical approaches. Biological and Pharmaceutical Bulletin, 37(6), 903-
915. 
 
Guha, P., Mukhopadhyay, R., & Gupta, K. (2005). Antifungal activity of the crude 
extracts and extracted phenols from gametophytes and sporophytes of two 
species of Adiantum. Taiwania, 50(4), 272-283.  
 
Gurib-Fakim, A. (2006). Medicinal plants: Traditions of yesterday and drugs of 
tomorrow. Molecular Aspects of Medicine, 27(1), 1-93. 
 
Hall, T. A. (1999). BioEdit: a user-friendly biological sequence alignment editor and 
analysis program for Windows 95/98/NT. Nucleic Acids Symposium Series, 41, 
95-98. 
 
Hamayun, M., Khan, S. A., Sohn, E. Y., & Lee, I.-J. (2006). Folk medicinal knowledge 
and conservation status of some economically valued medicinal plants of 
District Swat, Pakistan. Lyonia, 11(2), 101-113.  
 
Hamann, O. (1991). The joint IUCN-WWF plants conservation programme and its 
interest in medicinal plants. In O. Akerele, V. Heywood, & H. Synge (Eds.), 
Conservation of Medicinal Plants (pp. 13–22). Cambridge: Cambridge 
University Press. 
 
Hamilton, A. C. (2004). Medicinal plants, conservation and livelihoods. Biodiversity & 
Conservation, 13(8), 1477-1517. 
 
Hanlidou, E., Karousou, R., Kleftoyanni, V., & Kokkini, S. (2004). The herbal market 
of Thessaloniki (N Greece) and its relation to the ethnobotanical tradition. 






Hansen, M. C., Potapov, P. V., Moore, R., Hancher, M., Turubanova, S., Tyukavina, A., 
Thau, D., Stehman, S., Goetz, S., Loveland, T., Kommareddy, A., Egorov, A., 
Chini, L., Justice, C. O., & Townshend, J. R. G.  (2013). High-resolution global 
maps of 21st-century forest cover change. Science, 342(6160), 850-853.  
 
Haq, I. (2004). Safety of medicinal plants. Pakistan Journal of Medical Research, 
43(4), 203-210. 
 
Harmaja, H. (2012). The oldest record of Polypodium interjectum in Sweden, with notes 
on the variability of P. vulgare. Annales Botanici Fennici, 49(1-2), 13–20. 
 
Hasebe, M., Wolf, P. G., Pryer, K. M., Ueda, K., Sano, R., Gastony, G. J., Yokoyama, 
J., Manhart, J. R., Murakami, N., Crane, E. H., Haufler, C. H., & Hauk, W. D. 
(1995). Fern phylogeny based on rbcL nucleotide sequences. American Fern 
Journal, 134-181.  
 
Hassler, M., & Schmitt, B. (2015). World ferns: Checklist of ferns and lycophytes of the 
world, version 6. Website https://worldplants.webarchiv.kit.edu/ferns/(last 
accessed on July 2016). 
 
Hauk, W. D., Parks, C. R., & Chase, M. W. (2003). Phylogenetic studies of 
Ophioglossaceae: Evidence from rbcL and trnL-F plastid DNA sequences and 
morphology. Molecular Phylogenetics and  Evolution, 28(1), 131-151.  
 
Heath, T. A., Hedtke, S. M., & Hillis, D. M. (2008). Taxon sampling and the accuracy 
of phylogenetic analyses. Journal of Systematics and Evolution, 46(3), 239-257.  
 
Heinrich, M., Ankli, A., Frei, B., Weimann, C., & Sticher, O. (1998). Medicinal plants 
in Mexico: Healers' consensus and cultural importance. Social Science & 
Medicine, 47(11), 1859-1871.  
 
Heinrich, M. (2000). Ethnobotany and its role in drug development. Phytotherapy 
Research, 14(7), 479-488. 
 
Heinrich, M., & Bremner, P. (2006). Ethnobotany and ethnopharmacy-their role for 
anti-cancer drug development. Current Drug Targets, 7(3), 239-245. 
 
Hennequin, S., Ebihara, A., Ito, M., Iwatsuki, K., & Dubuisson, J. Y. (2003). Molecular 
systematics of the fern genus Hymenophyllum s.l. (Hymenophyllaceae) based on 
chloroplastic coding and noncoding regions. Molecular Phylogenetics and 
Evolution, 27(2), 283-301.  
 
Hennipman, E., Veldhoen, P., & Kramer, K. U. (1990). Polypodiaceae. In K. U. Kramer 
& P. S. Green (Eds.), The Families and Genera of Vascular plants. 
Pteridophytes and Gymnosperms. Vol. 1 (pp. 203–230). Berlin: Springer-Verlag. 
 
Hirono, I., & Weisburger, E. K. (1986). Carcinogenic principles isolated from bracken 





Hirono, I. (Ed.). (1987). Naturally Occurring Carcinogens of Plant Origin: Toxicology, 
Pathology, and Biochemistry. Tokyo: Elsevier Science. 
 
Hoareau, L., & DaSilva, E. J. (1999). Medicinal plants: A re-emerging health aid. 
Electronic Journal of Biotechnology, 2(2), 3-4.  
 
Horneber, M., Bueschel, G., Dennert, G., Less, D., Ritter, E., & Zwahlen, M. (2011). 
How many cancer patients use complementary and alternative medicine: A 
systematic review and metaanalysis. Integrative Cancer Therapies, 11(3), 187-
203. 
 
Hovenkamp, P. H., & Ho, B. C. (2012). A revision of the fern genus Oleandra 
(Oleandraceae) in Asia. PhytoKeys, (11), 1-37.  
 
Hovenkamp, P. H., & Miyamoto, F. (2005). A conspectus of the native and naturalized 
species of Nephrolepis (Nephrolepidaceae) in the world. Blumea-Biodiversity, 
Evolution and Biogeography of Plants, 50(2), 279-322.  
 
Huang, X. F., Yuan, S. J., & Yang, C. (2012). Effects of total flavonoids from Drynaria 
fortunei on the proliferation and osteogenic differentiation of rat dental pulp 
stem cells. Molecular Medicine Reports, 6(3), 547-552.  
 
Hunyadi, A., Chuang, D., Danko, B., Chiang, M. Y., Lee, C., Wang, H., Wu, C., Chang, 
F., & Wu, Y. (2011). Direct semi-synthesis of the anticancer lead-drug 
protoapigenone from apigenin, and synthesis of further new cytotoxic 
protoflavone derivatives. PLoS ONE,6(8), e23922. 
 
Hyodo, I., Amano, N., Eguchi, K., Narabayashi, M., Imanishi, J., Hirai, M., Nakano, T., 
& Takashima, S. (2005). Nationwide survey on complementary and alternative 
medicine in cancer patients in Japan. Journal of Clinical Oncology, 23(12), 
2645-2654. 
 
Ifeoma, O., & Oluwakanyinsola, S. (2013). Screening of herbal medicines for potential 
toxicities. In S. Gowder (Ed.), New Insights into Toxicity and Drug Testing (pp. 
63–88). Rijeka: InTech. 
 
Imperato, F. (1982a). New phenolic glycosides in the fern Adiantum capillus-veneris L. 
Chemistry and Industry, 23, 957–958. 
 
Imperato, F. (1982b). Sulphate esters of hydroxycinnamic acid—sugar derivatives from 
Adiantum capillus-veneris. Phytochemistry, 21(11), 2717-2718.  
 
IPNI. (2005). The International Plants Names Index. Retrieved November, 2015, from 
http://www.ipni.org 
 
Ize-Ludlow, D., Ragone, S., Bruck, I. S., Bernstein, J. N., Duchowny, M., & Peña, B. 
M. G. (2004). Neurotoxicities in infants seen with the consumption of star anise 





The IUCN Red List of Threatened Species. (2015). Retrieved February, 2016, from 
http://www.redlist.org 
 
Jain, A., Katewa, S., Galav, P., & Sharma, P. (2005). Medicinal plant diversity of 
Sitamata wildlife sanctuary, Rajasthan, India. Journal of Ethnopharmacology, 
102(2), 143-157.  
 
Jayaraj, P. (2010). Regulation of traditional and complementary medicinal products in 
Malaysia. International Journal of Green Pharmacy, 4(1), 10-14. 
 
Judd, W. S., Campbell, C. S., Kellogg, E. A., & Stevens, P. F. (1999). Plant 
Systematics: A Phylogenetic Approach. Sunderland: Sinauer Associates, Inc. 
 
Junejo, J. A., Ghoshal, A., Mondal, P., Nainwal, L., Zaman, K., Singh, K. D., & 
Chakraborty, T. (2015). In-vivo toxicity evaluation and phytochemical, 
physicochemical analysis of Diplazium esculentum (Retz.) Sw. leaves a 
traditionally used North-Eastern Indian vegetable. Advances in Bioresearch, 
6(5), 175-181.  
 
Kamon, S., & Hirayama, T. (1975). Epidemiology of cancer of the oesophagus in Miye, 
Nara and Wakayama Prefecture with special reference to the role of bracken 
fern. Proceedings of the Japanese Cancer Association, 34, 211. 
 
Kappor, L. D. (1990). Handbook of  Ayurvedic Medicinal Plants. Boca Raton: CRC 
Press. 
 
Keller, H. A., Meza Torres, E. I., & Prance, G. T. (2011). Ethnopteridology of the 
Guaranís of Misiones Province, Argentina. American Fern Journal, 101(3), 193-
204.  
 
Kelly, S., Grenyer, R., & Scotland, R. W. (2014). Phylogenetic trees do not reliably 
predict feature diversity. Diversity and Distributions, 20(5), 600-612. 
 
Kimberley, M. (2010). Ferns. Retrieved May, 2017, from 
 http://www.hortweek.com/ferns/ornamentals/article/99511 
 
Kimura, K., & Noro, Y. (1965). Pharmacognostical studies on Chinese drug" Gu-sui-
bu". Consideration on" gu-sui-bu" in old herbals (Pharmacognostical studies on 
fern drugs XI). Syoy-akugaku Zasshi, 19, 25-31.  
 
Knie, N., Fischer, S., Grewe, F., Polsakiewicz, M., & Knoop, V. (2015). Horsetails are 
the sister group to all other monilophytes and Marattiales are sister to 
leptosporangiate ferns. Molecular Phylogenetics and Evolution, 90, 140-149. 
 
Korall, P., Conant, D. S., Metzgar, J. S., Schneider, H., & Pryer, K. M. (2007). A 
molecular phylogeny of scaly tree ferns (Cyatheaceae). Amerian Journal of 





Korall, P., Conant, D. S., Schneider, H., Ueda, K., Nishida, H., & Pryer, K. M. (2006). 
On the phylogenetic position of Cystodium: It's not a tree fern-it's a Polypod! 
American Fern Journal, 96(2), 45-53.  
 
Krämer, U. (2010). Metal hyperaccumulation in plants. Annual Review of Plant 
Biology, 61, 517-534.  
 
Kreft, H., Jetz, W., Mutke, J., & Barthlott, W. (2010). Contrasting environmental and 
regional effects on global pteridophyte and seed plant diversity. Ecography, 
33(2), 408-419.  
 
Kreier, H.-P., Zhang, X.-C., Muth, H., & Schneider, H. (2008). The microsoroid ferns: 
Inferring the relationships of a highly diverse lineage of Paleotropical epiphytic 
ferns (Polypodiaceae, Polypodiopsida). Molecular Phylogenetics and Evolution, 
48(3), 1155-1167.  
 
Kress, W. J., Wurdack, K. J., Zimmer, E. A., Weigt, L. A., & Janzen, D. H. (2005). Use 
of DNA barcodes to identify flowering plants. Proceedings of the National 
Academy of Sciences of the United States of America, 102(23), 8369-8374. 
 
Kuete, V. (2014). Toxicological Survey of African Medicinal Plants. London: Elsevier. 
 
Kumar, G. N. (2004). Studies on pathological effects of linguda (Diplazium esculentum, 
Retz.) in laboratory rats and guinea pigs. Indian Journal of Veterinary 
Pathology, 28(2), 149.  
 
Kumar, A. (2009). Antioxidant effect of Adiantum capillus veneris Linn. on human 
lymphocyte: An in vitro study. Journal of Cell and Tissue Research, 9(2), 1899-
1902. 
 
Kumarpal, S. (2013). Study of activity of some medicinal ferns of Darjeeling. 
International Journal of Scientific and Research Publications, 3(8), 252-255. 
 
Lafont, R., Ho, R., Raharivelomanana, P., & Dinan, L. (2011). Ecdysteroids in Ferns: 
distribution, diversity, biosynthesis, and functions. In A. Kumar, H. Fernández, 
& M. A. Revilla (Eds.), Working with Ferns : Issues and Applications (pp. 305–
319). New York: Springer. 
 
Lai, H. Y., & Lim, Y. (2011). Evaluation of antioxidant activities of the methanolic 
extracts of selected ferns in Malaysia. International Journal of Environmental 
Science and Development, 2(6), 442-447. 
 
Lai, H. Y., Lim, Y. Y., & Kim, K. H. (2010). Blechnum orientale Linn-a fern with 
potential as antioxidant, anticancer and antibacterial agent. BMC 
Complementary and Alternative Medicine, 10(1), 15-23.  
 
Lee, S., Xiao, C., & Pei, S. (2008). Ethnobotanical survey of medicinal plants at 
periodic markets of Honghe prefecture in Yunnan Province, SW China. Journal 





Lehtonen, S. (2011). Towards resolving the complete fern tree of life. PLoS One, 6(10), 
e24851.  
 
Lehtonen, S., Wahlberg, N., & Christenhusz, M. J. M. (2012). Diversification of 
lindsaeoid ferns and phylogenetic uncertainty of early polypod relationships. 
Botanical Journal of the Linnean Society, 170(4), 489-503. 
 
Leonti, M., Sticher, O., & Heinrich, M. (2002). Medicinal plants of the Popoluca, 
México: Organoleptic properties as indigenous selection criteria. Journal of 
Ethnopharmacology, 81(3), 307-315.  
 
Leonti, M., Fernando, R. R., Sticher, O., & Heinrich, M. (2003). Medicinal flora of the 
Popoluca, Mexico: A botanical systematical perspective. Economic Botany, 
57(2), 218-230. 
 
Lev, E. (2002). The doctrine of signatures in the medieval and Ottoman Levant. 
Vesalius, 8(1), 13-22. 
 
Lewis, W. H., & Elvin-Lewis, M. P. (1995). Medicinal plants as sources of new 
therapeutics. Annals of the Missouri Botanical Garden, 16-24.  
 
Legume Phylogeny Working Group. (2013). Legume phylogeny and classification in 
the 21st century: Progress, prospects and lessons for other species-rich clades. 
Taxon, 62(2), 217-248.  
 
Li, F., Kuo, L., Rothfels, C., Ebihara, A., & Chiou, W. (2011). rbcL and matK earn two 
thumbs up as the core DNA barcode for ferns. PLoS One, 6(10), e26597.  
 
Li, F.M., Meng, F.-h., Xiong, Z. L., Li, Y., Liu, R., & Liu, H. (2006). Stimulative 
activity of Drynaria fortunei (Kunze) J. Sm. extracts and two of its flavonoids 
on the proliferation of osteoblastic like cells. Die Pharmazie, 61(11), 962-965.  
 
Lin, A. S., Chang, F. R., Wu, C. C., Liaw, C. C., & Wu, Y. C. (2005). New cytotoxic 
flavonoids from Thelypteris torresiana. Planta medica, 71(09), 867-870. 
 
Litsios, G., & Salamin, N. (2012). Effects of phylogenetic signal on ancestral state 
reconstruction. Systematic Biology, 61(3), 533-538.  
 
Little, D. P., & Barrington, D. S. (2003). Major evolutionary events in the origin and 
diversification of the fern genus Polystichum (Dryopteridaceae). American 
Journal of Botany, 90(3), 508-514.  
 
Liu, H. M., He, L. J., & Schneider, H. (2014). Towards the natural classification of 
tectarioid ferns: Confirming the phylogenetic relationships of Pleocnemia and 
Pteridrys (eupolypods I). Journal of Systematics and Evolution, 52(2), 161-174.  
 
Liu, H. M., Jiang, R.-H., Guo, J., Hovenkamp, P., Perrie, L., Shepherd, L., Hennequin, 
S., & Schneider, H. (2013). Towards a phylogenetic classification of the 





Lu, J.M., Barrington, D. S., & Li, D.-Z. (2007). Molecular phylogeny of the 
polystichoid ferns in Asia based on rbcL sequences. Systematic Botany, 32(1), 
26-33.  
 
Lu, S. (2007). Pteridology. Beijing: Higher Education Press. 
 
Lu, L., Sun. Miao., Zhang, J., Li, H., Lin, L., Yang, Tuo., Chen, M., & Chen, Z. 
 (2014). Tree of life and its application. Biodiversity Science, 22(1), 3-20. 
 
Lukhoba, C. W., Simmonds, M. S., & Paton, A. J. (2006). Plectranthus: A review of 
ethnobotanical uses. Journal of Ethnopharmacology, 103(1), 1-24. 
 
Ma, L. Q., Komar, K. M., Tu, C., Zhang, W., Cai, Y., & Kennelley, E. D. (2001). A 
fern that hyperaccumulates arsenic. Nature, 409(6820), 579-579.  
 
Mabberley, D. J. (2008). Mabberley's Plant-Book: A Portable Dictionary of Plants, 
Their Classifications and Uses (3rd ed.). Cambridge: Cambridge University 
Press. 
 
Maddison, W. P., & Maddison, D. R. (2001). Mesquite: a modular system for 
evolutionary analysis. http://mesquiteproject.org. 
 
Mahran, G., El-Alfy, T., Taha, K., & El-Tantawy, M. (1990). Chemical composition 
and antimicrobial activity of the volatile oil and extracts of fronds of Adiantum 
capillus veneris L. Bulletin of Faculty of Agriculture, University of Cairo, 41(3), 
555-572.  
 
Manandhar, N. P. (2002). Plants and People of Nepal. Portland: Timber Press. 
 
Mannan, M. M., Maridass, M., & Victor, B. (2008). A review on the potential uses of 
ferns. Ethnobotanical Leaflets, 12, 281-285.  
 
Markham, K., Chalk, T., & Stewart Jr, C. N. (2006). Evaluation of fern and moss 
protein‐based defenses against phytophagous insects. International Journal of 
Plant Sciences, 167(1), 111-117. 
 
Marino, A., Elberti, M., & Cataldo, A. (1989). Phytochemical investigation of Adiantum 
capillus veneris. Bollettino Della Società Italiana Di Biologia Sperimentale, 
65(5), 461-463.  
 
Marliere, C., Wathern, P., Freitas, S., Castro, M., Galvao, M., Taylor, J., & Smith, R. 
(1999). Bracken fern (Pteridium aquilinum) consumption and oesophageal and 
stomach cancer in the Ouro Preto region, Minas Gerais, Brazil. In J.A.Taylor & 
R. T. Smith (Eds.), Toxicity, Biology and Control, (pp. 144-149) Aberystwth: 
International Bracken Group Special Publication. 
 
Martin, G. J. (1995). Ethnobotany: A Methods Manual (Vol. 1). London: Earthscan. 
 
Mat-Salleh, K., & Latiff, A. (2002). Tumbuhan Ubatan Malaysia. Bangi: Pusat 




Mati, E., & de Boer, H. (2011). Ethnobotany and trade of medicinal plants in the 
Qaysari market, Kurdish autonomous region, Iraq. Journal of 
Ethnopharmacology, 133(2), 490-510.  
 
May, L. W. (1978). The economic uses and associated folklore of ferns and fern allies. 
The Botanical Review, 44(4), 491-528.  
 
Mattocks, A. R.(1968). Toxicity of pyrrolizidine alkaloids. Nature, 217(5130), 723-728. 
 
Mazel, F., Davies, J. T., Gallien, L., Renaud, J., Groussin, M., Münkemüller, T., & 
Thuiller, W. (2015). Influence of tree shape and evolutionary time-scale on 
phylogenetic diversity metrics. Ecography, 38(10), 913-920. 
 
McCormack, J. E., Hird, S. M., Zellmer, A. J., Carstens, B. C., & Brumfield, R. T. 
(2013). Applications of next-generation sequencing to phylogeography and 
phylogenetics. Molecular Phylogenetics and Evolution, 66(2), 526-538.  
 
McLaughlin, M. J., Zarcinas, B., Stevens, D., & Cook, N. (2000). Soil testing for heavy 
metals. Communications in Soil Science & Plant Analysis, 31(11-14), 1661-
1700.  
 
Meharg, A. A. (2003). Variation in arsenic accumulation–hyperaccumulation in ferns 
and their allies. New Phytologist, 157(1), 25-31. 
 
Mehltreter, K., Walker, L. R., & Sharpe, J. M. (2010). Fern Ecology. Cambridge: 
Cambridge University Press. 
 
Michl, J., Jennings, H. M., Kite, G. C., Ingrouille, M. J., Simmonds, M. S., & Heinrich, 
M. (2013). Is aristolochic acid nephropathy a widespread problem in developing 
countries?: A case study of Aristolochia indica L. in Bangladesh using an 
ethnobotanical–phytochemical approach. Journal of Ethnopharmacology, 
149(1), 235-244.  
 
Miller, L. G. (1998). Herbal medicinals: Selected clinical considerations focusing on 
known or potential drug-herb interactions. Archives of Internal Medicine, 
158(20), 2200-2211. 
 
Minamikawa, T., & Yoshida, S. (1972). Occurrence of quinic acid in the ferns. The 
Botanical Magazine Tokyo, 85(2), 153–155. 
 
Mitra, S., Kar, S., Surajlata, K., & Banerjee, E. R. (2016). Screening of Novel Natural 
Product Derived Compounds for Drug Discovery in Inflammation. Journal of 
Plant Biochemistry & Physiology, 3(4), 2-10. 
 
Moerman, D. E., Pemberton, R. W., Kiefer, D., & Berlin, B. (1999). A comparative 
analysis of five medicinal floras. Journal of Ethnobiology, 19(1), 49-67. 
 
Mohamed Said, M. S., Adam, J., & Ratnam, W. (1999). Biologi Sistematik. Bangi: 





Molares, S., & Ladio, A. (2009). Chemosensory perception and medicinal plants for 
digestive ailments in a Mapuche community in NW Patagonia, Argentina. 
Journal of Ethnopharmacology, 123(3), 397-406.  
 
Moran, R. C., Labiak, P. H., Hanks, J. G., & Prado, J. (2014). The phylogenetic 
relationship of Tectaria brauniana and Tectaria nicotianifolia, and the 
recognition of Hypoderris (Tectariaceae). Systematic Botany, 39(2), 384-395.  
 
Muellner, A. N., Samuel, R., Chase, M. W., Pannell, C. M., & Greger, H. (2005). 
Aglaia (Meliaceae): An evaluation of taxonomic concepts based on DNA data 
and secondary metabolites. American Journal of Botany, 92(3), 534-543. 
 
Nadkarni, K. M. (1996). Indian Materia Medica. Bombay: Popular Prakashan. 
 
Nakane, T., Arai, Y., Masuda, K., Ishizaki, Y., Ageta, H., & Shiojima, K. (1999). Fern 
constituents: Six new triterpenoid alcohols from Adiantum capillus-veneris. 
Chemical and Pharmaceutical Bulletin, 47(4), 543-547.  
 
Nakane, T., Maeda, Y., Ebihara, H., Arai, Y., Masuda, K., Takano, A., Ageta, H., 
Shiojima, K., Cai, S.-Q., & Abdel-Halim, O. B. (2002). Fern constituents: 
Triterpenoids from Adiantum capillus-veneris. Chemical and Pharmaceutical 
Bulletin, 50(9), 1273-1275.  
 
Nejad, B. S., & Deokule, S. S. (2009). Anti-dermatophytic activity of Drynaria 
quercifolia (L.) J. Smith. Jundishapur Journal of Microbiology, 2(1), 25-30.  
   
Ngā Tipu Whakaoranga database. (2016).   Retrieved Jun 2015, 2015, from 
http://maoriplantuse.landcareresearch.co.nz/ 
 
Ningthoujam, S. S., Talukdar, A. D., Potsangbam, K. S., & Choudhury, M. D. (2012). 
Challenges in developing medicinal plant databases for sharing 
ethnopharmacological knowledge. Journal of Ethnopharmacology, 141(1), 9-32. 
 
Niwa, H., Ojika, M., Wakamatsu, K., Yamada, K., Hirono, I., & Matsushita, K. 
(1983(a)). Ptaquiloside, a novel norsesquiterpene glucoside from bracken, 
Pteridium aquilinum var. latiusculum. Tetrahedron Letters, 24(38), 4117-4120.  
 
Niwa, H., Ojika, M., Wakamatsu, K., Yamada, K., Ohba, S., Saito, Y., Hirono, I., & 
Matsushita, K. (1983(b)). Stereochemistry of ptaquiloside, a novel 
norsesquiterpene glucoside from bracken, Pteridium aquilinum var. latiusculum. 
Tetrahedron Letters, 24(48), 5371-5372.  
 
Noor, M. A. F., Zimmerman, K. J., & Teeter, K. C. (2006). Data sharing: How much 
doesn't get submitted to GenBank? PLoS Biology, 4(7), 1113-1114.  
 
Nooteboom, H. (2012). Hypodematiaceae. Flora Malesiana-Series 2, Pteridophyta, 





Novais, M., Santos, I., Mendes, S., & Pinto-Gomes, C. (2004). Studies on 
pharmaceutical ethnobotany in Arrabida natural park (Portugal). Journal of 
Ethnopharmacology, 93(2), 183-195.  
 
Odugbemi, T. (2008). A Textbook of Medicinal Plants From Nigeria. Lagos: University 
of Lagos Press. 
 
Okello, J., & Ssegawa, P. (2007). Medicinal plants used by communities of Ngai 
Subcounty, Apac district, northern Uganda. African Journal of Ecology, 45(s1), 
76-83.  
 
Paciencia, M. L. B., & Prado, J. (2005). Effects of forest fragmentation on pteridophyte 
diversity in a tropical rain forest in Brazil. Plant Ecology, 180(1), 87-104.  
 
Page, C. N. (1979). The diversity of ferns. An ecological perspective. In A. F. Dyer 
(Ed.), The Experimental Biology of Ferns (pp. 10–56). London: Academic Press. 
 
Pagel, M., Meade, A., & Barker, D. (2004). Bayesian estimation of ancestral character 
states on phylogenies. Systematic Biology, 53(5), 673-684.  
 
Parihar, P., Parihar, L., & Bohra, A. (2010). In vitro antibacterial activity of fronds 
(leaves) of some important pteridophytes. Journal of Microbiology and 
Antimicrobials, 2(2), 19-22.  
 
Pan, S. Y., Litscher, G., Gao, S. H., Zhou, S. F., Yu, Z. L., Chen, H. Q., Zhang, S.F., 
Tang, M.K., Sun, J.N.,  & Ko, K. M. (2014). Historical perspective of traditional 
indigenous medical practices: The current renaissance and conservation of 
herbal resources. Evidence-Based Complementary and Alternative Medicine, 
2014, 1–20. 
 
Pardo de Santayana, M., & Morales, R. (2010). Chamomiles in Spain: The dynamics of 
plant nomenclature. In M. Pardo de Santayana, A. Pieroni, & R. K. Puri (Eds.), 
Ethnobotany in the New Europe : People, Health, and Wild Plant Resources 
(pp. 282–306). New York and Oxford: Berghahn Books. 
 
Parris, B. S., & Latiff, A. (1997). Towards a pteriodophyte flora of  Malaysia: A 
provisional checklist of taxa. Malayan Nature Journal, 50(4), 235-280.  
 
Pearse, W. D., & Purvis, A. (2013). PhyloGenerator: An automated phylogeny 
generation tool for ecologists. Methods in Ecology and Evolution, 4(7), 692-698. 
 
Perry, L. M., & Metzger, J. (1980). Medicinal Plants of East and Southeast Asia: 
Attributed Properties and Uses. Cambridge: The MIT Press. 
 
Philippe, H., Snell, E. A., Bapteste, E., Lopez, P., Holland, P. W., & Casane, D. (2004). 
Phylogenomics of eukaryotes: Impact of missing data on large alignments. 
Molecular Biology and Evolution, 21(9), 1740-1752.  
 
Pieroni, A., Quave, C., Nebel, S., & Heinrich, M. (2002). Ethnopharmacy of the ethnic 




Plants For Future. (2012). Retrieved Jun 2015, 2015, from 
http://www.pfaf.org/user/plantsearch.aspx 
 
Pohl, R. W. (1955). Toxicity of ferns and Equisetum. American Fern Journal, 45(3), 
95-97.  
 
Pollock, D. D., Zwickl, D. J., McGuire, J. A., & Hillis, D. M. (2002). Increased taxon 
sampling is advantageous for phylogenetic inference. Systematic Biology, 51(4), 
664-671.  
 
Pourmorad, F., Hosseinimehr, S., & Shahabimajd, N. (2006). Antioxidant activity, 
phenol and flavonoid contents of some selected Iranian medicinal plants. 
African Journal of Biotechnology, 5(11), 1142-1145.  
 
Prado, J., Rodrigues, C. D. N., Salatino, A., & Salatino, M. L. F. (2007). Phylogenetic 
relationships among Pteridaceae, including Brazilian species, inferred from rbcL 
sequences. Taxon, 56(2), 355-368.  
 
Prance, G., & Keller, H. A. (2015). The ethnobotany of ferns and fern allies. British 
Pteridological Society, 20(1), 1-14. 
 
Pryer, K. M., Schneider, H., Smith, A. R., Cranfill, R., Wolf, P. G., Hunt, J. S., & Sipes, 
S. D. (2001). Horsetails and ferns are a monophyletic group and the closest 
living relatives to seed plants. Nature, 409(6820), 618-622.  
 
Pryer, K. M., Schuettpelz, E., Wolf, P. G., Schneider, H., Smith, A. R., & Cranfill, R. 
(2004). Phylogeny and evolution of ferns (monilophytes) with a focus on the 
early leptosporangiate divergences. American Journal of Botany, 91(10), 1582-
1598.  
 
Pryer, K. M., Smith, A. R., & Skog, J. E. (1995). Phylogenetic relationships of extant 
ferns based on evidence from morphology and rbcL sequences. American Fern 
Journal, 85(4), 205-282.  
 
Puri, H. (1970). Indian pteridophytes used in folk remedies. American Fern Journal, 
60(4), 137-143.  
 
Qian, H., & Jin, Y. (2015). An updated megaphylogeny of plants, a tool for generating 
plant phylogenies and an analysis of phylogenetic community structure. Journal 
of Plant Ecology, 9(2), 233–239. 
 
Qian, H., & Zhang, J. (2014). Using an updated time‐calibrated family‐level phylogeny 
of seed plants to test for non‐random patterns of life forms across the phylogeny. 
Journal of Systematics and Evolution, 52(4), 423-430.  
 
Qiu, Y. L., Li, L., Wang, B., Chen, Z., Dombrovska, O., Lee, J., Kent, L., Li, R., 
Jobson, R. W., Hendry, T. A., Taylor, D. W., Testa, C. M., & Ambros, M. 
(2007). A nonflowering land plant phylogeny inferred from nucleotide 
sequences of seven chloroplast, mitochondrial, and nuclear genes. International 




Qiu, Y. L., Li, L., Wang, B., Chen, Z., Knoop, V., Groth-Malonek, M., Dombrovska, 
O., Lee, J., Kent, L., Rest, J., Estabrook, G. F., Hendry, T. A., Taylor, D. W., 
Testa, C. M., Ambros, M., Crandall-Stotler, B., Duff, R. J., Stech, M., Frey, W., 
Quandt, D., & Davis, C. C. (2006). The deepest divergences in land plants 
inferred from phylogenomic evidence. Proceedings of the National Academy of 
Sciences, 103(42), 15511-15516.  
 
Radulović, N., Stojanović, G., & Palić, R. (2006). Composition and antimicrobial 
activity of Equisetum arvense L. essential oil. Phytotherapy Research, 20(1), 85-
88.  
 
Rahman, M., Tondel, M., Chowdhury, I. A., & Axelson, O. (1999). Relations between 
exposure to arsenic, skin lesions, and glucosuria. Occupational and 
Environmental Medicine, 56(4), 277-281.  
 
Rai, H. S., & Graham, S. W. (2010). Utility of a large, multigene plastid data set in 
inferring higher-order relationships in ferns and relatives (monilophytes). 
American Journal of  Botany, 97(9), 1444-1456.  
 
Raintree-Tropical Plant Database. (1996).   Retrieved Jun 2015, 2015, from 
http://www.rain-tree.com/plants.html. 
 
Rangel, T. F., Colwell, R. K., Graves, G. R., Fučíková, K., Rahbek, C., & Diniz‐Filho, 
J. A. F. (2015). Phylogenetic uncertainty revisited: Implications for ecological 
analyses. Evolution, 69(5), 1301-1312.  
 
Ranker, T. A., Smith, A. R., Parris, B. S., Geiger, J. M., Haufler, C. H., Straub, S. C., & 
Schneider, H. (2004). Phylogeny and evolution of grammitid ferns 
(Grammitidaceae): A case of rampant morphological homoplasy. Taxon, 53(2), 
415-428.  
 
Ranker, T. A., & Haufler, C. H. (2008). Biology and Evolution of Ferns and 
Lycophytes. Cambridge: Cambridge University Press  
 
Rascio, N., & Navari-Izzo, F. (2011). Heavy metal hyperaccumulating plants: How and 
why do they do it? And what makes them so interesting? Plant Science, 180(2), 
169-181.  
 
Rasmussen, L. H., Kroghsbo, S., Frisvad, J. C., & Hansen, H. C. B. (2003). Occurrence 
of the carcinogenic Bracken constituent ptaquiloside in fronds, topsoils and 
organic soil layers in Denmark. Chemosphere, 51(2), 117-127.  
 
Rathinasabapathi, B., Rangasamy, M., Froeba, J., Cherry, R. H., McAuslane, H. J., 
Capinera, J. L., Srivastava, M., & Ma, L. Q. (2007). Arsenic hyperaccumulation 
in the chinese brake fern (Pteris vittata) deters grasshopper (Schistocerca 
americana) herbivory. New Phytologist, 175(2), 363-369. 
 
Reddy, V. N., Ravikanth, V., Rao, T. P., Diwan, P., & Venkateswarlu, Y. (2001). A 
new triterpenoid from the fern Adiantum lunulatum and evaluation of 




Robinson, T. (1974). Metabolism and function of alkaloids in plants. Science, 
184(4135), 430-435.  
 
Roeder, E., Wiedenfeld, H., & Edgar, J. A. (2015). Pyrrolizidine alkaloids in medicinal 
plants from North America. Die Pharmazie, 70(6), 357-367. 
 
Roeder, E., & Wiedenfeld, H. (2013). Plants containing pyrrolizidine alkaloids used in 
the Traditional Indian Medicine–including Ayurveda. Die Pharmazie, 68(2), 83-
92. 
 
Roeder, E. (2000). Medicinal plants in China containing pyrrolizidine alkaloids. Die 
Pharmazie, 55(10), 711-726. 
 
Rønsted, N., Savolainen, V., Mølgaard, P., & Jäger, A. K. (2008). Phylogenetic 
selection of Narcissus species for drug discovery. Biochemical Systematics and 
Ecology, 36(5), 417-422.  
 
Rønsted, N., Symonds, M. R., Birkholm, T., Christensen, S. B., Meerow, A. W., 
Molander, M., Mølgaard, P., Petersen, G., Rasmussen, N., van Staden, J., 
Stafford, G. I., & Jäger, A. K. (2012). Can phylogeny predict chemical diversity 
and potential medicinal activity of plants? A case study of Amaryllidaceae. 
BMC Evolutionary Biology, 12(182), 1-12.  
 
Roquet, C., Thuiller, W., & Lavergne, S. (2012). Building megaphylogenies for 
macroecology: Taking up the challenge. Ecography, 36(1), 13-26. 
 
Ross, I. A. (2007). Medicinal Plants of the World, Volume 3: Chemical Constituents, 
Traditional and Modern Medicinal Uses. Totowa: Humana Press.  
 
Rothfels, C. J., Windham, M. D., Grusz, A. L., Gastony, G. J., & Pryer, K. M. (2008). 
Toward a monophyletic Notholaena (Pteridaceae): Resolving patterns of 
evolutionary convergence in xeric-adapted ferns. Taxon, 57(3), 712-724.  
 
Rothfels, C. J., Sundue, M. A., Kuo, L. Y., Larsson, A., Kato, M., Schuettpelz, E., & 
Pryer, K. M. (2012). A revised family-level classification for eupolypod II ferns 
(Polypodiidae: Polypodiales). Taxon, 61(3), 515-533. 
 
Rothfels, C. J., Windham, M. D., & Pryer, K. M. (2013). A plastid phylogeny of the 
cosmopolitan fern family Cystopteridaceae (Polypodiopsida). Systematic 
Botany, 38(2), 295-306.  
 
Rothfels, C. J., Li, F. W., Sigel, E. M., Huiet, L., Larsson, A., Burge, D. O., Ruhsam, 
M.,Deyholos, M., Soltis, D. E., Stewart, C. N., Shaw, S.W., Pokorny, L., Chen, 
T., Depamphilis, C., Degironimo, L., Chen, L., Wei, X., Sun, X., Korall, P., 
Stevenson, D. W., Graham, S. W., Wong, G. K. S., & Pryer, K.M. (2015). The 
evolutionary history of ferns inferred from 25 low-copy nuclear genes. 





Rothwell, G. W., & Nixon, K. C. (2006). How does the inclusion of fossil data change 
our conclusions about the phylogenetic history of euphyllophytes? International 
Journal of Plant Sciences, 167(3), 737-749.  
 
Rouhan, G., Dubuisson, J.-Y., Rakotondrainibe, F., Motley, T. J., Mickel, J. T., Labat, 
J.-N., & Moran, R. C. (2004). Molecular phylogeny of the fern genus 
Elaphoglossum (Elaphoglossaceae) based on chloroplast non-coding DNA 
sequences: Contributions of species from the Indian Ocean area. Molecular 
Phylogenetics and Evolution, 33(3), 745-763.  
 
Rout, S. D., Panda, T., & Mishra, N. (2009). Ethnomedicinal studies on some 
pteridophytes of similipal biosphere reserve, Orissa, India. International Journal 
of Medicine and Medical Sciences, 1(5), 192-197. 
 
Roux, J. P. (2001). Conspectus of Southern African Pteridophyta: An Enumeration of 
the Pteridophyta of Angola, Botswana, Lesotho, Malawi, Mozambique, Namibia, 
South Africa (including the Marion Island Group), Swaziland, Zambia and 
Zimbabwe. Pretoria: Southern African Botanical Diversity Network Report.  
 
Roy, S., & Chaudhuri, T. K. (2015). Assessment of th1 and th2 cytokine modulatory 
activity of an edible fern, Diplazium esculentum. Food and Agricultural 
Immunology, 26(5), 690-702.  
 
Saito, H. (2000). Regulation of herbal medicines in Japan. Pharmacological Research, 
41(5), 515-519.  
 
Saito, K., Nagao, T., Matoba, M., Koyama, K., Natori, S., Murakami, T., & Saiki, Y. 
(1989). Chemical assay of ptaquiloside, the carcinogen of Pteridium aquilinum, 
and the distribution of related compounds in the Pteridaceae. Phytochemistry, 
28(6), 1605-1611.  
 
Saito, K., Nagao, T., Takatsuki, S., Koyama, K., & Natori, S. (1990). The 
sesquiterpenoid carcinogen of bracken fern, and some analogues, from the 
Pteridaceae. Phytochemistry, 29(5), 1475-1479. 
 
Samuelsson, G. (1999). Drugs of Natural Origin: A Textbook of Pharmacognosy. 
Stockholm: Swedish Pharmaceutical Society (Apotekarsocieten). 
 
Sanderson, M. J., & Wojciechowski, M. F. (2000). Improved bootstrap confidence 
limits in large-scale phylogenies, with an example from Neo-Astragalus 
(Leguminosae). Systematic Biology, 49(4), 671-685.  
 
Sandhu, N. S., Kaur, S., & Chopra, D. (2010). Equisetum arvense: Pharmacology and 
phytochemistry–a review. Asian Journal of Pharmacological Clinical 
Resources, 3(3), 146-150.  
 
Santos, M. G., Kelecom, A., Paiva, S., Moraes, M., Rocha, L., & Garrett, R. (2010). 
Phytochemical studies in pteridophytes growing in Brazil: A review. American 





Särkinen, T., Bohs, L., Olmstead, R. G., & Knapp, S. (2013). A phylogenetic 
framework for evolutionary study of the nightshades (Solanaceae): A dated 
1000-tip tree. BMC Evolutionary Biology, 13(1), 214-229.  
 
Sarma, H., Deka, S., Deka, H., & Saikia, R. R. (2010). Accumulation of heavy metals in 
selected medicinal plants. Reviews of Environmental Contamination and 
Toxicology, 214, 63-86. 
 
Sasidharan, S., Chen, Y., Saravanan, D., Sundram, K. M., & Latha, L. Y. (2011). 
Extraction, isolation and characterization of bioactive compounds from plants’ 
extracts. African Journal of Traditional, Complementary and Alternative 
Medicines, 8(1), 1-10. 
 
Saslis-Lagoudakis, C. H., Klitgaard, B. B., Forest, F., Francis, L., Savolainen, V., 
Williamson, E. M., & Hawkins, J. A. (2011). The use of phylogeny to interpret 
cross-cultural patterns in plant use and guide medicinal plant discovery: An 
example from Pterocarpus (Leguminosae). PLoS One, 6(7), e22275.  
 
Saslis-Lagoudakis, C. H., Savolainen, V., Williamson, E. M., Forest, F., Wagstaff, S. J., 
Baral, S. R., Watson, M. F., Pendry, C. A., & Hawkins, J. A. (2012). 
Phylogenies reveal predictive power of traditional medicine in bioprospecting. 
Proceedings of the National Academy of Sciences, 109(39), 15835-15840. 
 
Saslis-Lagoudakis, C. H., Hawkins, J. A., Greenhill, S. J., Pendry, C. A., Watson, M. F., 
Tuladhar-Douglas, W., Baral, S.R., & Savolainen, V. (2014). The evolution of 
traditional knowledge: Environment shapes medicinal plant use in Nepal. 
Proceedings of the Royal Society of London B: Biological Sciences, 281(1780), 
20132768. 
 
Saslis-Lagoudakis, C. H., Rønsted, N., C. Clarke, A., & A. Hawkins, J. (2015). 
Evolutionary approaches to ethnobiology. In U. Paulino Albuquerque, P. Muniz 
De Medeiros, & A. Casas (Eds.), Evolutionary Ethnobiology (pp. 59–72). Cham: 
Springer. 
 
Sato, N., & Furuya, M. (1983). Isolation and identification of diacylglyceryl-O-4′-(N, 
N, N-trimethyl)-homoserine from the ern Adiantum capillus-veneris L. Plant 
and Cell Physiology, 24(6), 1113-1120.  
 
Schippmann, U., J . Leaman, D., & Cunningham, A. B. (2002). Impact of cultivation 
and gathering of medicinal plants on biodiversity: Global trends and issues. In 
FAO (Ed.), Biodiversity and the Ecosystem Approach in Agriculture, Forestry 
and Fisheries (pp. 1–21). Rome: FAO Inter-Departmental Working Group on 
Biological Diversity for Food and Agriculture. 
  
Schneider, H., Schuettpelz, E., Pryer, K. M., Cranfill, R., Magallón, S., & Lupia, R. 
(2004). Ferns diversified in the shadow of Angiosperms. Nature, 428(6982), 
553-557.  
 
Schneider, H., Smith, A. R., & Pryer, K. M. (2009). Is morphology really at odds with 




Schuettpelz, E., Korall, P., & Pryer, K. M. (2006). Plastid atpA data provide improved 
support for deep relationships among ferns. Taxon, 55(4), 897-906.  
 
Schuettpelz, E., & Pryer, K. M. (2007). Fern phylogeny inferred from 400 
leptosporangiate species and three plastid genes. Taxon, 56(4), 1037-1050.  
 
Schuettpelz, E., Schneider, H., Huiet, L., Windham, M. D., & Pryer, K. M. (2007). A 
molecular phylogeny of the fern family Pteridaceae: Assessing overall 
relationships and the affinities of previously unsampled genera. Molecular 
Phylogenetics and Evolution, 44(3), 1172-1185.  
 
Schuettpelz, E., & Pryer, K. M. (2009). Evidence for a Cenozoic radiation of ferns in an 
Angiosperm-dominated canopy. Proceedings of the National Academy of 
Sciences, 106(27), 11200-11205. 
 
Schuster, S. C. (2007). Next-generation sequencing transforms today’s biology. Nature 
Methods, 5(1), 16–18. 
 
Shahin, M., Smith, B. L., & Prakash, A. S. (1999). Bracken carcinogens in the human 
diet. Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 
443(1-2), 69-79.  
 
Sheng-Ji, P. (2001). Ethnobotanical approaches of traditional medicine studies: Some 
experiences from Asia. Pharmaceutical Biology, 39(1), 74-79.  
 
Shrestha, P. M., & Dhillion, S. S. (2003). Medicinal plant diversity and use in the 
highlands of Dolakha district, Nepal. Journal of Ethnopharmacology, 86(1), 81-
96.  
 
Simán, S., Povey, A. C., Ward, T. H., Margison, G. P., & Sheffield, E. (2000). Fern 
spore extracts can damage DNA. British Journal of Cancer, 83(1), 69-73.  
 
Singh, M., Singh, N., Khare, P., & Rawat, A. (2008). Antimicrobial activity of some 
important Adiantum species used traditionally in indigenous systems of 
medicine. Journal of Ethnopharmacology, 115(2), 327-329.  
 
Singh, J., & Kalamdhad, A. (2011). Effects of heavy metals on soil, plants, human 
health and aquatic life. International Journal of Resources in Chemistry and 
Environments, 1(2), 15-21.  
 
Singh, S., & Singh, R. (2012). Ethnomedicinal use of pteridophytes in reproductive 
health of tribal women of Pachmarhi Biosphere Reserve, Madhya Pradesh, 
India. International Journal of Pharmaceutical and Science Research, 3(12), 
4780-4790.  
 
Smith, B. L., & Seawright, A. A. (1995). Bracken fern (Pteridium spp.) carcinogenicity 





Smith, S. A., Beaulieu, J. M., & Donoghue, M. J. (2009). Mega-phylogeny approach for 
comparative biology: An alternative to supertree and supermatrix approaches. 
BMC Evolutionary Biology, 9, 37-48.  
 
Smith, A. R., Pryer, K. M., Schuettpelz, E., Korall, P., Schneider, H., & Wolf, P. G. 
(2006). A classification for extant ferns. Taxon, 55(3), 705-731.  
 
Smith, W. L., & Wheeler, W. C. (2006). Venom evolution widespread in fishes: A 
phylogenetic road map for the bioprospecting of piscine venoms. Journal of 
Heredity, 97(3), 206-217.  
 
Smith, A. H., Arroyo, A. P., Mazumder, D., Kosnett, M. J., Hernandez, A. L., Beeris, 
M., Smith, M. M., & Moore, L. E. (2000). Arsenic-induced skin lesions among 
Atacameno people in Northern Chile despite good nutrition and centuries of 
exposure. Environmental Health Perspectives, 108(7), 617-620.  
 
Smith, E., Naidu, R., & Alston, A. (1998). Arsenic in the soil environment. Advances in 
Agronomy, 64, 149-195.  
 
Sodhi, N. S., Koh, L. P., Brook, B. W., & Ng, P. K. (2004). Southeast Asian 
biodiversity: An impending disaster. Trends in Ecology & Evolution, 19(12), 
654-660.  
 
Soltis, D. E., Moore, M. J., Burleigh, J. G., Bell, C. D., & Soltis, P. S. (2010). 
Assembling the Angiosperm tree of life: Progress and future prospects. Annals 
of the Missouri Botanical Garden, 97(4), 514-526.  
 
Somvanshi, R., Lauren, D., Smith, B., Dawra, R., Sharma, O., Sharma, V., Singh, A., & 
Gangwar, N. (2006). Estimation of the fern toxin, ptaquiloside, in certain Indian 
ferns other than bracken. Current Science, 91(11), 1547-1551.  
 
Speck, F. G. (1941). A list of plant curatives obtained from the Houma Indians of 
Louisiana. Primitive Man, 14(4), 49-73. 
  
Sriram, D., Yogeeswari, P., Thirumurugan, R., & Ratan Bal, T. (2005). Camptothecin 
and its analogues: A review on their chemotherapeutic potential. Natural 
Product Research, 19(4), 393-412. 
 
Srivastava, K. (2007). Importance of ferns in human medicine. Ethnobotanical 
Leaflets,11, 231-234.  
 
Srivastava, J., Lambert, J., & Vietmeyer, N. (1996). Medicinal Plants: An Expanding 
Role in Development. Washington: World Bank Publications. 
 
Srivastava, M., Ma, L. Q., & Santos, J. A. G. (2006). Three new arsenic 
hyperaccumulating ferns. Science of The Total Environment, 364(1), 24-31.  
 
Srivastava, M., Santos, J., Srivastava, P., & Ma, L. Q. (2010). Comparison of arsenic 
accumulation in 18 fern species and four Pteris vittata accessions. Bioresource 




Ssegawa, P., & Kasenene, J. M. (2007). Medicinal plant diversity and uses in the Sango 
bay area, Southern Uganda. Journal of Ethnopharmacology, 113(3), 521-540.  
 
Stamatakis, A., Hoover, P., & Rougemont, J. (2008). A rapid bootstrap algorithm for 
the RAxML web servers. Systematic Biology, 57(5), 758-771.  
 
Stepp, J. R., & Moerman, D. E. (2001). The importance of weeds in  
ethnopharmacology. Journal of Ethnopharmacology, 75(1), 19-23.  
 
Street, R., Stirk, W., & Van Staden, J. (2008). South African traditional medicinal plant 
trade—challenges in regulating quality, safety and efficacy. Journal of 
Ethnopharmacology, 119(3), 705-710.  
 
Sundue, M. A., Islam, M. B., & Ranker, T. A. (2010). Systematics of grammitid ferns 
(Polypodiaceae): Using morphology and plastid sequence data to resolve the 
circumscriptions of Melpomene and the polyphyletic genera Lellingeria and 
Terpsichore. Systematic Botany, 35(4), 701-715.  
 
Sundue, M. A., Parris, B. S., Ranker, T. A., Smith, A. R., Fujimoto, E. L., Zamora-
Crosby, D., Morden, C. W., Chiou, W. L., Chen, C. W., Rouhan, G., Hirai, R. 
Y., & Prado, J. (2014). Global phylogeny and biogeography of grammitid ferns 
(Polypodiaceae). Molecular Phylogenetics and Evolution, 81, 195-206.  
 
Talip, N., Abdul Rahman, M. R., Moksin, F.-M., Khamis, S., & Abdul Manap, T. 
(2013). Guide to Peninsular Malaysia Medicinal and Edible Ferns. Bangi: 
Penerbit Universiti Kebangsaan Malaysia. 
Tan, Y., & Xiang, Y. (2002). Effects of the alcohol extracts from rhizoma Adiantum 
capillus-veneris on rifampicin-resistant pulmonary tuberculosis cells. Journal of 
Wuhan Institute of Science and Technology, 16(3), 79-83.  
 
Taskova, R., Albach, D. C., & Grayer, R. (2004). Phylogeny of Veronica-a combination 
of molecular and chemical evidence. Plant Biology, 6(06), 673-682. 
 
Teklehaymanot, T., & Giday, M. (2007). Ethnobotanical study of medicinal plants used 
by people in Zegie Peninsula, Northwestern Ethiopia. Journal of Ethnobiology 
and Ethnomedicine, 3(1), 12-23.  
 
Thomas, T. (2011). Preliminary antibacterial and phytochemical assessment of 
Osmunda regalis L. International Journal of Pharmaceutical & Biological 
Archive, 2(1), 559-562. 
 
Tomšík, P. (2014). Ferns and Lycopods—A Potential Treasury of Anticancer Agents 
but Also a Carcinogenic Hazard. Phytotherapy Research, 28(6), 798-810.  
 
Trainer, V. L., Bates, S. S., Lundholm, N., Thessen, A. E., Cochlan, W. P., Adams, N. 
G., & Trick, C. G. (2012). Pseudo-nitzschia physiological ecology, phylogeny, 






Tropicos. (2016).   Retrieved November, 2015, from 
http://www.tropicos.org/Home.aspx 
 
Tseng, C.-H. (1999). Chronic arsenic intoxication in Asia: Current perspectives. 
Journal of  International Medicinal Taiwan, 10, 224-229.  
 
Unschuld, P. U. (1986). Medicine in China: A History of Pharmaceutics (Vol. 2). 
London: Univ of California Press. 
 
Upreti, K., Jalal, J. S., Tewari, L. M., Joshi, G., Pangtey, Y., & Tewari, G. (2009). 
Ethnomedicinal uses of pteridophytes of Kumaun Himalaya, Uttarakhand, India. 
Journal of American Science, 5(4), 167-170.  
 
Van der Hoeven, J., Lagerweij, W., Posthumus, M., Van Veldhuizen, A., & Holterman, 
H. (1983). Aquilide A, a new mutagenic compound isolated from bracken fern 
(Pteridium aquilinum (L.) Kuhn). Carcinogenesis, 4(12), 1587-1590.  
 
Van, T. K., Kang, Y., Fukui, T., Sakurai, K., Iwasaki, K., Aikawa, Y., & Phuong, N. M. 
(2006). Arsenic and heavy metal accumulation by Athyrium yokoscense from 
contaminated soils. Soil Science and Plant Nutrition, 52(6), 701-710.  
 
Van Maanen, J., Retel, J., De Vries, J., & Pinedo, H. (1988). Mechanism of action of 
antitumor drug etoposide: A review. Journal of the National Cancer Institute, 
80(19), 1526-1533. 
 
Van Wyk, B. E., & Wink, M. (2004). Medicinal Plants of the World: An Illustrated 
Scientific Guide to Important Medicinal Plants and Their Uses. Portland: 
Timber Press. 
 
Van Wyk, B. E., & Wink, M. (Eds.). (2015). Phytomedicines, Herbal Drugs, and 
Poisons. Chicago: University of Chicago Press. 
 
Vane-Wright, R. I., Humphries, C. J., & Williams, P. H. (1991). What to protect?—
Systematics and the agony of choice. Biological Conservation, 55(3), 235-254. 
 
Vetter, J. (2009). A biological hazard of our age: Bracken fern [Pteridium aquilinum 
(L.) Kuhn]—A review. Acta Veterinaria Hungarica, 57(1), 183-196.  
 
Vetter, J. (2011). Toxicological and medicinal aspects of the most frequent fern species, 
Pteridium aquilinum (L.) Kuhn. In A. Kumar, H. Fernández, & M. A. Revilla 
(Eds.), Working with Ferns : Issues and Applications (pp. 361–375). New York: 
Springer. 
 
Visoottiviseth, P., Francesconi, K., & Sridokchan, W. (2002). The potential of Thai 
indigenous plant species for the phytoremediation of arsenic contaminated land. 







Wang, L., Wu, Z. Q., Xiang, Q. P., Heinrichs, J., Schneider, H., & Zhang, X. C. 
(2010a). A molecular phylogeny and a revised classification of tribe Lepisoreae 
(Polypodiaceae) based on an analysis of four plastid DNA regions. Botanical 
Journal of the Linnean Society, 162(1), 28-38. 
 
Wang, L., Qi, X. P., Xiang, Q. P., Heinrichs, J., Schneider, H., & Zhang, X.C. (2010b). 
Phylogeny of the paleotropical fern genus Lepisorus (Polypodiaceae, 
Polypodiopsida) inferred from four chloroplast DNA regions. Molecular 
Phylogenetics and Evolution, 54(1), 211-225.  
 
Wang, X. L., Wang, N. L., Gao, H., Zhang, G., Qin, L., Wong, M. S., & Yao, X. S. 
(2010). Phenylpropanoid and flavonoids from osteoprotective fraction of 
Drynaria fortunei. Natural Product Research, 24(13), 1206-1213.  
 
Wang, X. L., Wang, N. L., Zhang, Y., Gao, H., Pang, W. Y., Wong, M. S., Zhang, G., 
Qin, L., & Yao, X. S. (2008). Effects of eleven flavonoids from the 
osteoprotective fraction of Drynaria fortunei (Kunze) J. SM. on osteoblastic 
proliferation using an osteoblast-like cell line. Chemical and Pharmaceutical 
Bulletin, 56(1), 46-51. 
 
Wang, H., Wong, M., Lan, C., Baker, A., Qin, Y., Shu, W., Chen, G., & Ye, Z. (2007). 
Uptake and accumulation of arsenic by 11 Pteris taxa from southern China. 
Environmental Pollution, 145(1), 225-233.  
  
Webb, C. O., Ackerly, D. D., & Kembel, S. W. (2008). Phylocom: Software for the 
analysis of phylogenetic community structure and trait evolution. 
Bioinformatics, 24(18), 2098-2100. 
 
Wiens, J. J. (2003). Missing data, incomplete taxa, and phylogenetic accuracy. 
Systematic Biology, 52(4), 528-538.  
 
Wiens, J. J. (2006). Missing data and the design of phylogenetic analyses. Journal of 
Biomedical Informatics, 39(1), 34-42.  
 
Wikström, N., & Pryer, K. M. (2005). Incongruence between primary sequence data 
and the distribution of a mitochondrial atp1 group II intron among ferns and 
horsetails. Molecular Phylogenetics and Evolution, 36(3), 484-493.  
 
Wink, M. (2003). Evolution of secondary metabolites from an ecological and molecular 
phylogenetic perspective. Phytochemistry, 64(1), 3-19.  
 
Wink, M., & Mohamed, G. (2003). Evolution of chemical defense traits in the 
Leguminosae: Mapping of distribution patterns of secondary metabolites on a 
molecular phylogeny inferred from nucleotide sequences of the rbcL gene. 
Biochemical Systematics and Ecology, 31(8), 897-917. 
 
Winter, W. d., & Amoroso, V. B. (2003). Plant Resources of South-East Asia No 15 (2). 





Wolf, P. G. (1995). Phylogenetic analysis of rbcL and nuclear ribosomal RNA gene 
sequences in Dennstaedtiaceae. American Fern Journal, 85(4), 306-327.  
 
Wolf, P. G., Soltis, P. S., & Soltis, D. E. (1994). Phylogenetic relationships of 
Dennstaedtioid ferns: Evidence from rbcL sequences. Molecular Phylogenetics 
and Evolution, 3(4), 383-392.  
 
Wong, K. C., Pang, W. Y., Wang, X. L., Mok, S. K., Lai, W. P., Chow, H. K., Leung, 
P. C., Yao, X. S., & Wong, M. S. (2013). Drynaria fortunei-derived total 
flavonoid fraction and isolated compounds exert oestrogen-like protective 
effects in bone. British Journal of Nutrition, 110(03), 475-485.  
 
Woo, S. O. (2000). Chinese Proprietary Medicine in Singapore. Drug Safety, 23(5), 
351-362. 
 
Wu, C. (1990). Outline of  New China herbals, Vol 3. Shanghai: Shanghai Press of 
Science and Technology. 
 
Yamada, K., Ojika, M., & Kigoshi, H. (2007). Ptaquiloside, the major toxin of bracken, 
and related terpene glycosides: Chemistry, biology and ecology. Natural 
Product Reports, 24(4), 798-813.  
 
Yessoufou, K., Daru, B. H., & Muasya, A. M. (2015). Phylogenetic exploration of 
commonly used medicinal plants in South Africa. Molecular Ecology 
Resources, 15(2), 405-413.   
 
Yonathan, M., Asres, K., Assefa, A., & Bucar, F. (2006). In vivo anti-inflammatory and 
anti-nociceptive activities of Cheilanthes farinosa. Journal of 
Ethnopharmacology, 108(3), 462-470.  
 
Zanne, A. E., Tank, D. C., Cornwell, W. K., Eastman, J. M., Smith, S. A., FitzJohn, R. 
G., McGlinn, D. J., O’Meara, B. C., Moles, A. T., Reich, P. B., Royer, D. L., 
Soltis, D. E., Stevens, P. F., Westoby, M., Wright, I. J., Aarssen, L., Bertin, R. 
I., Calaminus, A., Govaerts, R., Hemmings, F., Leishman, M. R., Oleksyn, J., 
Soltis, P. S., Swenson, N. G., Warman, L., & Beaulieu, J. M. (2014). Three keys 
to the radiation of angiosperms into freezing environments. Nature, 506(7486), 
89-92. 
 
Zhang, X., Lin, A.-J., Zhao, F.-J., Xu, G.-Z., Duan, G.-L., & Zhu, Y.-G. (2008). Arsenic 
accumulation by the aquatic fern Azolla: Comparison of arsenate uptake, 
speciation and efflux by A. caroliniana and A. filiculoides. Environmental 
Pollution, 156(3), 1149-1155.  
 
Zhang, J., Wider, B., Shang, H., Li, X., & Ernst, E. (2012). Quality of herbal medicines: 
Challenges and solutions. Complementary Therapies in Medicine, 20(1), 100-
106. 
 
Zhao, F., Dunham, S., & McGrath, S. (2002). Arsenic hyperaccumulation by different 





Zhu, F., Qin, C., Tao, L., Liu, X., Shi, Z., Ma, X., Jia, J., Tan, Y., Cui, C., Lin, J., Tan, 
C., Jiang, Y., & Chen, Y. (2011). Clustered patterns of species origins of nature-
derived drugs and clues for future bioprospecting. Proceedings of the National 





























The following Appendices are given on the CD attached at the end of this thesis: 
 
Appendix 2.1  
Summary of fern families and genera based on Christenhusz et al. (2011) with changes 
based on recent studies (Christenhusz & Schneider, 2011; Rothfels et al., 2012b; Liu et 
al., 2013). Taxonomic changes at generic level since 2011 are listed in Appendix 2.2. 
The two new families since 2011 are Hemidictyaceae (1 genus; 1 species (Christenhusz 
& Schneider, 2011)) and Arthropteridaceae  (1 genus, 15 species (Liu et al., 2013)). 
 
Appendix 2.2  
Taxonomic sampling for fern phylogenic reconstruction for this this study. Species are 
arranged under families and genera recognized based on based on Christenhusz et al. 
(2011) with changes based on recent studies (Christenhusz & Schneider, 2011; Rothfels 
et al., 2012b; Liu et al., 2013). Blank cells referring to the sequence not available; an 
asterisk (*) indicates newly generated sequences. 
 
Appendix 2.3  
Summary of changes in generic level classification since Christenhusz et al. (2011) 
based on recent studies. 
 
Appendix 2.4  
DNA extraction procedure for silica-gel dried material. 
 
Dataset F1 
Concatenated supermatrix in Nexus-format. 
 
Dataset F2 
The ML tree with bootstrap support values in Nexus-format (file can be opened for 







Appendix  3.1  
Data set, describing all use reports and associated information including therapeutic 
application, plant part used, mode of preparation and application and vernacular name. 
 
Appendix  3.2  
List of species that are used medicinally with references citing biological or 
pharmacological activities and toxicological studies. 
 
Appendix  4.1 
 
List of species that were added manually as polytomies on the phylogeny. 
 
Appendix  4.2  
R script for species pruning in phylogeny. 
 
Appendix  4.3  
Phylogenetic structure of all taxonomic levels of medicinal use of ferns. 
 
Appendix 5.1 and Appendix 5.2 
List of species with assessments of the toxicity and carcinogenicity focusing on arsenic 
PTA and arsenic accumulation. 
 
Appendix 5.3 
Ancestral reconstruction for arsenic in Pteridaceae. 
 
 
